SPG Product Citations

Product Citations List

The QuidelOrtho Specialty Products Group (SPG) has a broad portfolio for Bone/Renal health and Autoimmune/Complement System products. Our selection of ELISA kits, antibodies, proteins, sera, and reagents have been featured in thousands of peer reviewed articles. Use the drop-down menus below to target a protein or product of interest to see how it has been successfully used by the scientific community.

Area

Protein

Product Type

Application

Species

Sample Type

Add New Citation

Catalog: Product Title: URL Link: Citation Title : Publication Year: Applications: Sample Species: Sample Details: Area: Protein: Product Type: Sample Type:

Edit Citation

Cat. #	Product Title	Title	Publication Year	Applications	Sample Species	Sample Details	Area	Protein	Product Type	Sample Type	Unique ID
A020	SC5b-9 Plus EIA	A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease	2024	ELISA	Human	FSGS, MCD	Complement System	sC5b-9	ELISA	Urine	item_377
A021	C5a EIA	A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease	2024	ELISA	Human	FSGS, MCD	Complement System	C5a	ELISA	Urine	item_435
A312	Factor H Antibody (polyclonal)	Anti-factor H autoantibodies in patients with lupus nephritis	2024	WB	Human	Lupus nephritis	Complement	Factor H	Antibody	Plasma	A312-Factor H Antibody (polyclonal)-https://pubmed.ncbi.nlm.nih.gov/39003116/
A600	CVF, Cobra Venom Factor	Antibodies and complement are key drivers of thrombosis	2024	Complement depletion assay	Mouse	Venous thromboembolism	Complement	Cobra Venom Factor	Reagent	Protein Injection	A600-CVF, Cobra Venom Factor-https://pubmed.ncbi.nlm.nih.gov/39226900/
A917	Complement Multiplex - Panel 2 - Focused	Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis	2024	Multiplex	Human	Multiple Sclerosis	Complement	Complement Multiplex	Multiplex	Serum	A917-Complement Multiplex - Panel 2 - Focused-https://pubmed.ncbi.nlm.nih.gov/38912898/
A900	Complement Multiplex – Panel 1	Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis	2024	Multiplex	Human	Multiple Sclerosis	Complement	Complement Multiplex	Multiplex	Serum	A900-Complement Multiplex – Panel 1-https://pubmed.ncbi.nlm.nih.gov/38912898/
60-6100	Human FGF-23 C-Term ELISA	Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease	2024	ELISA	Human	Chronic Kidney Disease	Bone/Renal Health	FGF-23	ELISA	Plasma	60-6100-Human FGF-23 C-Term ELISA-https://pubmed.ncbi.nlm.nih.gov/38999530/
60-6100	Human FGF-23 C-Term ELISA	Blood concentrations of α-Klotho and FGF-23 exhibit no correlation with bone mineral density in elderly individuals	2024	ELISA	Human		Bone/Renal	FGF-23	ELISA	Serum	60-6100-Human FGF-23 C-Term ELISA-https://pubmed.ncbi.nlm.nih.gov/39319957/
60-6600	Human FGF-23 (Intact) ELISA	Both enantiomers of β-aminoisobutyric acid BAIBA regulate Fgf23 via MRGPRD receptor by activating distinct signaling pathways in osteocytes	2024	ELISA	Human		Bone/Renal	FGF-23	ELISA	Plasma	60-6600-Human FGF-23 (Intact) ELISA-https://pubmed.ncbi.nlm.nih.gov/38935499/
A403	C5 Protein	C5a-C5AR1 axis as a potential trigger of the rupture of intracranial aneurysms	2024	Complement Digestion Assay	Purified Protein	Aneurysm	Complement	C5	Protein	Purified Protein	A403-C5 Protein-https://pubmed.ncbi.nlm.nih.gov/38326494/
A403	C5 Protein	C5a–C5AR1 axis as a potential trigger of the rupture of intracranial aneurysms	2024	Complement Digestion Assay	Purified Protein	Aneurysm	Complement System	C5	Protein	Purified Protein	item_1085
A215	C4BP Antibody (monoclonal)	Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus	2024	ELISA	Human	Systemic lupus erythematosus	Complement	C4BP	Antibody	Serum	A215-C4BP Antibody (monoclonal)-https://pubmed.ncbi.nlm.nih.gov/39165045/
60-6300	Mouse/Rat FGF-23 C-Term ELISA	Cognitive Impairment Related to Chronic Kidney Disease Is Associated with a Decreased Abundance of Membrane-Bound Klotho in the Cerebral Cortex	2024	ELISA	Rat	Chronic Kidney Disease	Bone/Renal	FGF-23	ELISA	Plasma	60-6300-Mouse/Rat FGF-23 C-Term ELISA-https://pubmed.ncbi.nlm.nih.gov/38673780/
A917	Complement Multiplex - Panel 2 - Focused	Complement Activation Is Associated With Disease Severity in Multiple Sclerosis	2024	ELISA	Human	Multiple Sclerosis	Complement System	Complement Multiplex	Multiplex	Plasma	A917-Complement Multiplex - Panel 2 - Focused-https://pubmed.ncbi.nlm.nih.gov/38354323/
A900	Complement Multiplex - 8-plex	Complement Activation Is Associated With Disease Severity in Multiple Sclerosis	2024	ELISA	Human	Multiple sclerosis	Complement System	Complement Multiplex	Multiplex	CSF	item_1232
A900	Complement Multiplex - 8-plex	Complement Activation Is Associated With Disease Severity in Multiple Sclerosis.	2024	ELISA	Human	Multiple Sclerosis	Complement System	Complement Multiplex	Multiplex	Plasma	item_1231
A917	Complement Multiplex - 4-plex	Complement Activation Is Associated With Disease Severity in Multiple Sclerosis.	2024	ELISA	Human	Multiple Sclerosis	Complement System	Complement Multiplex	Multiplex	CSF	item_1238
A020	SC5b-9 Plus EIA	Complement system is overactivated in patients with IgA nephropathy after COVID-19	2024	ELISA	Human	IgAN, COVID-19	Complement	sC5b-9	ELISA	Plasma	A020-SC5b-9 Plus EIA-https://pubmed.ncbi.nlm.nih.gov/38701960/
A021	C5a EIA	Complement system is overactivated in patients with IgA nephropathy after COVID-19	2024	ELISA	Human	IgAN, COVID-19	Complement	C5a	ELISA	Plasma	A021-C5a EIA-https://pubmed.ncbi.nlm.nih.gov/38701960/
21-6310	Mouse FGF-23 Ab (186-206)	Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy.	2024	WB	Mouse	Pressure-induced Cardiac Hypertrophy	Bone/Renal Health	FGF-23	Antibody	Heart Tissue	item_109
60-6300	Mouse/Rat FGF-23 C-Term ELISA	Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy.	2024	ELISA	Mouse	Pressure-induced Cardiac Hypertrophy	Bone/Renal Health	FGF-23	ELISA	Plasma	item_189
60-6800	Mouse/Rat FGF-23 (Intact) ELISA	Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy.	2024	ELISA	Mouse	Pressure-induced Cardiac Hypertrophy	Bone/Renal Health	FGF-23	ELISA	Plasma	item_210
A209	iC3b Antibody (Monoclonal - neoantigen)	Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort	2024	FC	Purified Protein		Complement	iC3b	Antibody	Recombinant Protein	A209-iC3b Antibody (Monoclonal - neoantigen)-https://pubmed.ncbi.nlm.nih.gov/38852887/
A020	SC5b-9 Plus EIA	Decrease in multiple complement proteins associated with development of islet autoimmunity and type 1 diabetes.	2024	ELISA	Human	Diabetes, Type 1	Complement System	sC5b-9	ELISA	Plasma	item_374
A027	Bb Plus Fragment EIA	Decrease in multiple complement proteins associated with development of islet autoimmunity and type 1 diabetes.	2024	ELISA	Human	Diabetes, Type 1	Complement System	Bb	ELISA	Plasma	item_480
A031	C3a Plus EIA	Decrease in multiple complement proteins associated with development of islet autoimmunity and type 1 diabetes.	2024	ELISA	Human	Diabetes, Type 1	Complement System	C3a	ELISA	Plasma	item_544
A020	SC5b-9 Plus EIA	Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 Glomerulopathy	2024	ELISA	Human	C3G	Complement System	sC5b-9	ELISA	Plasma	item_376
A020	SC5b-9 Plus EIA	Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder	2024	ELISA	Human	MOGAD, AQP4-NMOSD	Complement	sC5b-9	ELISA	Serum	A020-SC5b-9 Plus EIA-https://pubmed.ncbi.nlm.nih.gov/38576611/
A006	iC3b EIA	Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder	2024	ELISA	Human	MOGAD, AQP4-NMOSD	Complement	iC3b	ELISA	Serum	A006-iC3b EIA-https://pubmed.ncbi.nlm.nih.gov/38576611/
A001	CIC-C1q EIA	Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder	2024	ELISA	Human	MOGAD, AQP4-NMOSD	Complement	C1q	ELISA	Serum	A001-CIC-C1q EIA-https://pubmed.ncbi.nlm.nih.gov/38576611/
A037	C1-lnhibitor Plus EIA	Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder	2024	ELISA	Human	MOGAD, AQP4-NMOSD	Complement	C1-INH	ELISA	Serum	A037-C1-lnhibitor Plus EIA-https://pubmed.ncbi.nlm.nih.gov/38576611/
A311	Factor B Antibody (Polyclonal)	Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy	2024	WB	Mouse	C3G	Complement	Factor B	Antibody	Plasma	A311-Factor B Antibody (Polyclonal)-https://pubmed.ncbi.nlm.nih.gov/38368725/
A306	C5 Antibody (Polyclonal)	Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy	2024	WB	Mouse	C3G	Complement	C5	Antibody	Plasma	A306-C5 Antibody (Polyclonal)-https://pubmed.ncbi.nlm.nih.gov/38368725/
A306	C5 Antibody (polyclonal)	Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy	2024	WB	Mouse	C3G	Complement System	C5	Antibody	Plasma	item_946
A311	Factor B Antibody (polyclonal)	Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy	2024	WB	Mouse	C3G	Complement System	Factor B	Antibody	Plasma	item_987
A235	Factor P Antibody (monoclonal) #2	Escalated complement activation during hospitalization is associated with higher risk of 60-day mortality in SARS-CoV-2-infected patients	2024	ELISA	Human	COVID-19	Complement	Factor P	Antibody	Plasma	A235-Factor P Antibody (monoclonal) #2-https://pubmed.ncbi.nlm.nih.gov/38539241/
A235	Factor P Antibody (monoclonal) #2	Escalated complement activation during hospitalization is associated with higher risk of 60‐day mortality in SARS‐CoV‐2‐infected patients	2024	ELISA	Human	COVID-19	Complement System	Factor P	Antibody	Plasma	item_822
60-6100	Human FGF-23 C-Term ELISA	FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD: A Revisit With Mediation Analysis	2024	ELISA	Human	Chronic Kidney Disease	Bone/Renal Health	FGF-23	ELISA	Plasma	60-6100-Human FGF-23 C-Term ELISA-https://pubmed.ncbi.nlm.nih.gov/38939808/
60-6100	Human FGF-23 C-Term ELISA	Fibroblast growth factor 23-mediated regulation of osteoporosis: Assessed via Mendelian randomization and in vitro study	2024	ELISA	Human	Osteoporosis	Bone/Renal	FGF-23	ELISA	Serum	60-6100-Human FGF-23 C-Term ELISA-https://pubmed.ncbi.nlm.nih.gov/39054573/
A408	Factor B Protein	Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression	2024	Multiplex	Human	Renal Cancer	Complement System	Factor B	Protein	Plasma	item_1098
A410	Factor H Protein	Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression	2024	Multiplex	Human	Renal Cancer	Complement System	Factor H	Protein	Plasma	item_1106
A900	Complement Multiplex - 8-plex	Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression	2024	ELISA	Human	Renal Cancer	Complement System	Complement Multiplex	Multiplex	Plasma	item_1233
A916	Complement Multiplex - 7-plex	Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression	2024	ELISA	Human	Renal Cancer	Complement System	Complement Multiplex	Multiplex	Plasma	item_1237
A211	C4 (C4c) Antibody (monoclonal)	Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer's Disease Patients	2024	ELISA	Human	Alzheimer's Disease	Complement System	C4c	Antibody	CSF	A211-C4 (C4c) Antibody (monoclonal)-https://pubmed.ncbi.nlm.nih.gov/39213066/
A600	CVF, Cobra Venom Factor	Increased Complement Activation and Decreased ADAMTS13 Activity Are Associated with Genetic Susceptibility in Patients with Preeclampsia/HELLP Syndrome Compared to Healthy Pregnancies: An Observational Case-Controlled Study	2024	Complement depletion assay	Human	COVID-19	Complement	Cobra Venom Factor	Reagent	Serum	A600-CVF, Cobra Venom Factor-https://pubmed.ncbi.nlm.nih.gov/38673014/
A020	SC5b-9 Plus EIA	Increased Complement Activation and Decreased ADAMTS13 Activity Are Associated with Genetic Susceptibility in Patients with Preeclampsia/HELLP Syndrome Compared to Healthy Pregnancies: An Observational Case-Controlled Study	2024	ELISA	Human	Preeclampsia, HELLP Syndrome	Complement	sC5b-9	ELISA	Serum	A020-SC5b-9 Plus EIA-https://pubmed.ncbi.nlm.nih.gov/38673014/
A209	iC3b Antibody (monoclonal - neoantigen)	Increased expression of complement C3c, iC3b and cells containing CD11b or CD14 in experimentally induced psoriatic lesion	2024	IHC	Human	Psoriasis	Complement System	iC3b	Antibody	Skin Tissue	item_730
A209	iC3b Antibody (monoclonal - neoantigen)	Increased expression of complement C3c, iC3b and cells containing CD11b or CD14 in experimentally induced psoriatic lesion	2024	ICC	Human	Psoriasis	Complement System	iC3b	Antibody	Keratinocytes	item_731
A209	iC3b Antibody (Monoclonal - neoantigen)	Increased expression of complement C3c, iC3b, and cells containing CD11b or CD14 in experimentally induced psoriatic lesion	2024	IHC	Human	Psoriasis	Complement System	iC3b	Antibody	Skin Tissue	A209-iC3b Antibody (Monoclonal - neoantigen)-https://pubmed.ncbi.nlm.nih.gov/38310540/
A100	Normal Human Serum Complement	Levels of complement factor H-related 4 protein do not influence susceptibility to age-related macular degeneration or its course of progression	2024	ELISA	Human	Age-Related Macular Degeneration	Complement System	Normal Human Serum	Reagent	Plasma, Serum	item_618
A254	Factor H Antibody (monoclonal) #2	Mechanisms by which Factor H protects Trypanosoma cruzi from the alternative pathway of complement	2024	FC	Parasite	Chagas disease	Complement System	Factor H	Antibody	Trypomastigotes, Epimastigotes	item_884
A402	C4 Protein	Microglial-derived C1q integrates into neuronal ribonucleoprotein complexes and impacts protein homeostasis in the aging brain	2024	Liquid-liquid phase separation assay	Human		Complement	C4	Protein	Purified Protein	A402-C4 Protein-https://pubmed.ncbi.nlm.nih.gov/38942014/
A401	C3 Protein	Microglial-derived C1q integrates into neuronal ribonucleoprotein complexes and impacts protein homeostasis in the aging brain	2024	Liquid-liquid phase separation assay	Human		Complement	C3	Protein	Purified Protein	A401-C3 Protein-https://pubmed.ncbi.nlm.nih.gov/38942014/
A400	C1q Protein	Microglial-derived C1q integrates into neuronal ribonucleoprotein complexes and impacts protein homeostasis in the aging brain	2024	Liquid-liquid phase separation assay	Human		Complement	C1q	Protein	Purified Protein	A400-C1q Protein-https://pubmed.ncbi.nlm.nih.gov/38942014/
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Multifunctional interaction of CihC/FbpC orthologs of relapsing fever spirochetes with host-derived proteins involved in adhesion, fibrinolysis, and complement evasion	2024	ELISA	Purified Protein	Relapsing fever	Complement	sC5b-9	Antibody	Recombinant protein	A239-sC5b-9 Antibody (monoclonal - neoantigen)-https://pubmed.ncbi.nlm.nih.gov/38726006/
60-6800	Mouse/Rat FGF-23 (Intact) ELISA	Organic phosphate but not inorganic phosphate regulates Fgf23 expression through MAPK and TGF-ꞵ signaling	2024	ELISA	Cell Culture		Bone/Renal	FGF-23	ELISA	MC3T3-E1 Cells	60-6800-Mouse/Rat FGF-23 (Intact) ELISA-https://pubmed.ncbi.nlm.nih.gov/38883842/
A018	CH50 Eq EIA	Persistent complement dysregulation with signs of thromboinflammation in active Long Covid	2024	ELISA	Human	COVID-19	Complement System	CH50	ELISA	Serum	item_281
A020	SC5b-9 Plus EIA	Persistent complement dysregulation with signs of thromboinflammation in active Long Covid	2024	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Serum	item_375
A033	Ba Fragment EIA	Persistent complement dysregulation with signs of thromboinflammation in active Long Covid	2024	ELISA	Human	COVID-19	Complement System	Ba	ELISA	Serum	item_578
A405	C7 Protein	Persistent complement dysregulation with signs of thromboinflammation in active Long Covid	2024	ELISA	Human	COVID-19	Complement System	C7	Protein	Serum	item_1092
60-2305	Mouse PTH (1-84) ELISA	Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid-Induced AKI	2024	ELISA	Mouse	Murine-Folic Acid-Induced Acute Kidney Injury	Bone/Renal Health	PTH	ELISA	Plasma	60-2305-Mouse PTH (1-84) ELISA-https://pubmed.ncbi.nlm.nih.gov/38189228/
60-6300	Mouse/Rat FGF-23 C-Term ELISA	Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid-Induced AKI	2024	ELISA	Mouse	Murine-Folic Acid-Induced Acute Kidney Injury	Bone/Renal Health	FGF-23	ELISA	Plasma	60-6300-Mouse/Rat FGF-23 C-Term ELISA-https://pubmed.ncbi.nlm.nih.gov/38189228/
60-6800	Mouse/Rat FGF-23 (Intact) ELISA	Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid-Induced AKI	2024	ELISA	Mouse	Murine-Folic Acid-Induced Acute Kidney Injury	Bone/Renal Health	FGF-23	ELISA	Plasma	60-6800-Mouse/Rat FGF-23 (Intact) ELISA-https://pubmed.ncbi.nlm.nih.gov/38189228/
60-2305	Mouse PTH 1-84 ELISA	Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid–Induced AKI	2024	ELISA	Mouse	Murine-Folic Acid-Induced Acute Kidney Injury	Bone/Renal Health	PTH	ELISA	Plasma	item_128
60-6300	Mouse/Rat FGF-23 C-Term ELISA	Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid–Induced AKI	2024	ELISA	Mouse	Murine-Folic Acid-Induced Acute Kidney Injury	Bone/Renal Health	FGF-23	ELISA	Plasma	item_190
60-6800	Mouse/Rat FGF-23 (Intact) ELISA	Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid–Induced AKI	2024	ELISA	Mouse	Murine-Folic Acid-Induced Acute Kidney Injury	Bone/Renal Health	FGF-23	ELISA	Plasma	item_211
A917	Complement Multiplex - Panel 2 - Focused	PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration	2024	ELISA	Cell Culture	Age-Related Macular Degeneration	Complement	Complement Multiplex	Multiplex	THP-1 Cells	A917-Complement Multiplex - Panel 2 - Focused-https://pubmed.ncbi.nlm.nih.gov/38675477/
A900	Complement Multiplex – Panel 1	PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration	2024	ELISA	Cell Culture	Age-Related Macular Degeneration	Complement	Complement Multiplex	Multiplex	THP-1 Cells	A900-Complement Multiplex – Panel 1-https://pubmed.ncbi.nlm.nih.gov/38675477/
60-3100	Human PTH ELISA	Prostaglandin E2 signaling through prostaglandin E receptor subtype 2 and Nurr1 induces fibroblast growth factor 23 production	2024	ELISA	Human		Bone/Renal	PTH	ELISA	Serum	60-3100-Human PTH ELISA-https://pubmed.ncbi.nlm.nih.gov/39332190/
60-6300	Mouse/Rat FGF-23 C-Term ELISA	Prostaglandin E2 signaling through prostaglandin E receptor subtype 2 and Nurr1 induces fibroblast growth factor 23 production	2024	ELISA	Cell Culture		Bone/Renal	FGF-23	ELISA	UMR-106 Cells	60-6300-Mouse/Rat FGF-23 C-Term ELISA-https://pubmed.ncbi.nlm.nih.gov/39332190/
60-6100	Human FGF-23 C-Term ELISA	Prostaglandin E2 signaling through prostaglandin E receptor subtype 2 and Nurr1 induces fibroblast growth factor 23 production	2024	ELISA	Human		Bone/Renal	FGF-23	ELISA	Serum	60-6100-Human FGF-23 C-Term ELISA-https://pubmed.ncbi.nlm.nih.gov/39332190/
60-6600	Human FGF-23 (Intact) ELISA	Prostaglandin E2 signaling through prostaglandin E receptor subtype 2 and Nurr1 induces fibroblast growth factor 23 production	2024	ELISA	Human		Bone/Renal	FGF-23	ELISA	Serum	60-6600-Human FGF-23 (Intact) ELISA-https://pubmed.ncbi.nlm.nih.gov/39332190/
60-6600	Human FGF-23 (Intact) ELISA	Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity	2024	ELISA	Human	Metabolic bone disease of prematurity	Bone/Renal	FGF-23	ELISA	Plasma	60-6600-Human FGF-23 (Intact) ELISA-https://pubmed.ncbi.nlm.nih.gov/38951759/
8012	BAP EIA	Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity	2024	ELISA	Human	Metabolic bone disease of prematurity	Bone/Renal	BAP	ELISA	Serum	8012-BAP EIA-https://pubmed.ncbi.nlm.nih.gov/38951759/
A700	C1q Antibody (monoclonal) biotin	Sex- and species-associated differences in complement-mediated immunity in humans and rhesus macaques	2024	Multiplex	Human, rhesus macaque		Complement System	C1q	Antibody	Serum	item_1204
A312	Factor H Antibody (polyclonal)	Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators	2024	ELISA	Purified Protein		Complement	Factor H	Antibody	Bispecific antibody	A312-Factor H Antibody (polyclonal)-https://pubmed.ncbi.nlm.nih.gov/38817607/
8012	BAP EIA	The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD - the exploratory randomized controlled double-blind ExplorIRON-CKD study	2024	ELISA	Human	Chronic Kidney Disease	Bone/Renal Health	BAP	ELISA	Serum	8012-BAP EIA-https://pubmed.ncbi.nlm.nih.gov/38347520/
8012	BAP EIA	The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD – the exploratory randomized controlled double-blind ExplorIRON-CKD study	2024	ELISA	Human	CKD	Bone/Renal Health	BAP	ELISA	Serum	item_71
A250	C3d Antibody (monoclonal - neoantigen)	The inhibition of several components of terminal complement pathway results in C3 binding to PNH red blood cells	2024	FC	Human	PNH	Complement System	C3d	Antibody	Red Blood Cells	item_866
A501	C5 Depleted Sera	The inhibition of several components of terminal complement pathway results in C3 binding to PNH red blood cells	2024	Complement Activation Assay	Human	PNH	Complement System	C5	Depleted Sera	Red Blood Cells	item_1127
A502	C6 Depleted Sera	The inhibition of several components of terminal complement pathway results in C3 binding to PNH red blood cells	2024	Complement Activation Assay	Human	PNH	Complement System	C6	Depleted Sera	Red Blood Cells	item_1134
A505	C9 Depleted Sera	The inhibition of several components of terminal complement pathway results in C3 binding to PNH red blood cells	2024	Complement Activation Assay	Human	PNH	Complement System	C9	Depleted Sera	Red Blood Cells	item_1142
A251	C4d Antibody (monoclonal - neoantigen)	The spectrum of thrombotic microangiopathy related to monoclonal gammopathy	2024	IHC	Cell Culture	Thrombotic microangiopathy, monoclonal gammopathy	Complement System	C4d	Antibody	HMEC-1	item_868
A600	CVF, Cobra Venom Factor	Treatment with Cobra Venom Factor Decreases Ischemic Tissue Damage in Mice	2024	Complement depletion assay	Mouse	Tissue ischemia	Complement System	Cobra Venom Factor	Reagent	Serum	item_1197
A702	C3d Antibody (monoclonal) biotin	Triple-fusion protein (TriFu): A potent, targeted, enzyme-like inhibitor of all three complement activation pathways	2024	FC	Cell Culture		Complement	C3d	Antibody	HMEC-1 Cells	A702-C3d Antibody (monoclonal) biotin-https://pubmed.ncbi.nlm.nih.gov/38401844/
A702	C3d Antibody (monoclonal) biotin	Triple-fusion protein (TriFu): A potent, targeted, enzyme-like inhibitor of all three complement activation pathways	2024	FC	Cell culture		Complement System	C3d	Antibody	HMEC-1	item_1207
A312	Factor H Antibody (polyclonal)	Truncated Complement Factor H Y402 Gene Therapy Cures C3 Glomerulonephritis	2024	WB	Mouse	C3 glomerulonephritis	Complement	Factor H	Antibody	Plasma	A312-Factor H Antibody (polyclonal)-https://pubmed.ncbi.nlm.nih.gov/39345485/
A211	C4 (C4c) Antibody (monoclonal)	Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease mouse models.	2023	ELISA	Human	Alzheimer's Disease	Complement System	C4c	Antibody	CSF	item_738
A252	Bb Antibody (monoclonal - neoantigen)	Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease mouse models.	2023	ELISA	Human	Alzheimer's Disease	Complement System	Bb	Antibody	CSF	item_873
A021	C5a EIA	Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity.	2023	ELISA	Human	Sepsis	Complement System	C5a	ELISA	Plasma	item_411
A900	Complement Multiplex - 8-plex	Complement activation profiles in anti-acetylcholine receptor positive myasthenia gravis.	2023	ELISA	Human	Myasthenia gravis	Complement System	Complement Multiplex	Multiplex	Plasma	item_1228
A020	SC5b-9 Plus EIA	Decrease in multiple complement protein levels is associated with the development of islet autoimmunity and type 1 diabetes.	2023	ELISA	Human	Diabetes	Complement System	sC5b-9	ELISA	Plasma	item_372
A027	Bb Plus Fragment EIA	Decrease in multiple complement protein levels is associated with the development of islet autoimmunity and type 1 diabetes.	2023	ELISA	Human	Diabetes	Complement System	Bb	ELISA	Plasma	item_479
A031	C3a Plus EIA	Decrease in multiple complement protein levels is associated with the development of islet autoimmunity and type 1 diabetes.	2023	ELISA	Human	Diabetes	Complement System	C3a	ELISA	Plasma	item_543
A209	iC3b Antibody (monoclonal - neoantigen)	Efficient complement-mediated clearance of immunosuppressed T cells by macrophages.	2023	IF	Human	Immunosuppressed	Complement System	iC3b	Antibody	T Cells	item_729
A255	Factor H Antibody (monoclonal) #3	Plasmodium falciparum Gametes and Sporozoites Hijack Plasmin and Factor H To Evade Host Complement Killing.	2023	IF	Plasmodium falciparum	Plasmodium falciparum	Complement System	Factor H	Antibody	Cell Culture	item_888
A410	Factor H Protein	Plasmodium falciparum Gametes and Sporozoites Hijack Plasmin and Factor H To Evade Host Complement Killing.	2023	WB	Plasmodium falciparum	Plasmodium falciparum	Complement System	Factor H	Protein	Cell Culture	item_1110
A031	C3a Plus EIA	Reduced binding of apoE4 to complement factor H promotes amyloid-β oligomerization and neuroinflammation.	2023	ELISA	Human	Latex beads with poE2, apoE3, or apoE4	Complement System	C3a	ELISA	Supernatent	item_542
A020	SC5b-9 Plus EIA	Serum and plasma levels of Ba, but not those of soluble C5b-9, might be affected by renal function in chronic kidney disease patients.	2023	ELISA	Human	Glomerulonephritis	Complement System	sC5b-9	ELISA	Plasma, Serum	item_338
A021	C5a EIA	Serum and plasma levels of Ba, but not those of soluble C5b-9, might be affected by renal function in chronic kidney disease patients.	2023	ELISA	Human	Glomerulonephritis	Complement System	C5a	ELISA	Plasma, Serum	item_410
A033	Ba Fragment EIA	Serum and plasma levels of Ba, but not those of soluble C5b-9, might be affected by renal function in chronic kidney disease patients.	2023	ELISA	Human	Glomerulonephritis	Complement System	Ba	ELISA	Plasma, Serum	item_571
A900	Complement Multiplex - 8-plex	Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies.	2023	ELISA	Human	Thrombotic Microangiopathy	Complement System	Complement Multiplex	Multiplex	Plasma, Serum	item_1229
A900	Complement Multiplex - 8-plex	Usefulness and analytical performances of complement multiplex assay for measuring complement biomarkers in plasma.	2023	ELISA	Human		Complement System	Complement Multiplex	Multiplex	Plasma	item_1230
A916	Complement Multiplex - 7-plex	Usefulness and analytical performances of complement multiplex assay for measuring complement biomarkers in plasma.	2023	ELISA	Human		Complement System	Complement Multiplex	Multiplex	Plasma	item_1236
A255	Factor H Antibody (monoclonal) #3	A proteogenomic signature of age-related macular degeneration in blood	2022	ELISA	Human	Age Related Macular Degeneration	Complement System	Factor H	Antibody	Plasma	item_886
A219	C6 Antibody (monoclonal)	A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor	2022	ELISA	Porcine	COVID-19	Complement System	C6	Antibody	Plasma	item_779
A031	C3a Plus EIA	A randomized diet-induced weight-loss intervention reduces plasma complement C3: Possible implication for endothelial dysfunction.	2022	ELISA	Human	Obesity	Complement System	C3a	ELISA	Plasma	item_516
A033	Ba Fragment EIA	Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy.	2022	ELISA	Human	IgA Nephropathy	Complement System	Ba	ELISA	Plasma	item_570
A020	SC5b-9 Plus EIA	Bothrops jararaca Snake Venom Inflammation Induced in Human Whole Blood: Role of the Complement System.	2022	ELISA	Human	B. jararaca venom	Complement System	sC5b-9	ELISA	Whole Blood	item_330
A020	SC5b-9 Plus EIA	C3a and C5b-9 Differentially Predict COVID-19 Progression and Outcome.	2022	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Plasma	item_337
A031	C3a Plus EIA	C3a and C5b-9 Differentially Predict COVID-19 Progression and Outcome.	2022	ELISA	Human	COVID-19	Complement System	C3a	ELISA	Plasma	item_517
A020	SC5b-9 Plus EIA	C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19.	2022	ELISA	Human	aHUS	Complement System	sC5b-9	ELISA	Plasma	item_319
A020	SC5b-9 Plus EIA	C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19.	2022	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Plasma	item_320
A021	C5a EIA	C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19.	2022	ELISA	Human	aHUS	Complement System	C5a	ELISA	Plasma	item_399
A021	C5a EIA	C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19.	2022	ELISA	Human	COVID-19	Complement System	C5a	ELISA	Plasma	item_400
A021	C5a EIA	CipA mediates complement resistance of Acinetobacter baumannii by formation of a factor I-dependent quadripartite assemblage.	2022	ELISA	Human	CipA	Complement System	C5a	ELISA	Serum	item_409
A239	sC5b-9 Antibody (monoclonal - neoantigen)	CipA mediates complement resistance of Acinetobacter baumannii by formation of a factor I-dependent quadripartite assemblage.	2022	ELISA	Human	CipA	Complement System	sC5b-9	Antibody	Serum	item_836
A311	Factor B Antibody (polyclonal)	CipA mediates complement resistance of Acinetobacter baumannii by formation of a factor I-dependent quadripartite assemblage.	2022	WB	Bacteria		Complement System	Factor B	Antibody	A. baumannii	item_971
A313	Factor I Antibody (polyclonal)	CipA mediates complement resistance of Acinetobacter baumannii by formation of a factor I-dependent quadripartite assemblage.	2022	WB	Bacteria		Complement System	Factor I	Antibody	A. baumannii	item_1020
A020	SC5b-9 Plus EIA	Circulating immune-complexes and complement activation through the classical pathway in myeloperoxidase-ANCA-associated glomerulonephritis.	2022	ELISA	Human	Myeloperoxidase-ANCA-associated glomerulonephritis	Complement System	sC5b-9	ELISA	Serum	item_327
A021	C5a EIA	Circulating immune-complexes and complement activation through the classical pathway in myeloperoxidase-ANCA-associated glomerulonephritis.	2022	ELISA	Human	Myeloperoxidase-ANCA-associated glomerulonephritis	Complement System	C5a	ELISA	Serum	item_406
A252	Bb Antibody (monoclonal - neoantigen)	Circulating immune-complexes and complement activation through the classical pathway in myeloperoxidase-ANCA-associated glomerulonephritis.	2022	IHC	Human	Myeloperoxidase-ANCA-associated glomerulonephritis	Complement System	Bb	Antibody	Kidney Tissue	item_874
A020	SC5b-9 Plus EIA	Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis.	2022	ELISA	Human	AAV, FSGS, IgAN, MN, and LN	Complement System	sC5b-9	ELISA	Urine	item_328
A021	C5a EIA	Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis.	2022	ELISA	Human	AAV, FSGS, IgAN, MN, and LN	Complement System	C5a	ELISA	Urine	item_407
A027	Bb Plus Fragment EIA	Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis.	2022	ELISA	Human	AAV, FSGS, IgAN, MN, and LN	Complement System	Bb	ELISA	Urine	item_451
A031	C3a Plus EIA	Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis.	2022	ELISA	Human	AAV, FSGS, IgAN, MN, and LN	Complement System	C3a	ELISA	Urine	item_511
A033	Ba Fragment EIA	Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis.	2022	ELISA	Human	AAV, FSGS, IgAN, MN, and LN	Complement System	Ba	ELISA	Urine	item_568
A035	C4a Fragment EIA	Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis.	2022	ELISA	Human	AAV, FSGS, IgAN, MN, and LN	Complement System	C4a	ELISA	Urine	item_590
A020	SC5b-9 Plus EIA	Complement Activation in Patients With Heat-Related Illnesses: Soluble CD59 Is a Novel Biomarker Indicating Severity of Heat-Related Illnesses.	2022	ELISA	Human	Heat-related illnesses	Complement System	sC5b-9	ELISA	Plasma	item_326
A021	C5a EIA	Complement Activation in Patients With Heat-Related Illnesses: Soluble CD59 Is a Novel Biomarker Indicating Severity of Heat-Related Illnesses.	2022	ELISA	Human	Heat-related illnesses	Complement System	C5a	ELISA	Plasma	item_405
A031	C3a Plus EIA	Complement Activation in Patients With Heat-Related Illnesses: Soluble CD59 Is a Novel Biomarker Indicating Severity of Heat-Related Illnesses.	2022	ELISA	Human	Heat-related illnesses	Complement System	C3a	ELISA	Plasma	item_510
A033	Ba Fragment EIA	Complement Activation in Patients With Heat-Related Illnesses: Soluble CD59 Is a Novel Biomarker Indicating Severity of Heat-Related Illnesses.	2022	ELISA	Human	Heat-related illnesses	Complement System	Ba	ELISA	Plasma	item_566
A039	Factor H EIA	Complement Activation in Patients With Heat-Related Illnesses: Soluble CD59 Is a Novel Biomarker Indicating Severity of Heat-Related Illnesses.	2022	ELISA	Human	Heat-related illnesses	Complement System	Factor H	ELISA	Plasma	item_616
A018	CH50 Eq EIA	Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study.	2022	ELISA	Human	COVID-19	Complement System	CH50	ELISA	Serum	item_272
A020	SC5b-9 Plus EIA	Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study.	2022	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Plasma	item_329
A031	C3a Plus EIA	Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study.	2022	ELISA	Human	COVID-19	Complement System	C3a	ELISA	Plasma	item_512
A020	SC5b-9 Plus EIA	Complement activation during cardiopulmonary bypass and association with clinical outcomes.	2022	ELISA	Human	Cardiopulmonary bypass	Complement System	sC5b-9	ELISA	Plasma	item_335
A027	Bb Plus Fragment EIA	Complement activation during cardiopulmonary bypass and association with clinical outcomes.	2022	ELISA	Human	Cardiopulmonary bypass	Complement System	Bb	ELISA	Plasma	item_452
A401	C3 Protein	Complement component 3 protects human bronchial epithelial cells from cigarette smoke-induced oxidative stress and prevents incessant apoptosis.	2022	Complement Activation Assay	Human	Cigarette smoke-induced oxidative stress	Complement System	C3	Protein	HBE Cells	item_1056
A311	Factor B Antibody (polyclonal)	Complement factor B is critical for sub-RPE deposit accumulation in a model of Doyne honeycomb retinal dystrophy with features of age-related macular degeneration.	2022	WB	Mouse		Complement System	Factor B	Antibody	Eye Tissue	item_984
60-3000	Human PTH ELISA 1 84 Bioactive	Density-Dependent Differentiation of Tonsil-Derived Mesenchymal Stem Cells into Parathyroid-Hormone-Releasing Cells	2022	ELISA	Cell Culture		Bone/Renal Health	PTH	ELISA	T-MSC	item_139
A302	C1s Antibody (polyclonal)	Distinct Roles of Classical and Lectin Pathways of Complement in Preeclamptic Placentae.	2022	IHC	Human		Complement System	C1s	Antibody	Placenta Tissue	item_911
A020	SC5b-9 Plus EIA	Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients.	2022	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Plasma	item_333
A020	SC5b-9 Plus EIA	Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.	2022	ELISA	Human	Thrombotic Microangiopathy - DI	Complement System	sC5b-9	ELISA	Plasma	item_331
A020	SC5b-9 Plus EIA	Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.	2022	ELISA	Human	Thrombotic Microangiopathy - DI	Complement System	sC5b-9	ELISA	Plasma	item_332
A020	SC5b-9 Plus EIA	High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets.	2022	ELISA	Human	Antiphospholipid syndrome	Complement System	sC5b-9	ELISA	Plasma	item_324
A021	C5a EIA	High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets.	2022	ELISA	Human	Antiphospholipid syndrome	Complement System	C5a	ELISA	Plasma	item_404
A018	CH50 Eq EIA	In Vitro Studies Regarding the Safety of Chitosan and Hyaluronic Acid-Based Nanohydrogels Containing Contrast Agents for Magnetic Resonance Imaging.	2022	ELISA	Human	Chitosan and Hyaluronic Acid-Based Nanohydrogels	Complement System	CH50	ELISA	Serum	item_271
A020	SC5b-9 Plus EIA	Indices of complement activation and coagulation changes in trauma patients	2022	ELISA	Human	Trauma	Complement System	sC5b-9	ELISA	Plasma	item_336
A027	Bb Plus Fragment EIA	Indices of complement activation and coagulation changes in trauma patients	2022	ELISA	Human	Trauma	Complement System	Bb	ELISA	Plasma	item_453
A033	Ba Fragment EIA	Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies.	2022	ELISA	Human		Complement System	Ba	ELISA	Complement Proteins	item_567
A020	SC5b-9 Plus EIA	Mechanism of Borrelia immune evasion by FhbA-related proteins	2022	ELISA	Human	Borrelia hermsii	Complement System	sC5b-9	ELISA	Plasma	item_325
A205	C3 (C3c) Antibody (monoclonal)	Mechanism of Borrelia immune evasion by FhbA-related proteins	2022	WB	Bacteria		Complement System	C3c	Antibody	Borrelia hermsii	item_682
A312	Factor H Antibody (polyclonal)	Mechanism of Borrelia immune evasion by FhbA-related proteins	2022	WB	Bacteria		Complement System	Factor H	Antibody	Borrelia hermsii	item_990
A009	C4d Fragment EIA	Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.	2022	ELISA	Human	COVID-19	Complement System	C4d	ELISA	Plasma	item_247
A009	C4d Fragment EIA	Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.	2022	ELISA	Human	COVID-19	Complement System	C4d	ELISA	Serum	item_248
A020	SC5b-9 Plus EIA	Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.	2022	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Plasma	item_322
A020	SC5b-9 Plus EIA	Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.	2022	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Serum	item_323
A021	C5a EIA	Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.	2022	ELISA	Human	COVID-19	Complement System	C5a	ELISA	Plasma	item_402
A021	C5a EIA	Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.	2022	ELISA	Human	COVID-19	Complement System	C5a	ELISA	Serum	item_403
A027	Bb Plus Fragment EIA	Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.	2022	ELISA	Human	COVID-19	Complement System	Bb	ELISA	Plasma	item_449
A027	Bb Plus Fragment EIA	Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.	2022	ELISA	Human	COVID-19	Complement System	Bb	ELISA	Serum	item_450
A033	Ba Fragment EIA	Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.	2022	ELISA	Human	COVID-19	Complement System	Ba	ELISA	Plasma	item_564
A033	Ba Fragment EIA	Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.	2022	ELISA	Human	COVID-19	Complement System	Ba	ELISA	Serum	item_565
A020	SC5b-9 Plus EIA	Plasma C4 level was associated with mortality, cardiovascular and cerebrovascular complications in hemodialysis patients.	2022	ELISA	Human	Hemodialysis	Complement System	sC5b-9	ELISA	Plasma	item_334
A021	C5a EIA	Plasma C4 level was associated with mortality, cardiovascular and cerebrovascular complications in hemodialysis patients.	2022	ELISA	Human	Hemodialysis	Complement System	C5a	ELISA	Plasma	item_408
A031	C3a Plus EIA	Plasma C4 level was associated with mortality, cardiovascular and cerebrovascular complications in hemodialysis patients.	2022	ELISA	Human	Hemodialysis	Complement System	C3a	ELISA	Plasma	item_515
A209	iC3b Antibody (monoclonal - neoantigen)	Sequential Increase in Complement Factor I, iC3b, and Cells Expressing CD11b or CD14 in Cutaneous Vasculitis.	2022	IHC	Human	Cutaneous Vasculitis	Complement System	iC3b	Antibody	Skin Tissue	item_722
A031	C3a Plus EIA	Sex and Age-Related Differences in Complement Factors Among Patients With Intermediate Age-Related Macular Degeneration.	2022	ELISA	Human	Age-Related Macular Degeneration	Complement System	C3a	ELISA	Plasma	item_513
A033	Ba Fragment EIA	Sex and Age-Related Differences in Complement Factors Among Patients With Intermediate Age-Related Macular Degeneration.	2022	ELISA	Human	Age-Related Macular Degeneration	Complement System	Ba	ELISA	Plasma	item_569
A219	C6 Antibody (monoclonal)	Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5.	2022	ELISA	Human	Escherichia coli	Complement System	C6	Antibody	Serum	item_776
A600	CVF, Cobra Venom Factor	Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5.	2022	Complement Depletion Assay	Human		Complement System	Cobra Venom Factor	Reagent	Serum	item_1181
A301	C1q Antibody (polyclonal)	The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy.	2022	ELISA	Human		Complement System	C1q	Antibody	Serum	item_897
A311	Factor B Antibody (polyclonal)	The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy.	2022	ELISA	Human		Complement System	Factor B	Antibody	Serum	item_973
A031	C3a Plus EIA	The Role of Complement in Microangiopathic Lesions of IgA Nephropathy.	2022	ELISA	Human	IgA Nephropathy	Complement System	C3a	ELISA	Serum	item_514
A305	C4 Antibody (polyclonal)	Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation.	2022	IF	Human	Lupus Nephritis	Complement System	C4	Antibody	Kidney Tissue	item_931
A219	C6 Antibody (monoclonal)	Venous Air Embolism Activates Complement C3 Without Corresponding C5 Activation and Trigger Thromboinflammation in Pigs	2022	ELISA	Porcine	Air embolism	Complement System	C6	Antibody	Plasma	item_778
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney.	2022	ELISA	Human	Antibody Mediated Rejection	Complement System	sC5b-9	Antibody	Plasma	item_835
A306	C5 Antibody (polyclonal)	Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney.	2022	IHC	Human	Antibody Mediated Rejection	Complement System	C5	Antibody	Kidney Tissue	item_941
A403	C5 Protein	A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin Activity.	2021	WB	Human		Complement System	C5	Protein	Purified protein	item_1083
A600	CVF, Cobra Venom Factor	A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin Activity.	2021	WB	Human		Complement System	Cobra Venom Factor	Reagent	Purified protein	item_1184
A901	Complement Multiplex - 5-plex	A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.	2021	ELISA	Human	COVID-19	Complement System	Complement Multiplex	Multiplex	Plasma	item_1235
A009	C4d Fragment EIA	Air Bubbles Activate Complement and Trigger Hemostasis and C3-Dependent Cytokine Release Ex Vivo in Human Whole Blood.	2021	ELISA	Human		Complement System	C4d	ELISA	Plasma	item_246
A031	C3a Plus EIA	Air Bubbles Activate Complement and Trigger Hemostasis and C3-Dependent Cytokine Release Ex Vivo in Human Whole Blood.	2021	ELISA	Human		Complement System	C3a	ELISA	Plasma	item_509
A035	C4a Fragment EIA	Air Bubbles Activate Complement and Trigger Hemostasis and C3-Dependent Cytokine Release Ex Vivo in Human Whole Blood.	2021	ELISA	Human		Complement System	C4a	ELISA	Plasma	item_589
A033	Ba Fragment EIA	Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA 1 Antibody in IgA Nephropathy Patients	2021	ELISA	Human	IgA Nephropathy	Complement System	Ba	ELISA	Plasma	item_561
A111	Normal Human Serum Complement	Analytical Similarity Assessment of ABP 959 in Comparison with Eculizumab Reference Product.	2021	ELISA	Human		Complement System	Normal Human Serum	Reagent	Serum	item_646
A020	SC5b-9 Plus EIA	CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis	2021	ELISA	Human	MPGN	Complement System	sC5b-9	ELISA	Plasma	item_307
A229	Factor H Antibody (monoclonal)	Clinicopathologic Implications of Complement Genetic Variants in Kidney Transplantation.	2021	ELISA	Human	Factor H WT and Variants	Complement System	Factor H	Antibody	Protein	item_801
A254	Factor H Antibody (monoclonal) #2	Clinicopathologic Implications of Complement Genetic Variants in Kidney Transplantation.	2021	ELISA	Human	Factor H WT and Variants	Complement System	Factor H	Antibody	Protein	item_880
A312	Factor H Antibody (polyclonal)	Clinicopathologic Implications of Complement Genetic Variants in Kidney Transplantation.	2021	ELISA	Human	Factor H WT and Variants	Complement System	Factor H	Antibody	Protein	item_997
A312	Factor H Antibody (polyclonal)	Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration.	2021	ELISA	Human	Age-Related Macular Degeneration	Complement System	Factor H	Antibody	Serum	item_995
A900	Complement Multiplex - 8-plex	Complement Activation Is a Prominent Feature of MOGAD.	2021	ELISA	Human	MOGAD	Complement System	Complement Multiplex	Multiplex	Serum	item_1227
A241	Clusterin Antibody (monoclonal)	Complement Inhibitors Vitronectin and Clusterin Are Recruited from Human Serum to the Surface of Coronavirus OC43-Infected Lung Cells through Antibody-Dependent Mechanisms	2021	FC	Cell Culture	Coronaviruses	Complement System	Clusterin	Antibody	Cell Culture	item_854
A201	C1q Antibody (monoclonal)	Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19.	2021	IF	Human	COVID-19	Complement System	C1q	Antibody	Kidney Tissue	item_673
A229	Factor H Antibody (monoclonal)	Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19.	2021	IF	Human	COVID-19	Complement System	Factor H	Antibody	Kidney Tissue	item_802
A027	Bb Plus Fragment EIA	Complement dysregulation is associated with severe COVID-19 illness.	2021	ELISA	Human	COVID-19	Complement System	Bb	ELISA	Serum	item_446
A018	CH50 Eq EIA	Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.	2021	ELISA	Human	COVID-19	Complement System	CH50	ELISA	Serum	item_270
A020	SC5b-9 Plus EIA	Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.	2021	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Serum	item_305
A021	C5a EIA	Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.	2021	ELISA	Human	COVID-19	Complement System	C5a	ELISA	Serum	item_391
A027	Bb Plus Fragment EIA	Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.	2021	ELISA	Human	COVID-19	Complement System	Bb	ELISA	Serum	item_443
A031	C3a Plus EIA	Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.	2021	ELISA	Human	COVID-19	Complement System	C3a	ELISA	Serum	item_502
A037	C1-lnhibitor Plus EIA	Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.	2021	ELISA	Human	COVID-19	Complement System	C1-INH	ELISA	Serum	item_603
A006	iC3b EIA	Complement receptor 3 mediates Aspergillus fumigatus internalization into alveolar epithelial cells with the increase of intracellular phosphatidic acid by activating FAK.	2021	ELISA	Human	Aspergillus incubated	Complement System	iC3b	ELISA	Serum	item_225
A209	iC3b Antibody (monoclonal - neoantigen)	Complement receptor 3 mediates Aspergillus fumigatus internalization into alveolar epithelial cells with the increase of intracellular phosphatidic acid by activating FAK.	2021	WB	Human	Aspergillus incubated	Complement System	iC3b	Antibody	Serum	item_728
A205	C3 (C3c) Antibody (monoclonal)	Complement-Mediated Selective Tumor Cell Lysis Enabled by Bi-Functional RNA Aptamers.	2021	IF	Cell Culture		Complement System	C3c	Antibody	MDA-MB-231 Cells	item_691
A401	C3 Protein	Complement-Mediated Selective Tumor Cell Lysis Enabled by Bi-Functional RNA Aptamers.	2021	Binding Assay	Cell Culture		Complement System	C3	Protein	MDA-MB-231 Cells	item_1055
A417	C3c Protein	Complement-Mediated Selective Tumor Cell Lysis Enabled by Bi-Functional RNA Aptamers.	2021	Binding Assay	Cell Culture		Complement System	C3c	Protein	MDA-MB-231 Cells	item_1118
A423	iC3b Protein	Complement-Mediated Selective Tumor Cell Lysis Enabled by Bi-Functional RNA Aptamers.	2021	Binding Assay	Cell Culture		Complement System	iC3b	Protein	MDA-MB-231 Cells	item_1119
A311	Factor B Antibody (polyclonal)	Cytokine and Complement Response in the Glaucomatous βB1-CTGF Mouse Model.	2021	IHC	Mouse		Complement System	Factor B	Antibody	Eye Tissue	item_981
A312	Factor H Antibody (polyclonal)	Defining the Glycosaminoglycan Interactions of Complement Factor H-Related Protein 5	2021	ELISA	Human		Complement System	Factor H	Antibody	Purified protein	item_994
A009	C4d Fragment EIA	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	ELISA	Human		Complement System	C4d	ELISA	Plasma	item_245
A020	SC5b-9 Plus EIA	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	ELISA	Human		Complement System	sC5b-9	ELISA	Plasma	item_311
A021	C5a EIA	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	ELISA	Human		Complement System	C5a	ELISA	Plasma	item_395
A027	Bb Plus Fragment EIA	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	ELISA	Human		Complement System	Bb	ELISA	Plasma	item_448
A031	C3a Plus EIA	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	ELISA	Human		Complement System	C3a	ELISA	Plasma	item_505
A400	C1q Protein	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	Protein Assay	Human		Complement System	C1q	Protein	Plasma	item_1043
A402	C4 Protein	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	ELISA	Human		Complement System	C4	Protein	Plasma	item_1072
A410	Factor H Protein	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	ELISA	Human		Complement System	Factor H	Protein	Plasma	item_1103
A411	Factor I Protein	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	ELISA	Human		Complement System	Factor I	Protein	Plasma	item_1111
A427	C2 Protein	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	ELISA	Human		Complement System	C2	Protein	Plasma	item_1123
A500	C2 Depleted Sera	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	ELISA	Human		Complement System	C2	Depleted Sera	Plasma	item_1124
A509	C1q Depleted Sera	Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.	2021	ELISA	Human		Complement System	C1q	Depleted Sera	Plasma	item_1163
A302	C1s Antibody (polyclonal)	Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.	2021	WB	Human, Mouse	C1q	Complement System	C1s	Antibody	Purified protein	item_914
A201	C1q Antibody (monoclonal)	Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration.	2021	ELISA	Human	Age-Related Macular Degeneration	Complement System	C1q	Antibody	Eye Tissue	item_659
A205	C3 (C3c) Antibody (monoclonal)	Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration.	2021	ELISA	Human	Age-Related Macular Degeneration	Complement System	C3c	Antibody	Eye Tissue	item_694
A254	Factor H Antibody (monoclonal) #2	Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration.	2021	ELISA	Human	Age-Related Macular Degeneration	Complement System	Factor H	Antibody	Eye Tissue	item_879
A301	C1q Antibody (polyclonal)	Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration.	2021	ELISA	Human	Age-Related Macular Degeneration	Complement System	C1q	Antibody	Eye Tissue	item_896
A020	SC5b-9 Plus EIA	Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy	2021	ELISA	Human	Thrombotic Microangiopathy - TA	Complement System	sC5b-9	ELISA	Plasma	item_310
A021	C5a EIA	Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy	2021	ELISA	Human	Thrombotic Microangiopathy - TA	Complement System	C5a	ELISA	Plasma	item_394
A033	Ba Fragment EIA	Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy	2021	ELISA	Human	Thrombotic Microangiopathy - TA	Complement System	Ba	ELISA	Plasma	item_562
A020	SC5b-9 Plus EIA	Eculizumab as a New Treatment for Severe Acute Post-infectious Glomerulonephritis: Two Case Reports.	2021	ELISA	Human	Glomerulonephritis	Complement System	sC5b-9	ELISA	Plasma	item_312
A020	SC5b-9 Plus EIA	Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study.	2021	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Plasma	item_321
A027	Bb Plus Fragment EIA	Elevated complement mediator levels in endothelial-derived plasma exosomes implicate endothelial innate inflammation in diminished brain function of aging humans.	2021	ELISA	Human		Complement System	Bb	ELISA	Plasma	item_447
A020	SC5b-9 Plus EIA	Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis.	2021	ELISA	Human	Supernatent	Complement System	sC5b-9	ELISA	Glomular Endothelial Cells	item_306
A225	Factor B (Ba) Antibody (monoclonal)	Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis.	2021	ELISA	Human		Complement System	Ba	Antibody	Serum	item_790
A020	SC5b-9 Plus EIA	Genetic abnormalities in biopsy-proven, adult-onset hemolytic uremic syndrome and C3 glomerulopathy.	2021	ELISA	Human	aHUS	Complement System	sC5b-9	ELISA	Serum	item_316
A020	SC5b-9 Plus EIA	Genetic abnormalities in biopsy-proven, adult-onset hemolytic uremic syndrome and C3 glomerulopathy.	2021	ELISA	Human	aHUS	Complement System	sC5b-9	ELISA	Urine	item_317
A209	iC3b Antibody (monoclonal - neoantigen)	Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation.	2021	ELISA	Human	Sickel Cell Anemia	Complement System	iC3b	Antibody	Plasma	item_709
A313	Factor I Antibody (polyclonal)	Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation.	2021	ELISA	Human	Sickel Cell Anemia	Complement System	Factor I	Antibody	Plasma	item_1021
A021	C5a EIA	Human Neutrophils Respond to Complement Activation and Inhibition in Microfluidic Devices.	2021	ELISA	Human		Complement System	C5a	ELISA	Serum	item_401
A900	Complement Multiplex - 8-plex	Impact of complement activation on clinical outcomes in multiple sclerosis.	2021	ELISA	Human	Multiple Sclerosis	Complement System	Complement Multiplex	Multiplex	Plasma	item_1223
A033	Ba Fragment EIA	Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection	2021	ELISA	Human	COVID-19	Complement System	Ba	ELISA	Plasma	item_560
A033	Ba Fragment EIA	Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.	2021	ELISA	Human	COVID-19	Complement System	Ba	ELISA	Plasma	item_563
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Inflammasome-Dependent Peroxiredoxin 2 Secretion Induces the Classical Complement Pathway Activation.	2021	Complement Activation Assay, WB	Human		Complement System	sC5b-9	Antibody	Serum	item_830
A509	C1q Depleted Sera	Inflammasome-Dependent Peroxiredoxin 2 Secretion Induces the Classical Complement Pathway Activation.	2021	Complement Activation Assay	Human		Complement System	C1q	Depleted Sera	Serum	item_1162
A111	Normal Human Serum Complement	Interleukin-1β and cathepsin D modulate formation of the terminal complement complex in cultured human disc tissue.	2021	Complement Activation Assay	Human		Complement System	Normal Human Serum	Reagent	Disc Tissue	item_645
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Interleukin-1β and cathepsin D modulate formation of the terminal complement complex in cultured human disc tissue.	2021	IHC	Human		Complement System	sC5b-9	Antibody	Disc Tissue	item_845
A410	Factor H Protein	Local complement factor H protects kidney endothelial cell structure and function	2021	IF	Human, Mouse		Complement System	Factor H	Protein	Kidney Tissue	item_1108
A900	Complement Multiplex - 8-plex	Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm.	2021	ELISA	Human		Complement System	Complement Multiplex	Multiplex	Peripheral blood mononuclear cells	item_1224
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients.	2021	ELISA	Human		Complement System	sC5b-9	Antibody	Plasma	item_834
A304	C3 Antibody (polyclonal)	Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients.	2021	IF	Human	COVID-19	Complement System	C3	Antibody	Kidney Tissue	item_924
A304	C3 Antibody (polyclonal)	Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients.	2021	IF	Human	COVID-19	Complement System	C3	Antibody	Liver Tissue	item_925
A304	C3 Antibody (polyclonal)	Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients.	2021	IF	Human	COVID-19	Complement System	C3	Antibody	Lung Tissue	item_926
A705	C5 Antibody (monoclonal) biotin	Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients.	2021	ELISA	Human		Complement System	C5	Antibody	Plasma	item_1213
A201	C1q Antibody (monoclonal)	Mycobacterium tuberculosis modifies cell wall carbohydrates during biofilm growth with a concomitant reduction in complement activation.	2021	ELISA	Bacteria		Complement System	C1q	Antibody	Mycobacterium tuberculosis	item_655
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study.	2021	IHC	Human		Complement System	sC5b-9	Antibody	Placenta Tissue	item_846
A900	Complement Multiplex - 8-plex	Profiling Complement System Components in Primary CNS Vasculitis.	2021	ELISA	Human	Primary CNS Vasculitis	Complement System	Complement Multiplex	Multiplex	CSF	item_1225
A900	Complement Multiplex - 8-plex	Profiling Complement System Components in Primary CNS Vasculitis.	2021	ELISA	Human	Primary CNS Vasculitis	Complement System	Complement Multiplex	Multiplex	Serum	item_1226
A304	C3 Antibody (polyclonal)	Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies	2021	FC	Cell Culture		Complement System	C3	Antibody	ciGEnCs Cells	item_919
A304	C3 Antibody (polyclonal)	Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies	2021	FC	Cell Culture		Complement System	C3	Antibody	HUVEC Cells	item_920
A407	C9 Protein	Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies	2021	FC	Cell Culture		Complement System	C9	Protein	ciGEnCs Cells	item_1093
A407	C9 Protein	Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies	2021	FC	Cell Culture		Complement System	C9	Protein	HUVEC Cells	item_1094
A020	SC5b-9 Plus EIA	Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.	2021	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Plasma	item_318
A235	Factor P Antibody (monoclonal) #2	Severe Congenital Thrombocytopenia Characterized by Decreased Platelet Sialylation and Moderate Complement Activation Caused by Novel Compound Heterozygous Variants in GNE.	2021	ELISA	Human	Congenital Thrombocytopenia	Complement System	Factor P	Antibody	Plasma	item_816
A302	C1s Antibody (polyclonal)	Sodium Iodate-Induced Degeneration Results in Local Complement Changes and Inflammatory Processes in Murine Retina.	2021	WB	Human		Complement System	C1s	Antibody	Retina Tissue	item_913
A302	C1s Antibody (polyclonal)	Sodium Iodate-Induced Degeneration Results in Local Complement Changes and Inflammatory Processes in Murine Retina.	2021	WB	Mouse	Retina, Sodium Iodate-Induced Degeneration	Complement System	C1s	Antibody	Eye Tissue	item_916
A311	Factor B Antibody (polyclonal)	Sodium Iodate-Induced Degeneration Results in Local Complement Changes and Inflammatory Processes in Murine Retina.	2021	WB	Human		Complement System	Factor B	Antibody	Retina Tissue	item_977
A311	Factor B Antibody (polyclonal)	Sodium Iodate-Induced Degeneration Results in Local Complement Changes and Inflammatory Processes in Murine Retina.	2021	WB	Mouse	Retina, Sodium Iodate-Induced Degeneration	Complement System	Factor B	Antibody	Eye Tissue	item_983
A235	Factor P Antibody (monoclonal) #2	Systemic complement levels in patients with age-related macular degeneration carrying rare or low frequency variants in the CFH gene.	2021	ELISA	Human		Complement System	Factor P	Antibody	Plasma	item_815
A312	Factor H Antibody (polyclonal)	Systemic complement levels in patients with age-related macular degeneration carrying rare or low frequency variants in the CFH gene.	2021	ELISA	Human		Complement System	Factor H	Antibody	Plasma	item_996
A901	Complement Multiplex - 5-plex	TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.	2021	ELISA	Human	Multisystem inflammatory syndrome in children	Complement System	Complement Multiplex	Multiplex	Plasma	item_1234
A235	Factor P Antibody (monoclonal) #2	The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure.	2021	ELISA	Human	Heart Failure	Complement System	Factor P	Antibody	Plasma	item_817
A031	C3a Plus EIA	The Inflammatory Feed-Forward Loop Triggered by the Complement Component C3 as a Potential Target in Endometriosis.	2021	ELISA	Human		Complement System	C3a	ELISA	Peritoneal fluid (w/ Endometriosis)	item_506
A401	C3 Protein	The Inflammatory Feed-Forward Loop Triggered by the Complement Component C3 as a Potential Target in Endometriosis.	2021	WB	N/A		Complement System	C3	Protein	Control	item_1068
A020	SC5b-9 Plus EIA	The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare.	2021	ELISA	Human	Lupus Nephritis	Complement System	sC5b-9	ELISA	Plasma	item_313
A021	C5a EIA	The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare.	2021	ELISA	Human	Lupus Nephritis	Complement System	C5a	ELISA	Plasma	item_396
A239	sC5b-9 Antibody (monoclonal - neoantigen)	The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare.	2021	ELISA	Human	Lupus Nephritis	Complement System	sC5b-9	Antibody	Plasma	item_833
A039	Factor H EIA	The role of complement factor H in gestational diabetes mellitus and pregnancy.	2021	ELISA	Human	Diabetes, gestational	Complement System	Factor H	ELISA	Serum	item_613
A020	SC5b-9 Plus EIA	Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.	2021	ELISA	Human	Cancer, COVID-19	Complement System	sC5b-9	ELISA	Plasma	item_314
A020	SC5b-9 Plus EIA	Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.	2021	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Plasma	item_315
A021	C5a EIA	Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.	2021	ELISA	Human	Cancer, COVID-19	Complement System	C5a	ELISA	Plasma	item_397
A021	C5a EIA	Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.	2021	ELISA	Human	COVID-19	Complement System	C5a	ELISA	Plasma	item_398
A031	C3a Plus EIA	Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.	2021	ELISA	Human	Cancer, COVID-19	Complement System	C3a	ELISA	Plasma	item_507
A031	C3a Plus EIA	Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.	2021	ELISA	Human	COVID-19	Complement System	C3a	ELISA	Plasma	item_508
A037	C1-lnhibitor Plus EIA	Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.	2021	ELISA	Human	Cancer, COVID-19	Complement System	C1-INH	ELISA	Plasma	item_604
A037	C1-lnhibitor Plus EIA	Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.	2021	ELISA	Human	COVID-19	Complement System	C1-INH	ELISA	Plasma	item_605
A039	Factor H EIA	Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.	2021	ELISA	Human	Cancer, COVID-19	Complement System	Factor H	ELISA	Plasma	item_614
A039	Factor H EIA	Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.	2021	ELISA	Human	COVID-19	Complement System	Factor H	ELISA	Plasma	item_615
A020	SC5b-9 Plus EIA	von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.	2021	ELISA	Human	C3G	Complement System	sC5b-9	ELISA	Plasma	item_308
A020	SC5b-9 Plus EIA	von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.	2021	ELISA	Human	C3G	Complement System	sC5b-9	ELISA	Urine	item_309
A021	C5a EIA	von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.	2021	ELISA	Human	C3G	Complement System	C5a	ELISA	Plasma	item_392
A021	C5a EIA	von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.	2021	ELISA	Human	C3G	Complement System	C5a	ELISA	Urine	item_393
A027	Bb Plus Fragment EIA	von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.	2021	ELISA	Human	C3G	Complement System	Bb	ELISA	Plasma	item_444
A027	Bb Plus Fragment EIA	von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.	2021	ELISA	Human	C3G	Complement System	Bb	ELISA	Urine	item_445
A031	C3a Plus EIA	von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.	2021	ELISA	Human	C3G	Complement System	C3a	ELISA	Plasma	item_503
A031	C3a Plus EIA	von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.	2021	ELISA	Human	C3G	Complement System	C3a	ELISA	Urine	item_504
A247	Factor I Antibody (monoclonal) #1	A Factor I-Like Activity Associated with Chikungunya Virus Contributes to Its Resistance to the Human Complement System	2020	Complement Inhibition Assay	Purified Protein	Chikungunya	Complement System	Factor I	Antibody	CHIKV Virus, Factor I Protein	item_860
A009	C4d Fragment EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	C4d	ELISA	Serum	item_243
A009	C4d Fragment EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	C4d	ELISA	Urine	item_244
A020	SC5b-9 Plus EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	sC5b-9	ELISA	Serum	item_301
A020	SC5b-9 Plus EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	sC5b-9	ELISA	Urine	item_302
A021	C5a EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	C5a	ELISA	Serum	item_389
A021	C5a EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	C5a	ELISA	Urine	item_390
A031	C3a Plus EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	C3a	ELISA	Serum	item_500
A031	C3a Plus EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	C3a	ELISA	Urine	item_501
A033	Ba Fragment EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	Ba	ELISA	Serum	item_555
A033	Ba Fragment EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	Ba	ELISA	Urine	item_556
A035	C4a Fragment EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	C4a	ELISA	Serum	item_587
A035	C4a Fragment EIA	Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.	2020	ELISA	Human	Lupus Nephritis, Thrombotic Microangiopathy	Complement System	C4a	ELISA	Urine	item_588
A219	C6 Antibody (monoclonal)	Bacterial Killing by Complement Requires Direct Anchoring of Membrane Attack Complex Precursor C5b-7.	2020	ELISA	Bacteria	Supernatent	Complement System	C6	Antibody	E. Coli	item_774
A039	Factor H EIA	C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice	2020	ELISA	Human	C3G	Complement System	Factor H	ELISA	Plasma	item_612
A306	C5 Antibody (polyclonal)	C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice	2020	WB	Mouse		Complement System	C5	Antibody	Plasma	item_942
A311	Factor B Antibody (polyclonal)	C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice	2020	WB	Mouse		Complement System	Factor B	Antibody	Plasma	item_982
A312	Factor H Antibody (polyclonal)	Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.	2020	ELISA, IF, WB	Mouse		Complement System	Factor H	Antibody	Kidney Tissue	item_1010
A312	Factor H Antibody (polyclonal)	Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.	2020	ELISA, IF, WB	Mouse		Complement System	Factor H	Antibody	Plasma	item_1011
A020	SC5b-9 Plus EIA	Cloaking Silica Nanoparticles with Functional Protein Coatings for Reduced Complement Activation and Cellular Uptake.	2020	ELISA	Human	SiNP coated proteins	Complement System	sC5b-9	ELISA	Serum	item_297
A027	Bb Plus Fragment EIA	Cloaking Silica Nanoparticles with Functional Protein Coatings for Reduced Complement Activation and Cellular Uptake.	2020	ELISA	Human	SiNP coated proteins	Complement System	Bb	ELISA	Serum	item_442
A031	C3a Plus EIA	Cloaking Silica Nanoparticles with Functional Protein Coatings for Reduced Complement Activation and Cellular Uptake.	2020	ELISA	Human	SiNP coated proteins	Complement System	C3a	ELISA	Serum	item_496
A035	C4a Fragment EIA	Cloaking Silica Nanoparticles with Functional Protein Coatings for Reduced Complement Activation and Cellular Uptake.	2020	ELISA	Human	SiNP coated proteins	Complement System	C4a	ELISA	Serum	item_586
A009	C4d Fragment EIA	Complement Activation Profile of Patients With Primary Focal Segmental Glomerulosclerosis.	2020	ELISA	Human	FSGS	Complement System	C4d	ELISA	Plasma	item_240
A009	C4d Fragment EIA	Complement Activation Profile of Patients With Primary Focal Segmental Glomerulosclerosis.	2020	ELISA	Human	FSGS	Complement System	C4d	ELISA	Serum	item_241
A020	SC5b-9 Plus EIA	Complement Activation Profile of Patients With Primary Focal Segmental Glomerulosclerosis.	2020	ELISA	Human	FSGS	Complement System	sC5b-9	ELISA	Plasma	item_295
A020	SC5b-9 Plus EIA	Complement Activation Profile of Patients With Primary Focal Segmental Glomerulosclerosis.	2020	ELISA	Human	FSGS	Complement System	sC5b-9	ELISA	Serum	item_296
A021	C5a EIA	Complement Activation Profile of Patients With Primary Focal Segmental Glomerulosclerosis.	2020	ELISA	Human	FSGS	Complement System	C5a	ELISA	Plasma	item_385
A021	C5a EIA	Complement Activation Profile of Patients With Primary Focal Segmental Glomerulosclerosis.	2020	ELISA	Human	FSGS	Complement System	C5a	ELISA	Serum	item_386
A027	Bb Plus Fragment EIA	Complement Activation Profile of Patients With Primary Focal Segmental Glomerulosclerosis.	2020	ELISA	Human	FSGS	Complement System	Bb	ELISA	Plasma	item_440
A027	Bb Plus Fragment EIA	Complement Activation Profile of Patients With Primary Focal Segmental Glomerulosclerosis.	2020	ELISA	Human	FSGS	Complement System	Bb	ELISA	Serum	item_441
A031	C3a Plus EIA	Complement Activation Profile of Patients With Primary Focal Segmental Glomerulosclerosis.	2020	ELISA	Human	FSGS	Complement System	C3a	ELISA	Plasma	item_492
A031	C3a Plus EIA	Complement Activation Profile of Patients With Primary Focal Segmental Glomerulosclerosis.	2020	ELISA	Human	FSGS	Complement System	C3a	ELISA	Serum	item_493
A031	C3a Plus EIA	Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy.	2020	ELISA	Human	Proliferative Diabetic Retinopathy	Complement System	C3a	ELISA	Plasma, Vitreous Humor	item_498
A033	Ba Fragment EIA	Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy.	2020	ELISA	Human	Proliferative Diabetic Retinopathy	Complement System	Ba	ELISA	Plasma, Vitreous Humor	item_554
A020	SC5b-9 Plus EIA	Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy.	2020	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Plasma	item_298
A031	C3a Plus EIA	Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy.	2020	ELISA	Human	COVID-19	Complement System	C3a	ELISA	Plasma	item_497
A033	Ba Fragment EIA	Complement Expression and Activation in Osteoarthritis Joint Compartments.	2020	ELISA	Human	Supernatent	Complement System	Ba	ELISA	Chondrocytes	item_557
A033	Ba Fragment EIA	Complement Expression and Activation in Osteoarthritis Joint Compartments.	2020	ELISA	Human	Supernatent	Complement System	Ba	ELISA	Synoviocytes	item_558
A020	SC5b-9 Plus EIA	Complement activation and endothelial perturbation parallel COVID-19 severity and activity.	2020	ELISA	Human	COVID-19	Complement System	sC5b-9	ELISA	Plasma	item_300
A021	C5a EIA	Complement activation and endothelial perturbation parallel COVID-19 severity and activity.	2020	ELISA	Human	COVID-19	Complement System	C5a	ELISA	Plasma	item_388
A009	C4d Fragment EIA	Complement activation on endothelium initiates antibody-mediated acute lung injury	2020	ELISA	Mouse		Complement System	C4d	ELISA	Plasma	item_265
A018	CH50 Eq EIA	Decreased immune response in monkeys administered a human T-effector cell agonist (OX40) antibody.	2020	ELISA	Cynomolgus Monkey	T-effector cell agonist (OX40) antibody	Complement System	CH50	ELISA	Plasma, Serum	item_266
A031	C3a Plus EIA	Decreased immune response in monkeys administered a human T-effector cell agonist (OX40) antibody.	2020	ELISA	Cynomolgus Monkey	T-effector cell agonist (OX40) antibody	Complement System	C3a	ELISA	Plasma, Serum	item_483
A213	C4 (C4d) Antibody (monoclonal)	Docked SARS CoV-2 Proteins within the Cutaneous and Subcutaneous Microvasculature and their Role in the Pathogenesis of Severe COVID-19.	2020	IHC	Human	COVID-19	Complement System	C4d	Antibody	Skin Tissue	item_755
A239	sC5b-9 Antibody (monoclonal - neoantigen)	EGFR modulates complement activation in head and neck squamous cell carcinoma.	2020	IF	Cell Culture		Complement System	sC5b-9	Antibody	HNSCC Cells	item_828
A400	C1q Protein	EGFR modulates complement activation in head and neck squamous cell carcinoma.	2020	IF	Cell Culture		Complement System	C1q	Protein	HNSCC Cells	item_1026
A506	Factor B Depleted Sera	EGFR modulates complement activation in head and neck squamous cell carcinoma.	2020	IF	Cell Culture		Complement System	Factor B	Depleted Sera	HNSCC Cells	item_1145
A509	C1q Depleted Sera	EGFR modulates complement activation in head and neck squamous cell carcinoma.	2020	IF	Cell Culture		Complement System	C1q	Depleted Sera	HNSCC Cells	item_1158
A006	iC3b EIA	Effect of Aerobic and Anaerobic Exercise on the Complement System of Proteins in Healthy Young Males.	2020	ELISA	Human		Complement System	iC3b	ELISA	Plasma	item_224
A031	C3a Plus EIA	Effect of Aerobic and Anaerobic Exercise on the Complement System of Proteins in Healthy Young Males.	2020	ELISA	Human		Complement System	C3a	ELISA	Plasma	item_494
60-3100	Human PTH ELISA	Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD: A Randomized Trial.	2020	ELISA	Human	Chronic Kidney Disease	Bone/Renal Health	PTH	ELISA	Plasma	item_142
60-6100	Human FGF-23 C-Term ELISA	Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD: A Randomized Trial.	2020	ELISA	Human	Chronic Kidney Disease	Bone/Renal Health	FGF-23	ELISA	Plasma	item_152
60-6600	Human FGF-23 (Intact) ELISA	Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD: A Randomized Trial.	2020	ELISA	Human	Chronic Kidney Disease	Bone/Renal Health	FGF-23	ELISA	Plasma	item_194
A020	SC5b-9 Plus EIA	Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation.	2020	ELISA	Human	Thrombotic Microangiopathy - TA	Complement System	sC5b-9	ELISA	Plasma	item_304
A033	Ba Fragment EIA	Establishing a Case for Anti-complement Therapy in Membranous Nephropathy.	2020	ELISA	Human	Membranous Nephropathy	Complement System	Ba	ELISA	Urine	item_559
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Establishing a Case for Anti-complement Therapy in Membranous Nephropathy.	2020	ELISA	Human	Membranous Nephropathy	Complement System	sC5b-9	Antibody	Urine	item_832
A600	CVF, Cobra Venom Factor	Graphene Oxide Nanosheets for Localized Hyperthermia-Physicochemical Characterization, Biocompatibility, and Induction of Tumor Cell Death.	2020	Complement Activation Assay	Human		Complement System	Cobra Venom Factor	Reagent	Plasma	item_1177
A227	Factor B (Bb) Antibody (monoclonal)	Immunological features of patients affected by Barraquer-Simons syndrome.	2020	ELISA	Human		Complement System	Bb	Antibody	Serum	item_791
A031	C3a Plus EIA	In vitro comparison of three percutaneous atrial septal defect closure devices for endothelialisation and haemocompatibility.	2020	ELISA	Human		Complement System	C3a	ELISA	Serum	item_495
A254	Factor H Antibody (monoclonal) #2	Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization	2020	ELISA	Cell Culture		Complement System	Factor H	Antibody	Jurkat Cells	item_878
A255	Factor H Antibody (monoclonal) #3	Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization	2020	ELISA	Cell Culture		Complement System	Factor H	Antibody	Insect Cells	item_885
A009	C4d Fragment EIA	Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpura.	2020	ELISA	Human	Immune‐mediated thrombotic thrombocytopenic purpura	Complement System	C4d	ELISA	Plasma	item_262
A020	SC5b-9 Plus EIA	Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpura.	2020	ELISA	Human	Immune‐mediated thrombotic thrombocytopenic purpura	Complement System	sC5b-9	ELISA	Plasma	item_370
A027	Bb Plus Fragment EIA	Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpura.	2020	ELISA	Human	Immune‐mediated thrombotic thrombocytopenic purpura	Complement System	Bb	ELISA	Plasma	item_474
A031	C3a Plus EIA	Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpura.	2020	ELISA	Human	Immune‐mediated thrombotic thrombocytopenic purpura	Complement System	C3a	ELISA	Plasma	item_540
8019	Serum PYD EIA	Linking skeletal muscle aging with osteoporosis by lamin A/C deficiency.	2020	ELISA	Mouse		Bone/Renal Health	PYD	ELISA	Serum	item_80
A009	C4d Fragment EIA	Local complement activation is associated with primary graft dysfunction after lung transplantation.	2020	ELISA	Human	Lung transplant	Complement System	C4d	ELISA	Bronchoalveolar lavage	item_242
A033	Ba Fragment EIA	Local complement activation is associated with primary graft dysfunction after lung transplantation.	2020	ELISA	Human	Lung transplant	Complement System	Ba	ELISA	Bronchoalveolar lavage	item_553
A201	C1q Antibody (monoclonal)	Molecular and Cellular Interactions of Scavenger Receptor SR-F1 With Complement C1q Provide Insights Into Its Role in the Clearance of Apoptotic Cells.	2020	FC	Cell Culture		Complement System	C1q	Antibody	THP-1 Cells	item_657
A020	SC5b-9 Plus EIA	P-MAPA, a Fungi-Derived Immunomodulatory Compound, Induces a Proinflammatory Response in a Human Whole Blood Model.	2020	ELISA	Human	P-MAPA	Complement System	sC5b-9	ELISA	Plasma	item_303
A205	C3 (C3c) Antibody (monoclonal)	Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.	2020	FC	Cell Culture		Complement System	C3c	Antibody	HUVEC Cells	item_684
A233	Factor P Antibody (monoclonal) #1	Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.	2020	Hemolytic Assay	Rabbit		Complement System	Factor P	Antibody	Red Blood Cells	item_813
60-2700	Rat Bioactive PTH ELISA	Selective pharmacological inhibition of the sodium-dependent phosphate co-transporter NPT2a promotes phosphate excretion.	2020	ELISA	Rat		Bone/Renal Health	PTH	ELISA	Plasma	item_133
60-6800	Mouse/Rat FGF-23 (Intact) ELISA	Selective pharmacological inhibition of the sodium-dependent phosphate co-transporter NPT2a promotes phosphate excretion.	2020	ELISA	Rat		Bone/Renal Health	FGF-23	ELISA	Plasma	item_212
A021	C5a EIA	Subvisible Particles in IVIg Formulations Activate Complement in Human Serum.	2020	ELISA	Human	IVIg formulations	Complement System	C5a	ELISA	Serum	item_383
A027	Bb Plus Fragment EIA	Subvisible Particles in IVIg Formulations Activate Complement in Human Serum.	2020	ELISA	Human	IVIg formulations	Complement System	Bb	ELISA	Serum	item_438
A031	C3a Plus EIA	Subvisible Particles in IVIg Formulations Activate Complement in Human Serum.	2020	ELISA	Human	IVIg formulations	Complement System	C3a	ELISA	Serum	item_489
A035	C4a Fragment EIA	Subvisible Particles in IVIg Formulations Activate Complement in Human Serum.	2020	ELISA	Human	IVIg formulations	Complement System	C4a	ELISA	Serum	item_583
8019	Serum PYD EIA	Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine.	2020	ELISA	Mouse		Bone/Renal Health	PYD	ELISA	Serum	item_78
A021	C5a EIA	Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression.	2020	ELISA	Human	COVID-19	Complement System	C5a	ELISA	Plasma	item_387
A031	C3a Plus EIA	Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression.	2020	ELISA	Human	COVID-19	Complement System	C3a	ELISA	Plasma	item_499
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Terminal complement complex formation is associated with intervertebral disc degeneration.	2020	IHC	Human		Complement System	sC5b-9	Antibody	Spinal Cord Tissue	item_844
A018	CH50 Eq EIA	The Immunologic Effect of Early Intravenous Two and Four Gram Bolus Dosing of Tranexamic Acid Compared to Placebo in Patients With Severe Traumatic Bleeding (TAMPITI): A Randomized, Double-Blind, Placebo-Controlled, Single-Center Trial.	2020	ELISA	Human	Severe Traumatic Bleeding	Complement System	CH50	ELISA	Plasma	item_269
A018	CH50 Eq EIA	The endogenous neuronal complement inhibitor SRPX2 protects against complement-mediated synapse elimination during development.	2020	ELISA	Human	HEK 293 Cells incubated	Complement System	CH50	ELISA	Serum	item_268
8012	BAP EIA	Vitamin D and Abdominal Aortic Calcification in Older African American Women, the PODA Clinical Trial.	2020	ELISA	Human	Older African American Women	Bone/Renal Health	BAP	ELISA	Serum	item_70
21-6310	Mouse FGF-23 Ab (186-206)	1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice	2019	IP, WB	Mouse		Bone/Renal Health	FGF-23	Antibody	Bone Tissue	item_108
21-6320	Mouse FGF-23 Ab (225-244)	1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice	2019	IP, WB	Mouse		Bone/Renal Health	FGF-23	Antibody	Bone Tissue	item_110
60-2305	Mouse PTH 1-84 ELISA	1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice	2019	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Serum	item_119
60-2305	Mouse PTH 1-84 ELISA	1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice	2019	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Urine	item_120
60-6300	Mouse/Rat FGF-23 C-Term ELISA	1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice	2019	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Serum	item_182
60-6300	Mouse/Rat FGF-23 C-Term ELISA	1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice	2019	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Urine	item_183
60-6800	Mouse/Rat FGF-23 (Intact) ELISA	1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice	2019	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Serum	item_205
60-6800	Mouse/Rat FGF-23 (Intact) ELISA	1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice	2019	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Urine	item_206
A020	SC5b-9 Plus EIA	A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.	2019	ELISA	Human	Chronic Lymphocytic Leukemia	Complement System	sC5b-9	ELISA	Plasma	item_288
A020	SC5b-9 Plus EIA	A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.	2019	ELISA	Human	Chronic Lymphocytic Leukemia	Complement System	sC5b-9	ELISA	Serum	item_289
A217	C5 Antibody (monoclonal)	A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.	2019	WB	Human	Chronic Lymphocytic Leukemia	Complement System	C5	Antibody	Plasma	item_773
A305	C4 Antibody (polyclonal)	A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.	2019	WB	Human	Chronic Lymphocytic Leukemia	Complement System	C4	Antibody	Plasma	item_932
A403	C5 Protein	A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.	2019	ELISA	Human	Chronic Lymphocytic Leukemia	Complement System	C5	Protein	Plasma	item_1078
A403	C5 Protein	A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.	2019	ELISA	Human	Chronic Lymphocytic Leukemia	Complement System	C5	Protein	Serum	item_1079
60-6800	Mouse/Rat FGF-23 (Intact) ELISA	A G Protein-Coupled, IP3/protein Kinase C Pathway Controlling the Synthesis of Phosphaturic Hormone FGF23.	2019	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Serum	item_207
A312	Factor H Antibody (polyclonal)	Anti-Factor H Antibody Reactivity in Young Adults Vaccinated With a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein.	2019	Hemolytic Assay	Human		Complement System	Factor H	Antibody	Serum	item_1003
A205	C3 (C3c) Antibody (monoclonal)	Anti-inflammatory activity of intravenous immunoglobulin through scavenging of heme.	2019	FC	Cell Culture		Complement System	C3c	Antibody	HUVEC Cells	item_690
A312	Factor H Antibody (polyclonal)	ApoE Attenuates Unresolvable Inflammation by Complex Formation With Activated C1q.	2019	IF	Human		Complement System	Factor H	Antibody	Choroid plexus Tissue	item_1004
A001	CIC-C1q EIA	Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex-mediated immune responses.	2019	ELISA	Human		Complement System	C1q	ELISA	Serum	item_214
A035	C4a Fragment EIA	C1R Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos Syndrome.	2019	ELISA	Human	Supernatent	Complement System	C4a	ELISA	Fibroblasts	item_584
A217	C5 Antibody (monoclonal)	C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro.	2019	Complement Activation Assay	Human		Complement System	C5	Antibody	B-Cells	item_768
A020	SC5b-9 Plus EIA	Clinical Use of Complement, Inflammation, and Fibrosis Biomarkers in Autoimmune Glomerulonephritis.	2019	ELISA	Human	FSGS, MN, IgAN, LN, AAV, or MPGN	Complement System	sC5b-9	ELISA	Urine	item_299
A020	SC5b-9 Plus EIA	Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy	2019	ELISA	Human	Diabetic nephropathy	Complement System	sC5b-9	ELISA	Urine	item_290
A027	Bb Plus Fragment EIA	Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy	2019	ELISA	Human	Diabetic nephropathy	Complement System	Bb	ELISA	Urine	item_436
A035	C4a Fragment EIA	Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy	2019	ELISA	Human	Diabetic nephropathy	Complement System	C4a	ELISA	Urine	item_582
8033	TRAP5b EIA	Clinical and Biological Signature of Osteochondritis Dissecans in a Cross-Sectional Study.	2019	ELISA	Human	Osteochondritis Dissecans	Bone/Renal Health	TRAP5b	ELISA	Serum	item_88
A235	Factor P Antibody (monoclonal) #2	Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood	2019	ELISA	Human	Heme, various concentrations	Complement System	Factor P	Antibody	Whole Blood	item_814
A020	SC5b-9 Plus EIA	Complement factor H contributes to mortality in humans and mice with bacterial meningitis.	2019	ELISA	Human	Bacterial meningitis	Complement System	sC5b-9	ELISA	CSF	item_293
A021	C5a EIA	Complement factor H contributes to mortality in humans and mice with bacterial meningitis.	2019	ELISA	Human	Bacterial meningitis	Complement System	C5a	ELISA	CSF	item_384
A031	C3a Plus EIA	Complement factor H contributes to mortality in humans and mice with bacterial meningitis.	2019	ELISA	Human	Bacterial meningitis	Complement System	C3a	ELISA	CSF	item_491
A039	Factor H EIA	Complement factor H contributes to mortality in humans and mice with bacterial meningitis.	2019	ELISA	Human	Bacterial meningitis	Complement System	Factor H	ELISA	CSF	item_611
A020	SC5b-9 Plus EIA	Complement fragments are biomarkers of antibody-mediated endothelial injury.	2019	ELISA	Human	Antibody-mediated endothelial injury	Complement System	sC5b-9	ELISA	Plasma	item_294
A033	Ba Fragment EIA	Complement fragments are biomarkers of antibody-mediated endothelial injury.	2019	ELISA	Human	Antibody-mediated endothelial injury	Complement System	Ba	ELISA	Plasma	item_552
A035	C4a Fragment EIA	Complement fragments are biomarkers of antibody-mediated endothelial injury.	2019	ELISA	Human	Antibody-mediated endothelial injury	Complement System	C4a	ELISA	Plasma	item_585
A215	C4BP Antibody (monoclonal)	Complement in Human Pre-implantation Embryos: Attack and Defense	2019	IF	Human		Complement System	C4BP	Antibody	Embryo Tissue	item_762
8001	Osteocalcin EIA	Comprehensive assessment of tissue and serum parameters of bone metabolism in a series of orthopaedic patients.	2019	ELISA	Human		Bone/Renal Health	Osteocalcin	ELISA	Serum	item_6
8033	TRAP5b EIA	Comprehensive assessment of tissue and serum parameters of bone metabolism in a series of orthopaedic patients.	2019	ELISA	Human		Bone/Renal Health	TRAP5b	ELISA	Serum	item_91
60-3100	Human PTH ELISA	Comprehensive assessment of tissue and serum parameters of bone metabolism in a series of orthopaedic patients.	2019	ELISA	Human		Bone/Renal Health	PTH	ELISA	Serum	item_141
A031	C3a Plus EIA	Early local activation of complement in aqueous humour of patients with age-related macular degeneration.	2019	ELISA	Human	Age-Related Macular Degeneration	Complement System	C3a	ELISA	Aqueous humour	item_488
A033	Ba Fragment EIA	Early local activation of complement in aqueous humour of patients with age-related macular degeneration.	2019	ELISA	Human	Age-Related Macular Degeneration	Complement System	Ba	ELISA	Aqueous humour	item_551
8001	Osteocalcin EIA	Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice.	2019	ELISA	Mouse		Bone/Renal Health	Osteocalcin	ELISA	Plasma	item_7
8007	DPD EIA	Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice.	2019	ELISA	Mouse		Bone/Renal Health	DPD	ELISA	Urine	item_35
60-2305	Mouse PTH 1-84 ELISA	Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice.	2019	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Plasma	item_121
60-6300	Mouse/Rat FGF-23 C-Term ELISA	Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice.	2019	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Plasma	item_184
60-6800	Mouse/Rat FGF-23 (Intact) ELISA	Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice.	2019	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Plasma	item_208
21-6120	FGF-23 Ab (C-term 225-244)	Elevated FGF23 in a patient with hypophosphatemic osteomalacia associated with neurofibromatosis type 1	2019	IHC	Human		Bone/Renal Health	FGF-23	Antibody	Neurofibromas	item_101
21-6120	FGF-23 Ab (C-term 225-244)	Elevated FGF23 in a patient with hypophosphatemic osteomalacia associated with neurofibromatosis type 1	2019	IHC	Human		Bone/Renal Health	FGF-23	Antibody	Skin Tissue	item_102
60-2305	Mouse PTH 1-84 ELISA	Feature Article: Altered morpho-functional features of bones in autoimmune disease-prone BXSB/MpJ-Yaa mice.	2019	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Serum	item_118
60-2305	Mouse PTH 1-84 ELISA	Human Heterozygous ENPP1 Deficiency Is Associated With Early Onset Osteoporosis, a Phenotype Recapitulated in a Mouse Model of Enpp1 Deficiency.	2019	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Plasma	item_122
60-6800	Mouse/Rat FGF-23 (Intact) ELISA	Human Heterozygous ENPP1 Deficiency Is Associated With Early Onset Osteoporosis, a Phenotype Recapitulated in a Mouse Model of Enpp1 Deficiency.	2019	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Plasma	item_209
8007	DPD EIA	Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass.	2019	ELISA	Mouse		Bone/Renal Health	DPD	ELISA	Urine	item_34
8009	Creatinine EIA	Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass.	2019	ELISA	Mouse		Bone/Renal Health	Creatinine	ELISA	Urine	item_43
8033	TRAP5b EIA	Interferon Gamma-1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant Osteopetrosis.	2019	ELISA	Human	Albers- Schönberg disease	Bone/Renal Health	TRAP5b	ELISA	Serum	item_90
60-6100	Human FGF-23 C-Term ELISA	Iron Deficiency, Elevated Erythropoietin, Fibroblast Growth Factor 23, and Mortality in the General Population of the Netherlands: A Cohort Study.	2019	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_151
8001	Osteocalcin EIA	Low-Salt' Bread as an Important Component of a Pragmatic Reduced-Salt Diet for Lowering Blood Pressure in Adults with Elevated Blood Pressure	2019	ELISA	Human		Bone/Renal Health	Osteocalcin	ELISA	Urine	item_5
8009	Creatinine EIA	Low-Salt' Bread as an Important Component of a Pragmatic Reduced-Salt Diet for Lowering Blood Pressure in Adults with Elevated Blood Pressure	2019	ELISA	Human		Bone/Renal Health	Creatinine	ELISA	Serum	item_41
8012	BAP EIA	Low-Salt' Bread as an Important Component of a Pragmatic Reduced-Salt Diet for Lowering Blood Pressure in Adults with Elevated Blood Pressure	2019	ELISA	Human		Bone/Renal Health	BAP	ELISA	Serum	item_69
A009	C4d Fragment EIA	Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.	2019	ELISA	Human	ANCA-AAV	Complement System	C4d	ELISA	Plasma	item_238
A020	SC5b-9 Plus EIA	Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.	2019	ELISA	Human	ANCA-AAV	Complement System	sC5b-9	ELISA	Plasma	item_291
A021	C5a EIA	Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.	2019	ELISA	Human	ANCA-AAV	Complement System	C5a	ELISA	Plasma	item_382
A027	Bb Plus Fragment EIA	Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.	2019	ELISA	Human	ANCA-AAV	Complement System	Bb	ELISA	Plasma	item_437
A031	C3a Plus EIA	Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.	2019	ELISA	Human	ANCA-AAV	Complement System	C3a	ELISA	Plasma	item_487
A217	C5 Antibody (monoclonal)	Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.	2019	ELISA	Human		Complement System	C5	Antibody	Plasma	item_769
A217	C5 Antibody (monoclonal)	Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.	2019	ELISA	Human		Complement System	C5	Antibody	Serum	item_770
A229	Factor H Antibody (monoclonal)	Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.	2019	ELISA	Human		Complement System	Factor H	Antibody	Plasma	item_799
A229	Factor H Antibody (monoclonal)	Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.	2019	ELISA	Human		Complement System	Factor H	Antibody	Serum	item_800
A233	Factor P Antibody (monoclonal) #1	Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.	2019	ELISA	Human		Complement System	Factor P	Antibody	Plasma	item_805
A233	Factor P Antibody (monoclonal) #1	Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.	2019	ELISA	Human		Complement System	Factor P	Antibody	Serum	item_806
A306	C5 Antibody (polyclonal)	Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.	2019	ELISA	Human		Complement System	C5	Antibody	Plasma	item_939
A306	C5 Antibody (polyclonal)	Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.	2019	ELISA	Human		Complement System	C5	Antibody	Serum	item_940
A312	Factor H Antibody (polyclonal)	Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.	2019	ELISA	Human		Complement System	Factor H	Antibody	Plasma	item_992
A312	Factor H Antibody (polyclonal)	Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.	2019	ELISA	Human		Complement System	Factor H	Antibody	Serum	item_993
60-6100	Human FGF-23 C-Term ELISA	Plasma Fibroblast Growth Factor 23 Is Elevated in Pediatric Primary Hypertension.	2019	ELISA	Human	Hypertension (Children)	Bone/Renal Health	FGF-23	ELISA	Plasma	item_150
A009	C4d Fragment EIA	Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura.	2019	ELISA	Human	aHUS	Complement System	C4d	ELISA	Plasma	item_239
A020	SC5b-9 Plus EIA	Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura.	2019	ELISA	Human	aHUS	Complement System	sC5b-9	ELISA	Plasma	item_292
A027	Bb Plus Fragment EIA	Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura.	2019	ELISA	Human	aHUS	Complement System	Bb	ELISA	Plasma	item_439
A031	C3a Plus EIA	Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura.	2019	ELISA	Human	aHUS	Complement System	C3a	ELISA	Plasma	item_490
8005	CICP EIA	Re-Differentiation Capacity of Human Chondrocytes in Vitro Following Electrical Stimulation with Capacitively Coupled Fields.	2019	ELISA	Human		Bone/Renal Health	CICP	ELISA	Chondrocytes	item_21
8012	BAP EIA	Selected serum microRNA, abdominal aortic calcification and risk of osteoporotic fracture.	2019	ELISA	Human		Bone/Renal Health	BAP	ELISA	Serum	item_67
8012	BAP EIA	Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers.	2019	ELISA	Human	Chronic Kidney Disease	Bone/Renal Health	BAP	ELISA	Serum	item_66
8033	TRAP5b EIA	Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers.	2019	ELISA	Human	Chronic Kidney Disease	Bone/Renal Health	TRAP5b	ELISA	Serum	item_89
A302	C1s Antibody (polyclonal)	Single-cell reconstruction of follicular remodeling in the human adult ovary.	2019	IF	Human	Follicular degeneration	Complement System	C1s	Antibody	Ovary Tissue	item_909
A255	Factor H Antibody (monoclonal) #3	The role of anti complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function	2019	Platlet Aggregation Assay	Human	aHUS	Complement System	Factor H	Antibody	Plasma	item_887
60-6100	Human FGF-23 C-Term ELISA	Tumor-induced osteomalacia: experience from three tertiary care centres In India	2019	ELISA	Human	Hypoparathyroidism	Bone/Renal Health	FGF-23	ELISA	Serum	item_181
A219	C6 Antibody (monoclonal)	A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the Staphylococcus aureus SSL7 Protein.	2018	ELISA	Human		Complement System	C6	Antibody	Serum	item_775
A239	sC5b-9 Antibody (monoclonal - neoantigen)	A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the Staphylococcus aureus SSL7 Protein.	2018	ELISA	Human		Complement System	sC5b-9	Antibody	Serum	item_831
A415	SC5b-9 Protein	A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the Staphylococcus aureus SSL7 Protein.	2018	ELISA	Human		Complement System	sC5b-9	Protein	Serum	item_1117
A006	iC3b EIA	A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease	2018	ELISA	Human	Age-Related Macular Degeneration	Complement System	iC3b	ELISA	Plasma	item_234
A006	iC3b EIA	A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease	2018	ELISA	Human	Alzheimer's Disease	Complement System	iC3b	ELISA	Plasma	item_235
A209	iC3b Antibody (monoclonal - neoantigen)	A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease	2018	ELISA	Human	Age-Related Macular Degeneration	Complement System	iC3b	Antibody	Plasma	item_713
A209	iC3b Antibody (monoclonal - neoantigen)	A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease	2018	ELISA	Human	Alzheimer's Disease	Complement System	iC3b	Antibody	Plasma	item_714
8012	BAP EIA	Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.	2018	ELISA	Cynomolgus Monkey		Bone/Renal Health	BAP	ELISA	Serum	item_52
A111	Normal Human Serum Complement	Antigenic Variation in Streptococcus pneumoniae PspC Promotes Immune Escape in the Presence of Variant-Specific Immunity.	2018	FC	Bacteria		Complement System	Normal Human Serum	Reagent	Streptococcus pneumoniae	item_620
A229	Factor H Antibody (monoclonal)	Antigenic Variation in Streptococcus pneumoniae PspC Promotes Immune Escape in the Presence of Variant-Specific Immunity.	2018	WB	N/A	PspC	Complement System	Factor H	Antibody	Protein	item_803
A312	Factor H Antibody (polyclonal)	Antigenic Variation in Streptococcus pneumoniae PspC Promotes Immune Escape in the Presence of Variant-Specific Immunity.	2018	FC	Bacteria		Complement System	Factor H	Antibody	Streptococcus pneumoniae	item_989
A410	Factor H Protein	Antigenic Variation in Streptococcus pneumoniae PspC Promotes Immune Escape in the Presence of Variant-Specific Immunity.	2018	WB	N/A	PspC	Complement System	Factor H	Protein	Protein	item_1109
60-6100	Human FGF-23 C-Term ELISA	Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients	2018	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Serum	item_179
8007	DPD EIA	Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro.	2018	ELISA	Rat		Bone/Renal Health	DPD	ELISA	Urine	item_39
8005	CICP EIA	Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421.	2018	ELISA	Human		Bone/Renal Health	CICP	ELISA	Serum	item_20
8012	BAP EIA	Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421.	2018	ELISA	Human		Bone/Renal Health	BAP	ELISA	Serum	item_68
8019	Serum PYD EIA	Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421.	2018	ELISA	Human		Bone/Renal Health	PYD	ELISA	Serum	item_75
A021	C5a EIA	Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells.	2018	ELISA	Human		Complement System	C5a	ELISA	GMVEC cells, BMVEC cells	item_381
A033	Ba Fragment EIA	Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells.	2018	ELISA	Human		Complement System	Ba	ELISA	GMVEC cells, BMVEC cells	item_549
A225	Factor B (Ba) Antibody (monoclonal)	Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells.	2018	ELISA	Human		Complement System	Ba	Antibody	GMVEC cells, BMVEC cells	item_789
60-6100	Human FGF-23 C-Term ELISA	Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease	2018	ELISA	Human	Acute Coronary Syndrome	Bone/Renal Health	FGF-23	ELISA	Plasma	item_170
A400	C1q Protein	Complement C1q stimulates the progression of hepatocellular tumor through the activation of discoidin domain receptor 1	2018	Cell Migration Assay	Cell Culture		Complement System	C1q	Protein	HepG2 cells	item_1024
A037	C1-lnhibitor Plus EIA	Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study.	2018	ELISA	Human	Cardiometabolic disease increased risk	Complement System	C1-INH	ELISA	Plasma	item_602
A027	Bb Plus Fragment EIA	Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies	2018	ELISA	Human		Complement System	Bb	ELISA	Serum	item_473
60-6100	Human FGF-23 C-Term ELISA	Fibroblast Growth Factor 23-Induced Hypophosphatemia in Acute Leukemia.	2018	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_178
A205	C3 (C3c) Antibody (monoclonal)	Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1.	2018	FC	Cell Culture	HUVEC Cells, HMEC Cells, HRGEC Cells	Complement System	C3c	Antibody	Endothelial Cells	item_683
A229	Factor H Antibody (monoclonal)	Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1.	2018	FC	Cell Culture	HUVEC Cells, HMEC Cells, HRGEC Cells	Complement System	Factor H	Antibody	Endothelial Cells	item_798
A239	sC5b-9 Antibody (monoclonal - neoantigen)	High-Mobility Group Box 1-Induced Complement Activation Causes Sterile Inflammation.	2018	ELISA, IF	Human	HMGB1-coated microplates	Complement System	sC5b-9	Antibody	Serum	item_840
8007	DPD EIA	Histone methylation regulator PTIP is required to maintain normal and leukemic bone marrow niches.	2018	ELISA	Mouse		Bone/Renal Health	DPD	ELISA	Urine	item_33
8009	Creatinine EIA	Histone methylation regulator PTIP is required to maintain normal and leukemic bone marrow niches.	2018	ELISA	Mouse		Bone/Renal Health	Creatinine	ELISA	Urine	item_42
60-6300	Mouse/Rat FGF-23 C-Term ELISA	Increased Plasmodium chabaudi malaria mortality in mice with nutritional iron deficiency can be reduced by short-term adjunctive iron supplementation	2018	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Serum	item_188
A209	iC3b Antibody (monoclonal - neoantigen)	Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1.	2018	ELISA	Human		Complement System	iC3b	Antibody	Serum	item_712
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1.	2018	ELISA	Human		Complement System	sC5b-9	Antibody	Serum	item_838
A020	SC5b-9 Plus EIA	Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.	2018	ELISA	Human	Microvesicles with heme	Complement System	sC5b-9	ELISA	Serum	item_287
A033	Ba Fragment EIA	Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.	2018	ELISA	Human	Microvesicles with heme	Complement System	Ba	ELISA	Serum	item_550
A205	C3 (C3c) Antibody (monoclonal)	Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.	2018	FC	Human	Microvesicles with heme	Complement System	C3c	Antibody	HUVEC Cells	item_696
A400	C1q Protein	Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis	2018	ELISA	Human	Immune Complexes	Complement System	C1q	Protein	Serum	item_1039
A037	C1-lnhibitor Plus EIA	Pharmacokinetics of human recombinant C1-esterase inhibitor and development of anti-drug antibodies in healthy dogs.	2018	ELISA	Canine		Complement System	C1-INH	ELISA	Serum	item_598
A302	C1s Antibody (polyclonal)	Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway.	2018	WB	Human, Mouse	Diabetes exosomes	Complement System	C1s	Antibody	Plasma	item_915
A205	C3 (C3c) Antibody (monoclonal)	Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway.	2018	ELISA	Human	Platelet factor 4 (PF4)/heparin complexes	Complement System	C3c	Antibody	Plasma	item_693
A201	C1q Antibody (monoclonal)	Proteinase 3 Interferes With C1q-Mediated Clearance of Apoptotic Cells.	2018	FC, IF	Human		Complement System	C1q	Antibody	Red Blood Cells	item_671
A201	C1q Antibody (monoclonal)	Proteinase 3 Interferes With C1q-Mediated Clearance of Apoptotic Cells.	2018	FC, IF	Rat		Complement System	C1q	Antibody	Basophilic Leukemia cells	item_676
8010	PYD EIA	Reducing protein oxidation reverses lung fibrosis.	2018	ELISA	Human		Bone/Renal Health	PYD	ELISA	Lung Tissue	item_47
A037	C1-lnhibitor Plus EIA	Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency.	2018	ELISA	Human	Hereditary Angioedema	Complement System	C1-INH	ELISA	Plasma	item_601
8007	DPD EIA	Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction.	2018	ELISA	Mouse		Bone/Renal Health	DPD	ELISA	Urine	item_32
A201	C1q Antibody (monoclonal)	Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus	2018	ELISA	Human	Systemic Lupus Erythematosus	Complement System	C1q	Antibody	Serum	item_664
A301	C1q Antibody (polyclonal)	Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus	2018	ELISA	Human	Systemic Lupus Erythematosus	Complement System	C1q	Antibody	Serum	item_899
60-6100	Human FGF-23 C-Term ELISA	The Heart and Kidney: Abnormal Phosphate Homeostasis Is Associated With Atherosclerosis.	2018	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_180
A301	C1q Antibody (polyclonal)	The Surface-Exposed Protein SntA Contributes to Complement Evasion in Zoonotic Streptococcus suis	2018	ELISA	Human		Complement System	C1q	Antibody	Purified protein	item_898
A400	C1q Protein	The Surface-Exposed Protein SntA Contributes to Complement Evasion in Zoonotic Streptococcus suis	2018	ELISA	Human		Complement System	C1q	Protein	Purified protein	item_1038
A509	C1q Depleted Sera	The Surface-Exposed Protein SntA Contributes to Complement Evasion in Zoonotic Streptococcus suis	2018	ELISA	N/A		Complement System	C1q	Depleted Sera	C1q Depleted Sera	item_1173
A037	C1-lnhibitor Plus EIA	The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis.	2018	ELISA	Human	Endometriosis	Complement System	C1-INH	ELISA	Peritoneal fluid	item_600
21-2310	Mouse PTH Antibody (53-84)	Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice.	2018	IP, WB	Mouse		Bone/Renal Health	PTH	Antibody	Liver Tissue	item_94
21-2310	Mouse PTH Antibody (53-84)	Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice.	2018	IP, WB	Mouse		Bone/Renal Health	PTH	Antibody	Parathyroid Tissue	item_95
21-2310	Mouse PTH Antibody (53-84)	Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice.	2018	IP, WB	Mouse		Bone/Renal Health	PTH	Antibody	Thymus Tissue	item_96
21-2320	Mouse PTH Antibody (1-12)	Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice.	2018	IHC, IP, WB	Mouse		Bone/Renal Health	PTH	Antibody	Liver Tissue	item_97
21-2320	Mouse PTH Antibody (1-12)	Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice.	2018	IHC, IP, WB	Mouse		Bone/Renal Health	PTH	Antibody	Parathyroid Tissue	item_98
21-2320	Mouse PTH Antibody (1-12)	Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice.	2018	IHC, IP, WB	Mouse		Bone/Renal Health	PTH	Antibody	Thymus Tissue	item_99
60-2305	Mouse PTH 1-84 ELISA	Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice.	2018	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Plasma	item_117
60-6600	Human FGF-23 (Intact) ELISA	Under-recognized Hypoparathyroidism in Thalassemia	2018	ELISA	Human	Hypoparathyroidism	Bone/Renal Health	FGF-23	ELISA	Plasma	item_203
60-6100	Human FGF-23 C-Term ELISA	Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes.	2018	ELISA	Human	Diabetes	Bone/Renal Health	FGF-23	ELISA	Plasma	item_149
A020	SC5b-9 Plus EIA	Venom from Bothrops lanceolatus, a Snake Species Native to Martinique, Potently Activates the Complement System	2018	ELISA	Human	B. lanceolatus venom	Complement System	sC5b-9	ELISA	Serum	item_369
A037	C1-lnhibitor Plus EIA	Venom from Bothrops lanceolatus, a Snake Species Native to Martinique, Potently Activates the Complement System	2018	ELISA	Human	B. lanceolatus venom	Complement System	C1-INH	ELISA	Serum	item_610
A305	C4 Antibody (polyclonal)	Venom from Bothrops lanceolatus, a Snake Species Native to Martinique, Potently Activates the Complement System	2018	ELISA	Human	B. lanceolatus venom	Complement System	C4	Antibody	Serum	item_930
A401	C3 Protein	Venom from Bothrops lanceolatus, a Snake Species Native to Martinique, Potently Activates the Complement System	2018	Silver Stain	Human	B. lanceolatus venom incubated	Complement System	C3	Protein	Purified protein	item_1063
A402	C4 Protein	Venom from Bothrops lanceolatus, a Snake Species Native to Martinique, Potently Activates the Complement System	2018	Silver Stain	Human	B. lanceolatus venom incubated	Complement System	C4	Protein	Purified protein	item_1074
A403	C5 Protein	Venom from Bothrops lanceolatus, a Snake Species Native to Martinique, Potently Activates the Complement System	2018	Silver Stain	Human	B. lanceolatus venom incubated	Complement System	C5	Protein	Purified protein	item_1082
A426	C1-INH Protein	Venom from Bothrops lanceolatus, a Snake Species Native to Martinique, Potently Activates the Complement System	2018	Silver Stain	Human	B. lanceolatus venom incubated	Complement System	C1-INH	Protein	Purified protein	item_1120
A020	SC5b-9 Plus EIA	rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs	2018	ELISA	Human	Fc activation	Complement System	sC5b-9	ELISA	Serum	item_368
A021	C5a EIA	rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs	2018	ELISA	Human	Fc activation	Complement System	C5a	ELISA	Serum	item_434
A035	C4a Fragment EIA	rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs	2018	ELISA	Human	Fc activation	Complement System	C4a	ELISA	Serum	item_596
A400	C1q Protein	rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs	2018	ELISA	Human	Fc activation	Complement System	C1q	Protein	Serum	item_1037
A509	C1q Depleted Sera	rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs	2018	ELISA	Human	Fc activation	Complement System	C1q	Depleted Sera	Serum	item_1168
A111	Normal Human Serum Complement	A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action.	2017	CDC Assay	Human		Complement System	Normal Human Serum	Reagent	A549 cells	item_643
A111	Normal Human Serum Complement	A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action.	2017	CDC Assay	Human		Complement System	Normal Human Serum	Reagent	WIL2-S cells	item_644
A033	Ba Fragment EIA	Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator.	2017	ELISA	Human	ARMS2 protein	Complement System	Ba	ELISA	Serum	item_576
A209	iC3b Antibody (monoclonal - neoantigen)	Arabinosylation of recombinant human immunoglobulin-based protein therapeutics	2017	ELISA	Human		Complement System	iC3b	Antibody	Serum	item_711
A021	C5a EIA	Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia	2017	ELISA	Human		Complement System	C5a	ELISA	Plasma	item_432
A031	C3a Plus EIA	Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia	2017	ELISA	Human		Complement System	C3a	ELISA	Plasma	item_537
A702	C3d Antibody (monoclonal) biotin	Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial	2017	FC	Human	HLA Positive	Complement System	C3d	Antibody	Serum	item_1211
8012	BAP EIA	Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis.	2017	ELISA	Human		Bone/Renal Health	BAP	ELISA	Serum	item_65
8033	TRAP5b EIA	Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis.	2017	ELISA	Human		Bone/Renal Health	TRAP5b	ELISA	Serum	item_87
A020	SC5b-9 Plus EIA	Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery	2017	ELISA	Human	Trauma, newborn brain	Complement System	sC5b-9	ELISA	Serum	item_364
A021	C5a EIA	Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery	2017	ELISA	Human	Trauma, newborn brain	Complement System	C5a	ELISA	Serum	item_431
A301	C1q Antibody (polyclonal)	Broad Susceptibility of Nucleolar Proteins and Autoantigens to Complement C1 Protease Degradation.	2017	WB	Human		Complement System	C1q	Antibody	HeLa Cells	item_902
A302	C1s Antibody (polyclonal)	Broad Susceptibility of Nucleolar Proteins and Autoantigens to Complement C1 Protease Degradation.	2017	WB	Human		Complement System	C1s	Antibody	HeLa Cells	item_912
8005	CICP EIA	Circulating LOXL 2 Levels Reflect Severity of Intestinal Fibrosis and GALT CD4 + T Lymphocyte Depletion in Treated HIV Infection.	2017	ELISA	Human	HIV	Bone/Renal Health	CICP	ELISA	Plasma	item_17
A001	CIC-C1q EIA	Circulating LOXL 2 Levels Reflect Severity of Intestinal Fibrosis and GALT CD4 + T Lymphocyte Depletion in Treated HIV Infection.	2017	ELISA	Human	HIV	Complement System	C1q	ELISA	Plasma	item_213
A009	C4d Fragment EIA	Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma	2017	ELISA	Human		Complement System	C4d	ELISA	Plasma	item_261
A031	C3a Plus EIA	Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma	2017	ELISA	Human		Complement System	C3a	ELISA	Plasma	item_539
A020	SC5b-9 Plus EIA	Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes.	2017	ELISA	Human	Diabetes	Complement System	sC5b-9	ELISA	Serum	item_285
A207	C3 (C3d) Antibody (monoclonal)	Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes.	2017	ELISA	Human	Diabetes	Complement System	C3d	Antibody	Serum	item_700
A111	Normal Human Serum Complement	Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCs.	2017	FC	Human		Complement System	Normal Human Serum	Reagent	Peripheral blood mononuclear cells	item_649
A600	CVF, Cobra Venom Factor	Complement Depletion Improves Human Red Blood Cell Reconstitution in Immunodeficient Mice	2017	Complement Depletion Assay	Mouse		Complement System	Cobra Venom Factor	Reagent	Serum	item_1195
A201	C1q Antibody (monoclonal)	Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth	2017	ELISA	Human		Complement System	C1q	Antibody	Mesenchymal Cells	item_663
A031	C3a Plus EIA	Complement Protein C3 Suppresses Axon Growth and Promotes Neuron Loss	2017	ELISA	Mouse		Complement System	C3a	ELISA	Neuron Cells	item_546
A401	C3 Protein	Complement Protein C3 Suppresses Axon Growth and Promotes Neuron Loss	2017	ELISA	Mouse		Complement System	C3	Protein	Neuron Cells	item_1066
A006	iC3b EIA	Complement Receptor 3 Has Negative Impact on Tumor Surveillance through Suppression of Natural Killer Cell Function	2017	ELISA	Human		Complement System	iC3b	ELISA	Serum	item_233
A209	iC3b Antibody (monoclonal - neoantigen)	Complement Receptor 3 Has Negative Impact on Tumor Surveillance through Suppression of Natural Killer Cell Function	2017	FC	Human		Complement System	iC3b	Antibody	NK Cells	item_719
A233	Factor P Antibody (monoclonal) #1	Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.	2017	WB	Human	SPIO nanoworms	Complement System	Factor P	Antibody	Plasma	item_810
A233	Factor P Antibody (monoclonal) #1	Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.	2017	WB	Human	SPIO nanoworms	Complement System	Factor P	Antibody	Serum	item_811
A401	C3 Protein	Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.	2017	Dot Blot	Human	SPIO nanoworms	Complement System	C3	Protein	Serum	item_1057
A408	Factor B Protein	Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.	2017	Dot Blot	Human	SPIO nanoworms	Complement System	Factor B	Protein	Serum	item_1096
A409	Factor D Protein	Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.	2017	Dot Blot	Human	SPIO nanoworms	Complement System	Factor D	Protein	Serum	item_1099
A412	Factor P Protein	Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.	2017	Dot Blot	Human	SPIO nanoworms	Complement System	Factor P	Protein	Serum	item_1113
A508	C3 Depleted Sera	Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.	2017	Dot Blot	Human	SPIO nanoworms	Complement System	C3	Depleted Sera	Serum	item_1153
A404	C6 Protein	Complement-Mediated Regulation of Apolipoprotein E in Cultured Human RPE Cells	2017	WB	Cell Culture		Complement System	C6	Protein	RPE Cells	item_1087
A502	C6 Depleted Sera	Complement-Mediated Regulation of Apolipoprotein E in Cultured Human RPE Cells	2017	WB	Cell Culture		Complement System	C6	Depleted Sera	RPE Cells	item_1132
A509	C1q Depleted Sera	Complement-Mediated Regulation of Apolipoprotein E in Cultured Human RPE Cells	2017	WB	Cell Culture		Complement System	C1q	Depleted Sera	RPE Cells	item_1160
A020	SC5b-9 Plus EIA	Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attack.	2017	ELISA	Human	Hereditary Angioedema	Complement System	sC5b-9	ELISA	Plasma	item_286
A021	C5a EIA	Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attack.	2017	ELISA	Human	Hereditary Angioedema	Complement System	C5a	ELISA	Plasma	item_380
A031	C3a Plus EIA	Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attack.	2017	ELISA	Human	Hereditary Angioedema	Complement System	C3a	ELISA	Plasma	item_486
A035	C4a Fragment EIA	Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attack.	2017	ELISA	Human	Hereditary Angioedema	Complement System	C4a	ELISA	Plasma	item_581
A600	CVF, Cobra Venom Factor	Discovery of monoclonal antibodies cross-reactive to novel subserotypes of K. pneumoniae O3	2017	Complement Depletion Assay	Human		Complement System	Cobra Venom Factor	Reagent	Serum	item_1183
A221	C7 Antibody (monoclonal)	Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults.	2017	Serum Bactericidal Assay	Human	Neisseria meningitidis	Complement System	C7	Antibody	Serum	item_782
A209	iC3b Antibody (monoclonal - neoantigen)	Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes.	2017	FC	Human	PNH	Complement System	iC3b	Antibody	Red Blood Cells	item_718
A227	Factor B (Bb) Antibody (monoclonal)	Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes.	2017	FC	Human	PNH	Complement System	Bb	Antibody	Red Blood Cells	item_796
A250	C3d Antibody (monoclonal - neoantigen)	Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes.	2017	FC	Human	PNH	Complement System	C3d	Antibody	Red Blood Cells	item_865
A020	SC5b-9 Plus EIA	Effect of Immobilized Antithrombin III on the Thromboresistance of Polycarbonate Urethane	2017	ELISA	Human		Complement System	sC5b-9	ELISA	Serum	item_365
A702	C3d Antibody (monoclonal) biotin	Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study	2017	FC	Human		Complement System	C3d	Antibody	Endothelial Cells	item_1209
A704	C4d Antibody (monoclonal) biotin	Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study	2017	FC	N/A		Complement System	C4d	Antibody	Single Antigen Flow Bead (CVF Treated)	item_1212
A400	C1q Protein	Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice	2017	ELISA	Human	Binding Assay	Complement System	C1q	Protein	C1q Protein	item_1035
A020	SC5b-9 Plus EIA	Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model	2017	ELISA	Mouse		Complement System	sC5b-9	ELISA	Serum	item_378
A600	CVF, Cobra Venom Factor	Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258	2017	Complement Depletion Assay	Mouse		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1194
8007	DPD EIA	Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells.	2017	ELISA	Mouse		Bone/Renal Health	DPD	ELISA	Urine	item_30
60-1305	Mouse Osteocalcin ELISA	Extra-nuclear effects of estrogen on cortical bone in males require ERαAF-1	2017	ELISA	Mouse		Bone/Renal Health	Osteocalcin	ELISA	Serum	item_113
A401	C3 Protein	Extracellular vesicles from KSHV-infected endothelial cells activate the complement system	2017	ELISA	Human	KSHV infection	Complement System	C3	Protein	HUVEC Cells	item_1062
A408	Factor B Protein	Extracellular vesicles from KSHV-infected endothelial cells activate the complement system	2017	ELISA	Human	KSHV infection	Complement System	Factor B	Protein	HUVEC Cells	item_1097
A412	Factor P Protein	Extracellular vesicles from KSHV-infected endothelial cells activate the complement system	2017	ELISA	Human	KSHV infection	Complement System	Factor P	Protein	HUVEC Cells	item_1114
A502	C6 Depleted Sera	Extracellular vesicles from KSHV-infected endothelial cells activate the complement system	2017	ELISA	Human	KSHV infection	Complement System	C6	Depleted Sera	HUVEC Cells	item_1133
A506	Factor B Depleted Sera	Extracellular vesicles from KSHV-infected endothelial cells activate the complement system	2017	ELISA	Human	KSHV infection	Complement System	Factor B	Depleted Sera	HUVEC Cells	item_1148
A508	C3 Depleted Sera	Extracellular vesicles from KSHV-infected endothelial cells activate the complement system	2017	ELISA	Human	KSHV infection	Complement System	C3	Depleted Sera	HUVEC Cells	item_1154
A100	Human Complement Standard	Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity.	2017	CDC Assay	Cell Culture		Complement System	Complement Standard	Reagent	Raji cells	item_617
A201	C1q Antibody (monoclonal)	Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity.	2017	FC	Cell Culture		Complement System	C1q	Antibody	Raji cells	item_656
A501	C5 Depleted Sera	Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity.	2017	CDC Assay	Cell Culture		Complement System	C2	Depleted Sera	Raji cells	item_1125
A700	C1q Antibody (monoclonal) biotin	Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity.	2017	FC	Cell Culture		Complement System	C1q	Antibody	Raji cells	item_1202
A020	SC5b-9 Plus EIA	High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients	2017	ELISA	Human		Complement System	sC5b-9	ELISA	Peritoneal dialysis fluid	item_363
A018	CH50 Eq EIA	Host- and pathogen-derived adjuvant coatings on protein nanoparticle vaccines	2017	ELISA	Human	Nanoparticles incubated	Complement System	CH50	ELISA	Serum	item_279
A009	C4d Fragment EIA	IgG Fc Domains That Bind C1q but Not Effector Fcγ Receptors Delineate the Importance of Complement-Mediated Effector Functions	2017	ELISA	Human		Complement System	C4d	ELISA	Serum	item_237
20261	Pan-Specific C3 Reagent Kit	Immunological response to nitroglycerin-loaded shear-responsive liposomes in vitro and in vivo	2017	ELISA	Porcine		Bone/Renal Health	C3	ELISA	Serum	item_93
A009	C4d Fragment EIA	Immunological response to nitroglycerin-loaded shear-responsive liposomes in vitro and in vivo	2017	ELISA	Human		Complement System	C4d	ELISA	Serum	item_259
A020	SC5b-9 Plus EIA	Immunological response to nitroglycerin-loaded shear-responsive liposomes in vitro and in vivo	2017	ELISA	Human		Complement System	sC5b-9	ELISA	Serum	item_366
A027	Bb Plus Fragment EIA	Immunological response to nitroglycerin-loaded shear-responsive liposomes in vitro and in vivo	2017	ELISA	Human		Complement System	Bb	ELISA	Serum	item_472
A706	C6 Antibody (monoclonal) biotin	Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis	2017	ELISA	Human		Complement System	C6	Antibody	Plasma	item_1219
A301	C1q Antibody (polyclonal)	Neurotoxic reactive astrocytes are induced by activated microglia	2017	Neutralization	Rat		Complement System	C1q	Antibody	Protein Injection	item_908
8005	CICP EIA	New insights into tenocyte-immune cell interplay in an in vitro model of inflammation.	2017	ELISA	Human		Bone/Renal Health	CICP	ELISA	Peripheral blood mononuclear cells	item_19
A253	C4d Antibody (monoclonal)	Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus.	2017	ELISA	Human		Complement System	C4d	Antibody	Plasma	item_877
A207	C3 (C3d) Antibody (monoclonal)	Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases.	2017	IHC	Human		Complement System	C3d	Antibody	Aorta Tissue	item_705
A009	C4d Fragment EIA	Platelets are activated in ANCA-associated vasculitis via thrombin-PARs pathway and can activate the alternative complement pathway	2017	ELISA	Human	ANCA-AAV	Complement System	C4d	ELISA	Plasma	item_260
A020	SC5b-9 Plus EIA	Platelets are activated in ANCA-associated vasculitis via thrombin-PARs pathway and can activate the alternative complement pathway	2017	ELISA	Human	ANCA-AAV	Complement System	sC5b-9	ELISA	Plasma	item_367
A021	C5a EIA	Platelets are activated in ANCA-associated vasculitis via thrombin-PARs pathway and can activate the alternative complement pathway	2017	ELISA	Human	ANCA-AAV	Complement System	C5a	ELISA	Plasma	item_433
A031	C3a Plus EIA	Platelets are activated in ANCA-associated vasculitis via thrombin-PARs pathway and can activate the alternative complement pathway	2017	ELISA	Human	ANCA-AAV	Complement System	C3a	ELISA	Plasma	item_538
A233	Factor P Antibody (monoclonal) #1	Properdin binding to complement activating surfaces depends on initial C3b deposition	2017	ELISA, WB	Human		Complement System	Factor P	Antibody	Serum	item_807
A235	Factor P Antibody (monoclonal) #2	Properdin binding to complement activating surfaces depends on initial C3b deposition	2017	ELISA, WB	Human		Complement System	Factor P	Antibody	Serum	item_820
A401	C3 Protein	Properdin binding to complement activating surfaces depends on initial C3b deposition	2017	ELISA	Human		Complement System	C3	Protein	Serum	item_1061
A706	C6 Antibody (monoclonal) biotin	Surface modification of pig endothelial cells with a branched heparin conjugate improves their compatibility with human blood	2017	ELISA	Human		Complement System	C6	Antibody	Plasma	item_1218
A111	Normal Human Serum Complement	T0001, a variant of TNFR2-Fc fusion protein, exhibits improved Fc effector functions through increased binding to membrane-bound TNFα.	2017	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	CHO cells	item_635
8007	DPD EIA	The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction	2017	ELISA	Mouse		Bone/Renal Health	DPD	ELISA	Urine	item_31
60-2305	Mouse PTH 1-84 ELISA	The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction	2017	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Plasma	item_116
60-6800	Mouse/Rat FGF-23 (Intact) ELISA	The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction	2017	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Plasma	item_204
A702	C3d Antibody (monoclonal) biotin	V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.	2017	FC	Human	HIV	Complement System	C3d	Antibody	Plasma	item_1210
A009	C4d Fragment EIA	A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface	2016	ELISA	Human		Complement System	C4d	ELISA	Serum	item_257
A009	C4d Fragment EIA	Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking.	2016	ELISA	Human		Complement System	C4d	ELISA	Serum	item_258
A020	SC5b-9 Plus EIA	Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking.	2016	ELISA	Human		Complement System	sC5b-9	ELISA	Serum	item_361
A021	C5a EIA	Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking.	2016	ELISA	Human		Complement System	C5a	ELISA	Serum	item_428
A027	Bb Plus Fragment EIA	Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking.	2016	ELISA	Human		Complement System	Bb	ELISA	Serum	item_471
A312	Factor H Antibody (polyclonal)	Annexin A2 Enhances Complement Activation by Inhibiting Factor H	2016	ELISA, WB	Mouse		Complement System	Factor H	Antibody	Kidney Tissue	item_1012
A312	Factor H Antibody (polyclonal)	Annexin A2 Enhances Complement Activation by Inhibiting Factor H	2016	ELISA, WB	Mouse		Complement System	Factor H	Antibody	Plasma	item_1013
A400	C1q Protein	Apoptosis signal-regulating kinase 1 mediates striatal degeneration via the regulation of C1q	2016	Complement Activation Assay	Rat		Complement System	C1q	Protein	Protein Injection	item_1053
A209	iC3b Antibody (monoclonal - neoantigen)	Bacillus anthracis Spore Surface Protein BclA Mediates Complement Factor H Binding to Spores and Promotes Spore Persistence.	2016	FC	Human	B. anthracis incubated	Complement System	iC3b	Antibody	Serum	item_717
60-6100	Human FGF-23 C-Term ELISA	C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population	2016	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_175
60-6600	Human FGF-23 (Intact) ELISA	C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population	2016	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_201
A400	C1q Protein	C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus	2016	ELISA	Human		Complement System	C1q	Protein	Serum	item_1036
A302	C1s Antibody (polyclonal)	C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.	2016	IHC	Human	Malignant cancer	Complement System	C1s	Antibody	Breast Tissue, Colon Tissue, Lung Tissue, Pancreas Tissue, Skin Tissue	item_910
A201	C1q Antibody (monoclonal)	C1q propagates microglial activation and neurodegeneration in the visual axis following retinal ischemia/reperfusion injury.	2016	IF	Mouse		Complement System	C1q	Antibody	Retina Tissue	item_675
8005	CICP EIA	Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis.	2016	ELISA	Rabbit		Bone/Renal Health	CICP	ELISA	Plasma	item_23
8007	DPD EIA	Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis.	2016	ELISA	Rabbit		Bone/Renal Health	DPD	ELISA	Urine	item_36
8009	Creatinine EIA	Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis.	2016	ELISA	Rabbit		Bone/Renal Health	Creatinine	ELISA	Urine	item_44
A600	CVF, Cobra Venom Factor	Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft	2016	Complement Depletion Assay	Baboon		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1176
A706	C6 Antibody (monoclonal) biotin	Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis	2016	ELISA	Human		Complement System	C6	Antibody	Plasma	item_1216
A600	CVF, Cobra Venom Factor	Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies	2016	Complement Depletion Assay	Rat		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1201
A600	CVF, Cobra Venom Factor	Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G	2016	Complement Depletion Assay	Rat		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1200
60-6600	Human FGF-23 (Intact) ELISA	Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals	2016	ELISA	Human	HIV	Bone/Renal Health	FGF-23	ELISA	Plasma	item_200
A706	C6 Antibody (monoclonal) biotin	Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in Pigs	2016	ELISA	Human	Myocardial necrosis, vascular damage and inflammation	Complement System	C6	Antibody	Serum	item_1217
60-2305	Mouse PTH 1-84 ELISA	Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia	2016	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Serum	item_127
60-3100	Human PTH ELISA	Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia	2016	ELISA	Human		Bone/Renal Health	PTH	ELISA	Plasma	item_146
60-6100	Human FGF-23 C-Term ELISA	Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia	2016	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_176
60-6300	Mouse/Rat FGF-23 C-Term ELISA	Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia	2016	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Serum	item_187
60-6600	Human FGF-23 (Intact) ELISA	Dietary phosphate supplement does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia	2016	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_202
8007	DPD EIA	Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain.	2016	ELISA	Rat		Bone/Renal Health	DPD	ELISA	Urine	item_38
60-1505	Rat Osteocalcin ELISA	Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain.	2016	ELISA	Rat		Bone/Renal Health	Osteocalcin	ELISA	Serum	item_114
A400	C1q Protein	Evading pre-existing anti-hinge antibody binding by hinge engineering	2016	ELISA	Human	Anti-hinge antibodies	Complement System	C1q	Protein	Serum	item_1034
A407	C9 Protein	Exome Sequencing Reveals Primary Immunodeficiencies in Children with Community-Acquired Pseudomonas aeruginosa Sepsis	2016	Lysis assay	Human	C9 deficient and EA cells incubated	Complement System	C9	Protein	Serum	item_1095
8010	PYD EIA	Exposure to chronic alcohol accelerates development of wall stress and eccentric remodeling in rats with volume overload.	2016	ELISA	Rat		Bone/Renal Health	PYD	ELISA	Heart Tissue	item_51
A306	C5 Antibody (polyclonal)	FACIN, a Double-Edged Sword of the Emerging Periodontal Pathogen Filifactor Alocis: A Metabolic Enzyme Moonlighting as a Complement Inhibitor.	2016	ELISA	Human		Complement System	C5	Antibody	Serum	item_938
A311	Factor B Antibody (polyclonal)	FACIN, a Double-Edged Sword of the Emerging Periodontal Pathogen Filifactor Alocis: A Metabolic Enzyme Moonlighting as a Complement Inhibitor.	2016	WB	Bacteria		Complement System	Factor B	Antibody	Filifactor alocis	item_970
60-2305	Mouse PTH 1-84 ELISA	Hypochlorhydria-induced calcium malabsorption does not affect fracture healing but increases post-traumatic bone loss in the intact skeleton	2016	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Serum	item_126
A018	CH50 Eq EIA	Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation	2016	ELISA	Human		Complement System	CH50	ELISA	Serum	item_278
A020	SC5b-9 Plus EIA	Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation	2016	ELISA	Human	Imprime yeast treated	Complement System	sC5b-9	ELISA	Plasma	item_362
A021	C5a EIA	Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation	2016	ELISA	Human	Imprime yeast treated	Complement System	C5a	ELISA	Plasma	item_429
A035	C4a Fragment EIA	Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation	2016	ELISA	Human	Imprime yeast treated	Complement System	C4a	ELISA	Plasma	item_595
A201	C1q Antibody (monoclonal)	Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation	2016	FC	Human	Imprime yeast treated	Complement System	C1q	Antibody	Neutrophils	item_669
A201	C1q Antibody (monoclonal)	Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation	2016	FC	Human		Complement System	C1q	Antibody	Monocytes	item_670
A020	SC5b-9 Plus EIA	In vitro eradication of citrullinated protein specific B-lymphocytes of rheumatoid arthritis patients by targeted bifunctional nanoparticles	2016	ELISA	Human	Nanoparticles incubated	Complement System	sC5b-9	ELISA	Serum	item_358
60-2305	Mouse PTH 1-84 ELISA	Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production	2016	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Serum	item_125
60-6300	Mouse/Rat FGF-23 C-Term ELISA	Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production	2016	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Serum	item_186
A020	SC5b-9 Plus EIA	Inflammatory Response in Preterm and Very Preterm Newborns with Sepsis	2016	ELISA	Human		Complement System	sC5b-9	ELISA	Serum	item_360
A301	C1q Antibody (polyclonal)	Intravenous Immunoglobulin With Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes.	2016	ELISA	N/A	Exposed to ferrous ions	Complement System	C1q	Antibody	IVIg	item_906
A309	C8 Antibody (polyclonal)	Invasive meningococcal disease in three siblings with hereditary deficiency of the 8(th) component of complement: evidence for the importance of an early diagnosis.	2016	WB	Human	C8 Deficient w/Invasive meningococcal disease	Complement System	C8	Antibody	Serum	item_960
A207	C3 (C3d) Antibody (monoclonal)	Ligation of Glycophorin A Generates Reactive Oxygen Species Leading to Decreased Red Blood Cell Function	2016	FC	Human		Complement System	C3d	Antibody	Red Blood Cells	item_703
A213	C4 (C4d) Antibody (monoclonal)	Ligation of Glycophorin A Generates Reactive Oxygen Species Leading to Decreased Red Blood Cell Function	2016	FC	Human		Complement System	C4d	Antibody	Red Blood Cells	item_752
A254	Factor H Antibody (monoclonal) #2	Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD	2016	ELISA	Human		Complement System	Factor H	Antibody	Purified Protein	item_881
A254	Factor H Antibody (monoclonal) #2	Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD	2016	ELISA	Human		Complement System	Factor H	Antibody	Serum	item_882
A312	Factor H Antibody (polyclonal)	Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD	2016	ELISA	Human		Complement System	Factor H	Antibody	Purified Protein	item_999
A312	Factor H Antibody (polyclonal)	Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD	2016	ELISA	Human		Complement System	Factor H	Antibody	Serum	item_1000
8010	PYD EIA	Maternal Dietary Supplementation with Oligofructose-Enriched Inulin in Gestating/Lactating Rats Preserves Maternal Bone and Improves Bone Microarchitecture in Their Offspring.	2016	ELISA	Mouse		Bone/Renal Health	PYD	ELISA	Urine	item_50
60-2700	Rat Bioactive PTH ELISA	Moderately Low Magnesium Intake Impairs Growth of Lean Body Mass in Obese-Prone and Obese-Resistant Rats Fed a High-Energy Diet	2016	ELISA	Rat		Bone/Renal Health	PTH	ELISA	Serum	item_137
8007	DPD EIA	Moderately Low Magnesium Intake Impairs Growth of Lean Body Mass in Obese-Prone and Obese-Resistant Rats Fed a High-Energy Diet.	2016	ELISA	Rat		Bone/Renal Health	DPD	ELISA	Urine	item_37
A600	CVF, Cobra Venom Factor	Molecular response of chorioretinal endothelial cells to complement injury: implications for macular degeneration	2016	Complement Depletion Assay	Human		Complement System	Cobra Venom Factor	Reagent	Serum	item_1182
A600	CVF, Cobra Venom Factor	Nanoparticles size-dependently initiate self-limiting NETosis-driven inflammation	2016	Complement Activation Assay	Human		Complement System	Cobra Venom Factor	Reagent	Serum	item_1180
8001	Osteocalcin EIA	Negative Effects of Total Gastrectomy on Bone Tissue Metabolism and Volumetric Bone Mineral Density (vBMD) of Lumbar Spine in 1-Year Study in Men.	2016	ELISA	Human		Bone/Renal Health	Osteocalcin	ELISA	Serum	item_4
8005	CICP EIA	Negative Effects of Total Gastrectomy on Bone Tissue Metabolism and Volumetric Bone Mineral Density (vBMD) of Lumbar Spine in 1-Year Study in Men.	2016	ELISA	Human		Bone/Renal Health	CICP	ELISA	Serum	item_16
8019	Serum PYD EIA	Negative Effects of Total Gastrectomy on Bone Tissue Metabolism and Volumetric Bone Mineral Density (vBMD) of Lumbar Spine in 1-Year Study in Men.	2016	ELISA	Human		Bone/Renal Health	PYD	ELISA	Serum	item_74
A400	C1q Protein	Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival	2016	Binding Assay	Human	dnDSA	Complement System	C1q	Protein	Serum	item_1028
A700	C1q Antibody (monoclonal) biotin	Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival	2016	Binding Assay	Human	dnDSA	Complement System	C1q	Antibody	Serum	item_1203
A020	SC5b-9 Plus EIA	Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation.	2016	ELISA	Human		Complement System	sC5b-9	ELISA	ARPE-19 Cells	item_284
A021	C5a EIA	Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation.	2016	ELISA	Human		Complement System	C5a	ELISA	ARPE-19 Cells	item_379
A031	C3a Plus EIA	Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation.	2016	ELISA	Human		Complement System	C3a	ELISA	ARPE-19 Cells	item_485
A201	C1q Antibody (monoclonal)	Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation.	2016	WB	Human		Complement System	C1q	Antibody	ARPE-19 Cells	item_674
A311	Factor B Antibody (polyclonal)	Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation.	2016	WB	Human		Complement System	Factor B	Antibody	ARPE-19 cells	item_976
60-6100	Human FGF-23 C-Term ELISA	Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease	2016	ELISA	Human	Acute Coronary Syndrome	Bone/Renal Health	FGF-23	ELISA	Plasma	item_174
A021	C5a EIA	Platelet-borne complement proteins and their role in platelet–bacteria interactions	2016	ELISA	Human		Complement System	C5a	ELISA	Plasma	item_427
A031	C3a Plus EIA	Platelet-borne complement proteins and their role in platelet–bacteria interactions	2016	ELISA	Human		Complement System	C3a	ELISA	Plasma	item_536
A301	C1q Antibody (polyclonal)	Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis	2016	WB	Cell Culture		Complement System	C1q	Antibody	Jurkat Cells	item_895
A111	Normal Human Serum Complement	Recruitment of Factor H to the Streptococcus suis Cell Surface is Multifactorial.	2016	Phagocytosis assay	Cell Culture		Complement System	Normal Human Serum	Reagent	THP-1 Cells	item_636
A312	Factor H Antibody (polyclonal)	Recruitment of Factor H to the Streptococcus suis Cell Surface is Multifactorial.	2016	ELISA	Bacteria		Complement System	Factor H	Antibody	Streptococcus suis	item_988
A306	C5 Antibody (polyclonal)	Regulation of C3 Activation by the Alternative Complement Pathway in the Mouse Retina	2016	WB	Mouse		Complement System	C5	Antibody	Plasma	item_945
A311	Factor B Antibody (polyclonal)	Regulation of C3 Activation by the Alternative Complement Pathway in the Mouse Retina	2016	WB	Mouse		Complement System	Factor B	Antibody	Plasma	item_986
A312	Factor H Antibody (polyclonal)	Regulation of C3 Activation by the Alternative Complement Pathway in the Mouse Retina	2016	WB	Mouse		Complement System	Factor H	Antibody	Plasma	item_1016
8012	BAP EIA	Relationship of serum GDF11 levels with bone mineral density and bone turnover markers in postmenopausal Chinese women.	2016	ELISA	Human	Postmenopausal women	Bone/Renal Health	BAP	ELISA	Serum	item_64
60-6100	Human FGF-23 C-Term ELISA	Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy	2016	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_177
60-1505	Rat Osteocalcin ELISA	Standardization of A Physiologic Hypoparathyroidism Animal Model	2016	ELISA	Rat		Bone/Renal Health	Osteocalcin	ELISA	Serum	item_115
60-2700	Rat Bioactive PTH ELISA	Standardization of A Physiologic Hypoparathyroidism Animal Model	2016	ELISA	Rat		Bone/Renal Health	PTH	ELISA	Serum	item_138
A020	SC5b-9 Plus EIA	Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.	2016	ELISA	Human		Complement System	sC5b-9	ELISA	Serum	item_359
A227	Factor B (Bb) Antibody (monoclonal)	Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.	2016	ELISA	Human		Complement System	Bb	Antibody	Serum	item_793
A253	C4d Antibody (monoclonal)	Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.	2016	ELISA	Human		Complement System	C4d	Antibody	Serum	item_875
A111	Normal Human Serum Complement	The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®.	2016	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	KIT225/K6 cells	item_634
A710	iC3b Antibody (monoclonal) biotin	The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation	2016	ELISA	Human		Complement System	iC3b	Antibody	Serum	item_1221
A239	sC5b-9 Antibody (monoclonal - neoantigen)	The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement	2016	IF, WB	Cell Culture		Complement System	sC5b-9	Antibody	Plasmodium falciparum culture	item_829
A239	sC5b-9 Antibody (monoclonal - neoantigen)	The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement	2016	IF, WB	Human	Plasmodium falciparum incubated	Complement System	sC5b-9	Antibody	Red Blood Cells	item_843
A304	C3 Antibody (polyclonal)	The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement	2016	IF, WB	Cell Culture		Complement System	C3	Antibody	Plasmodium falciparum culture	item_921
A304	C3 Antibody (polyclonal)	The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement	2016	IF, WB	Human	Plasmodium falciparum incubated	Complement System	C3	Antibody	Red Blood Cells	item_927
A701	C3c Antibody (monoclonal) biotin	The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21).	2016	FC	Human	Platelet factor 4 (PF4)/heparin complexes	Complement System	C3c	Antibody	Serum	item_1206
A219	C6 Antibody (monoclonal)	The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis	2016	ELISA	Human		Complement System	C6	Antibody	Synovial fluid	item_777
A235	Factor P Antibody (monoclonal) #2	The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis	2016	ELISA	Human		Complement System	Factor P	Antibody	Synovial fluid	item_818
A253	C4d Antibody (monoclonal)	The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis	2016	ELISA	Human		Complement System	C4d	Antibody	Synovial fluid	item_876
A509	C1q Depleted Sera	The relevance of coagulation factor X protection of adenoviruses in human sera	2016	ELISA	Human	Adenovirus incubated	Complement System	C1q	Depleted Sera	Serum	item_1167
A021	C5a EIA	VEGF regulates local inhibitory complement proteins in the eye and kidney	2016	ELISA	Human		Complement System	C5a	ELISA	Aqueous humour	item_430
A207	C3 (C3d) Antibody (monoclonal)	VEGF regulates local inhibitory complement proteins in the eye and kidney	2016	IF	Human	ARMD CFH 402 polymorphism	Complement System	C3d	Antibody	iPS cells	item_704
A213	C4 (C4d) Antibody (monoclonal)	VEGF regulates local inhibitory complement proteins in the eye and kidney	2016	IF	Human		Complement System	C4d	Antibody	iPS cells	item_754
A006	iC3b EIA	quantitative lateral flow assay to detect complement activation in blood.	2015	ELISA	Human		Complement System	iC3b	ELISA	Plasma	item_231
A209	iC3b Antibody (monoclonal - neoantigen)	quantitative lateral flow assay to detect complement activation in blood.	2015	Lateral Flow Assay	Human		Complement System	iC3b	Antibody	Plasma	item_727
A037	C1-lnhibitor Plus EIA	A Nationwide Study of Norwegian Patients with Hereditary Angioedema with C1 Inhibitor Deficiency Identified Six Novel Mutations in SERPING1	2015	ELISA	Human	Hereditary Angioedema	Complement System	C1-INH	ELISA	Serum	item_608
A111	Normal Human Serum Complement	A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus.	2015	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	CHO Cells	item_633
A020	SC5b-9 Plus EIA	A serine protease isolated from the bristles of the Amazonic caterpillar, Premolis semirufa, is a potent complement system activator.	2015	ELISA	Human	Premolis semirufa caterpillar bristle extract	Complement System	sC5b-9	ELISA	Serum	item_354
A305	C4 Antibody (polyclonal)	A serine protease isolated from the bristles of the Amazonic caterpillar, Premolis semirufa, is a potent complement system activator.	2015	ELISA	Human	Premolis semirufa caterpillar bristle extract	Complement System	C4	Antibody	Serum	item_929
A401	C3 Protein	A serine protease isolated from the bristles of the Amazonic caterpillar, Premolis semirufa, is a potent complement system activator.	2015	Silver Stain	Premolis semirufa (Caterpillar)		Complement System	C3	Protein	Bristle Extract	item_1070
A402	C4 Protein	A serine protease isolated from the bristles of the Amazonic caterpillar, Premolis semirufa, is a potent complement system activator.	2015	Silver Stain	Premolis semirufa (Caterpillar)		Complement System	C4	Protein	Bristle Extract	item_1076
A403	C5 Protein	A serine protease isolated from the bristles of the Amazonic caterpillar, Premolis semirufa, is a potent complement system activator.	2015	Silver Stain	Premolis semirufa (Caterpillar)		Complement System	C5	Protein	Bristle Extract	item_1084
A217	C5 Antibody (monoclonal)	Activation of complement system in kidney after ketoprofen-induced kidney injury in sheep	2015	IHC	Human		Complement System	C5	Antibody	Kidney Tissue	item_772
A223	C9 Antibody (monoclonal)	Activation of complement system in kidney after ketoprofen-induced kidney injury in sheep	2015	IHC	Human		Complement System	C9	Antibody	Kidney Tissue	item_784
A312	Factor H Antibody (polyclonal)	Activation of complement system in kidney after ketoprofen-induced kidney injury in sheep	2015	IHC	Human		Complement System	Factor H	Antibody	Kidney Tissue	item_1006
A009	C4d Fragment EIA	Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome	2015	ELISA	Human	Stx-HUS	Complement System	C4d	ELISA	Plasma	item_254
A020	SC5b-9 Plus EIA	Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome	2015	ELISA	Human	Stx-HUS	Complement System	sC5b-9	ELISA	Plasma	item_353
A027	Bb Plus Fragment EIA	Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome	2015	ELISA	Human	Stx-HUS	Complement System	Bb	ELISA	Plasma	item_466
A217	C5 Antibody (monoclonal)	An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA.	2015	FC	Cell Culture		Complement System	C5	Antibody	HAEC Cells	item_765
A251	C4d Antibody (monoclonal - neoantigen)	An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA.	2015	Complement Activation Assay	Human		Complement System	C4d	Antibody	EBC B Cells	item_869
8005	CICP EIA	Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy.	2015	ELISA	Rhesus Monkey		Bone/Renal Health	CICP	ELISA	Serum	item_24
60-6100	Human FGF-23 C-Term ELISA	Aortic Artery and Cardiac Valve Calcification are Associated with Mortality in Chinese Hemodialysis Patients: A 3.5 Years Follow-up	2015	ELISA	Human	MHD	Bone/Renal Health	FGF-23	ELISA	Plasma	item_173
A403	C5 Protein	CD14 and complement crosstalk and largely mediate the transcriptional response to Escherichia coli in human whole blood as revealed by DNA microarray	2015	Microarray	Human		Complement System	C5	Protein	Whole Blood	item_1081
8019	Serum PYD EIA	Cardioprotective effects of lysyl oxidase inhibition against volume overload-induced extracellular matrix remodeling.	2015	ELISA	Rat		Bone/Renal Health	PYD	ELISA	Heart Tissue	item_81
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy	2015	IHC	Human	Thrombotic Microangiopathy	Complement System	sC5b-9	Antibody	Kidney Tissue	item_847
A031	C3a Plus EIA	Complement Factor H Expressed by Retinal Pigment Epithelium Cells Can Suppress Neovascularization of Human Umbilical Vein Endothelial Cells: An in vitro Study	2015	ELISA	Human		Complement System	C3a	ELISA	ARPE-19 Cells	item_533
A031	C3a Plus EIA	Complement Factor H Expressed by Retinal Pigment Epithelium Cells Can Suppress Neovascularization of Human Umbilical Vein Endothelial Cells: An in vitro Study	2015	ELISA	Human		Complement System	C3a	ELISA	Serum	item_534
A312	Factor H Antibody (polyclonal)	Complement Factor H Expressed by Retinal Pigment Epithelium Cells Can Suppress Neovascularization of Human Umbilical Vein Endothelial Cells: An in vitro Study	2015	IF, WB	Human		Complement System	Factor H	Antibody	ARPE-19 cells	item_1005
A027	Bb Plus Fragment EIA	Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia	2015	ELISA	Human		Complement System	Bb	ELISA	Amniotic Fluid	item_469
A027	Bb Plus Fragment EIA	Complement factor B activation in patients with preeclampsia	2015	ELISA	Human		Complement System	Bb	ELISA	Umbillical cord blood	item_465
A600	CVF, Cobra Venom Factor	Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques	2015	Complement Depletion Assay	Rat		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1199
A301	C1q Antibody (polyclonal)	Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo	2015	IP	Mouse	Cerebellum myelin substrate	Complement System	C1q	Antibody	Brain Tissue	item_905
A400	C1q Protein	Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo	2015	ELISA, IP	Mouse	Cerebellum myelin substrate	Complement System	C1q	Protein	Brain Tissue	item_1045
A401	C3 Protein	Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo	2015	ELISA	Mouse	Cerebellum myelin substrate	Complement System	C3	Protein	Brain Tissue	item_1065
A111	Normal Human Serum Complement	Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells.	2015	ELISA	Virus	Purified	Complement System	Normal Human Serum	Reagent	HIV	item_652
A001	CIC-C1q EIA	DNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria Patients	2015	ELISA	Human	Malaria	Complement System	C1q	ELISA	Serum	item_221
8012	BAP EIA	Different health behaviours and clinical factors associated with bone mineral density and bone turnover in premenopausal women with and without type 1 diabetes.	2015	ELISA	Human	Premenopausal Women w/wo Type 1 Diabetes	Bone/Renal Health	BAP	ELISA	Serum	item_61
8033	TRAP5b EIA	Different health behaviours and clinical factors associated with bone mineral density and bone turnover in premenopausal women with and without type 1 diabetes.	2015	ELISA	Human	Premenopausal Women w/wo Type 1 Diabetes	Bone/Renal Health	TRAP5b	ELISA	Serum	item_85
8012	BAP EIA	Effects of an 8-Month Ashtanga-Based Yoga Intervention on Bone Metabolism in Middle-Aged Premenopausal Women: A Randomized Controlled Study.	2015	ELISA	Human	Middle-Aged Premenopausal Women	Bone/Renal Health	BAP	ELISA	Serum	item_63
8033	TRAP5b EIA	Effects of an 8-Month Ashtanga-Based Yoga Intervention on Bone Metabolism in Middle-Aged Premenopausal Women: A Randomized Controlled Study.	2015	ELISA	Human	Middle-Aged Premenopausal Women	Bone/Renal Health	TRAP5b	ELISA	Serum	item_86
A600	CVF, Cobra Venom Factor	Efficiency of conditionally attenuated Salmonella enterica serovar Typhimurium in bacterium-mediated tumor therapy	2015	Complement Depletion Assay	Mouse		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1193
8012	BAP EIA	Ethnic differences in urinary calcium and phosphate excretion between Gambian and British older adults	2015	ELISA	Human		Bone/Renal Health	BAP	ELISA	Plasma	item_60
60-2305	Mouse PTH 1-84 ELISA	Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23	2015	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Serum	item_124
60-2500	Rat PTH ELISA	Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23	2015	ELISA	Rat		Bone/Renal Health	PTH	ELISA	Serum	item_132
A227	Factor B (Bb) Antibody (monoclonal)	Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding Protein	2015	FC	Human	Meningococcal infected	Complement System	Bb	Antibody	Serum	item_795
A033	Ba Fragment EIA	Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis	2015	ELISA	Human		Complement System	Ba	ELISA	Serum	item_575
A205	C3 (C3c) Antibody (monoclonal)	Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis	2015	FC	Human		Complement System	C3c	Antibody	Endothelial Cells	item_697
A021	C5a EIA	Genetic engineering strategies to prevent the effects of antibody and complement on xenogeneic chondrocytes	2015	ELISA	Human	Porcine articular chondrocytes	Complement System	C5a	ELISA	Serum	item_424
A027	Bb Plus Fragment EIA	Genetic engineering strategies to prevent the effects of antibody and complement on xenogeneic chondrocytes	2015	ELISA	Human		Complement System	Bb	ELISA	Serum	item_470
A031	C3a Plus EIA	Genetic engineering strategies to prevent the effects of antibody and complement on xenogeneic chondrocytes	2015	ELISA	Human	Porcine articular chondrocytes	Complement System	C3a	ELISA	Serum	item_535
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Genetic engineering strategies to prevent the effects of antibody and complement on xenogeneic chondrocytes	2015	FC	Porcine		Complement System	sC5b-9	Antibody	Articular chondrocytes	item_850
A504	C8 Depleted Sera	Genetic engineering strategies to prevent the effects of antibody and complement on xenogeneic chondrocytes	2015	FC	Porcine		Complement System	C8	Depleted Sera	Articular chondrocytes	item_1140
60-1305	Mouse Osteocalcin ELISA	High insulin levels in KK-Ay diabetic mice cause increased cortical bone mass and impaired trabecular micro-structure	2015	ELISA	Mouse		Bone/Renal Health	Osteocalcin	ELISA	Serum	item_112
8001	Osteocalcin EIA	Higher daily physical activity is associated with higher osteocalcin levels in adolescents.	2015	ELISA	Human	Obesity, children	Bone/Renal Health	Osteocalcin	ELISA	Serum	item_3
8012	BAP EIA	Higher daily physical activity is associated with higher osteocalcin levels in adolescents.	2015	ELISA	Human	Obesity, children	Bone/Renal Health	BAP	ELISA	Serum	item_62
A509	C1q Depleted Sera	Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation	2015	CDC Assay	Human		Complement System	C1q	Depleted Sera	Daudi Cells	item_1161
8005	CICP EIA	Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C.	2015	ELISA	Human	HCV Infected	Bone/Renal Health	CICP	ELISA	Liver Myofibroblasts	item_15
A018	CH50 Eq EIA	Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.	2015	ELISA	Human	Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS)	Complement System	CH50	ELISA	Serum	item_267
A207	C3 (C3d) Antibody (monoclonal)	Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.	2015	WB	Human	Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS)	Complement System	C3d	Antibody	Serum	item_706
A213	C4 (C4d) Antibody (monoclonal)	Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.	2015	WB	Human	Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS)	Complement System	C4d	Antibody	Serum	item_756
A301	C1q Antibody (polyclonal)	Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.	2015	WB	Human	Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS)	Complement System	C1q	Antibody	Serum	item_901
A307	C6 Antibody (polyclonal)	Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.	2015	ELISA, WB	Human	Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS)	Complement System	C6	Antibody	Serum	item_950
A308	C7 Antibody (polyclonal)	Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.	2015	ELISA, WB	Human	Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS)	Complement System	C7	Antibody	Serum	item_953
A309	C8 Antibody (polyclonal)	Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.	2015	ELISA, WB	Human	Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS)	Complement System	C8	Antibody	Serum	item_958
A310	C9 Antibody (polyclonal)	Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.	2015	ELISA, WB	Human	Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS)	Complement System	C9	Antibody	Serum	item_963
A409	Factor D Protein	Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.	2015	ELISA, WB	Human	Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS)	Complement System	Factor D	Protein	Serum	item_1100
A412	Factor P Protein	Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.	2015	ELISA, WB	Human	Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS)	Complement System	Factor P	Protein	Serum	item_1115
A426	C1-INH Protein	Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.	2015	WB	Human	Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS)	Complement System	C1-INH	Protein	Serum	item_1121
A400	C1q Protein	Intramolecular immunological signal hypothesis revived--structural background of signalling revealed by using Congo Red as a specific tool	2015	Complement Activation Assay	Sheep		Complement System	C1q	Protein	Red Blood Cells	item_1054
A033	Ba Fragment EIA	Iron-induced Local Complement Component 3 (C3) Up-regulation via Non-canonical Transforming Growth Factor (TGF)-β Signaling in the Retinal Pigment Epithelium	2015	ELISA	Human		Complement System	Ba	ELISA	ARPE-19 Cells	item_574
A205	C3 (C3c) Antibody (monoclonal)	Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome	2015	FC	Cell Culture		Complement System	C3c	Antibody	HUVEC Cells	item_688
A009	C4d Fragment EIA	Nanoparticle biointerfacing by platelet membrane cloaking	2015	ELISA	Human	Nanoparticles incubated	Complement System	C4d	ELISA	Serum	item_256
A027	Bb Plus Fragment EIA	Nanoparticle biointerfacing by platelet membrane cloaking	2015	ELISA	Human	Nanoparticles incubated	Complement System	Bb	ELISA	Serum	item_468
A021	C5a EIA	Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency	2015	ELISA	Human		Complement System	C5a	ELISA	Plasma	item_425
A037	C1-lnhibitor Plus EIA	Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency	2015	ELISA	Human		Complement System	C1-INH	ELISA	Plasma	item_609
A300	C1-INH Antibody (polyclonal)	Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency	2015	Radial Immunodiffusion	Human		Complement System	C1-INH	Antibody	Plasma	item_894
A035	C4a Fragment EIA	Optimized Treatment of Heparinized Blood Fractions to Make Them Suitable for Analysis	2015	ELISA	Human		Complement System	C4a	ELISA	Plasma	item_580
21-6120	FGF-23 Ab (C-term 225-244)	Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients	2015	IHC, WB	Human		Bone/Renal Health	FGF-23	Antibody	Bone Tissue	item_104
60-3100	Human PTH ELISA	Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients	2015	ELISA	Human		Bone/Renal Health	PTH	ELISA	Plasma	item_145
60-6100	Human FGF-23 C-Term ELISA	Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients	2015	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_172
A201	C1q Antibody (monoclonal)	Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats	2015	ELISA	Human		Complement System	C1q	Antibody	C1 protein	item_662
A009	C4d Fragment EIA	Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis	2015	ELISA	Human		Complement System	C4d	ELISA	Plasma	item_255
A020	SC5b-9 Plus EIA	Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis	2015	ELISA	Human		Complement System	sC5b-9	ELISA	Plasma	item_356
A021	C5a EIA	Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis	2015	ELISA	Human		Complement System	C5a	ELISA	Plasma	item_423
A027	Bb Plus Fragment EIA	Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis	2015	ELISA	Human		Complement System	Bb	ELISA	Plasma	item_467
A031	C3a Plus EIA	Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis	2015	ELISA	Human		Complement System	C3a	ELISA	Plasma	item_532
A509	C1q Depleted Sera	Rapid and efficient purification of ficolin-2 using a disposable CELLine bioreactor	2015	FC	Human	Streptococcus pneumoniae	Complement System	C1q	Depleted Sera	Serum	item_1170
A205	C3 (C3c) Antibody (monoclonal)	Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney	2015	FC	Cell Culture		Complement System	C3c	Antibody	CHO Cells	item_689
A207	C3 (C3d) Antibody (monoclonal)	Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney	2015	FC	Cell Culture		Complement System	C3d	Antibody	CHO Cells	item_699
A211	C4 (C4c) Antibody (monoclonal)	Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney	2015	FC	Cell Culture		Complement System	C4c	Antibody	CHO Cells	item_734
A213	C4 (C4d) Antibody (monoclonal)	Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney	2015	FC	Cell Culture		Complement System	C4d	Antibody	CHO Cells	item_747
A506	Factor B Depleted Sera	Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney	2015	Complement Activation Assay	Cell Culture		Complement System	Factor B	Depleted Sera	CHO Cells	item_1143
A221	C7 Antibody (monoclonal)	Seroprevalence of Antibody-Mediated, Complement-Dependent Opsonophagocytic Activity against Neisseria meningitidis Serogroup B in England.	2015	Opsonophagocytic killing assay	Bacteria		Complement System	C7	Antibody	Neisseria meningitidis	item_780
A033	Ba Fragment EIA	TNF Regulates Essential Alternative Complement Pathway Components and Impairs Activation of Protein C in Human Glomerular Endothelial Cells.	2015	ELISA	Human		Complement System	Ba	ELISA	GMVEC cells, HUVEC cells	item_548
A225	Factor B (Ba) Antibody (monoclonal)	TNF Regulates Essential Alternative Complement Pathway Components and Impairs Activation of Protein C in Human Glomerular Endothelial Cells.	2015	ELISA	Human		Complement System	Ba	Antibody	GMVEC cells, HUVEC cells	item_788
A021	C5a EIA	The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study	2015	ELISA	Human		Complement System	C5a	ELISA	Plasma	item_421
A239	sC5b-9 Antibody (monoclonal - neoantigen)	The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study	2015	IF	Human		Complement System	sC5b-9	Antibody	Skin Tissue	item_842
8005	CICP EIA	Tumor necrosis factor-α-accelerated degradation of type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivo.	2015	ELISA	Human		Bone/Renal Health	CICP	ELISA	Skin Tissue	item_14
A209	iC3b Antibody (monoclonal - neoantigen)	Tumor necrosis-initiated complement activation stimulates proliferation of medulloblastoma cells.	2015	IHC	Human	Medullablastoma	Complement System	iC3b	Antibody	Brain Tissue	item_726
A020	SC5b-9 Plus EIA	Tumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakiness	2015	ELISA	Human		Complement System	sC5b-9	ELISA	Serum	item_357
A021	C5a EIA	Tumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakiness	2015	ELISA	Human		Complement System	C5a	ELISA	Serum	item_426
A001	CIC-C1q EIA	Universal pooled plasma (Uniplas(®)) does not induce complement-mediated hemolysis of human red blood cells in vitro	2015	ELISA	Human		Complement System	C1q	ELISA	Plasma	item_219
A002	CIC-Raji Cell Replacement EIA	Universal pooled plasma (Uniplas(®)) does not induce complement-mediated hemolysis of human red blood cells in vitro	2015	ELISA	Human		Complement System	C3d	ELISA	Plasma	item_223
A254	Factor H Antibody (monoclonal) #2	α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.	2015	FC	Human	N. gonorrhoeae incubated	Complement System	Factor H	Antibody	Serum	item_883
A311	Factor B Antibody (polyclonal)	α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.	2015	ELISA	Human	N. gonorrhoeae incubated	Complement System	Factor B	Antibody	Serum	item_974
A217	C5 Antibody (monoclonal)	A Novel Antibody Against Human Properdin Inhibits the Alternative Complement System and Specifically Detects Properdin From Blood Samples.	2014	Complement Activation Assay	Human		Complement System	C5	Antibody	Serum	item_767
A225	Factor B (Ba) Antibody (monoclonal)	A Novel Antibody Against Human Properdin Inhibits the Alternative Complement System and Specifically Detects Properdin From Blood Samples.	2014	Complement Activation Assay	Human		Complement System	Ba	Antibody	Serum	item_787
A233	Factor P Antibody (monoclonal) #1	A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples.	2014	ELISA	Human		Complement System	Factor P	Antibody	Plasma	item_804
A235	Factor P Antibody (monoclonal) #2	A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples.	2014	ELISA, Complement Activation Assay	Human		Complement System	Factor P	Antibody	Plasma	item_819
A412	Factor P Protein	A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples.	2014	Antibody generation	Mouse		Complement System	Factor P	Protein	Balb/c	item_1116
8007	DPD EIA	Age-related bone turnover markers and osteoporotic risk in native Chinese women.	2014	ELISA	Human		Bone/Renal Health	DPD	ELISA	Serum	item_26
8012	BAP EIA	Age-related bone turnover markers and osteoporotic risk in native Chinese women.	2014	ELISA	Human		Bone/Renal Health	BAP	ELISA	Serum	item_56
A001	CIC-C1q EIA	Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro	2014	ELISA	Human		Complement System	C1q	ELISA	Serum	item_220
A111	Normal Human Serum Complement	Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus.	2014	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	Daudi Cells	item_631
A021	C5a EIA	Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health	2014	ELISA	Human		Complement System	C5a	ELISA	Plasma	item_419
A031	C3a Plus EIA	Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health	2014	ELISA	Human		Complement System	C3a	ELISA	Plasma	item_530
A035	C4a Fragment EIA	Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health	2014	ELISA	Human		Complement System	C4a	ELISA	Plasma	item_594
A307	C6 Antibody (polyclonal)	Aurin tricarboxylic acid protects against red blood cell hemolysis in patients with paroxysmal nocturnal hemoglobinemia.	2014	WB	Human	PNH	Complement System	C6	Antibody	Red Blood Cells	item_951
A031	C3a Plus EIA	Autocrine Effects of Tumor-Derived Complement	2014	ELISA	Cell Culture		Complement System	C3a	ELISA	SKOV3ip1 cells	item_482
A111	Normal Human Serum Complement	Bioactive lysophospholipids generated by hepatic lipase degradation of lipoproteins lead to complement activation via the classical pathway	2014	ELISA	Human		Complement System	Normal Human Serum	Reagent	Serum	item_647
A250	C3d Antibody (monoclonal - neoantigen)	Bioactive lysophospholipids generated by hepatic lipase degradation of lipoproteins lead to complement activation via the classical pathway	2014	ELISA	Human		Complement System	C3d	Antibody	Serum	item_863
A506	Factor B Depleted Sera	Bioactive lysophospholipids generated by hepatic lipase degradation of lipoproteins lead to complement activation via the classical pathway	2014	ELISA	Human		Complement System	Factor B	Depleted Sera	Serum	item_1147
A509	C1q Depleted Sera	Bioactive lysophospholipids generated by hepatic lipase degradation of lipoproteins lead to complement activation via the classical pathway	2014	ELISA	Human		Complement System	C1q	Depleted Sera	Serum	item_1166
8007	DPD EIA	Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.	2014	ELISA	Human	Mucopolysaccharidosis Types I, II, and VI, children	Bone/Renal Health	DPD	ELISA	Urine	item_27
8009	Creatinine EIA	Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.	2014	ELISA	Human	Mucopolysaccharidosis Types I, II, and VI, children	Bone/Renal Health	Creatinine	ELISA	Urine	item_40
8010	PYD EIA	Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.	2014	ELISA	Human	Mucopolysaccharidosis Types I, II, and VI, children	Bone/Renal Health	PYD	ELISA	Urine	item_46
8012	BAP EIA	Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.	2014	ELISA	Human	Mucopolysaccharidosis Types I, II, and VI in children	Bone/Renal Health	BAP	ELISA	Serum	item_58
A306	C5 Antibody (polyclonal)	C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo	2014	WB	Mouse		Complement System	C5	Antibody	Plasma	item_944
A311	Factor B Antibody (polyclonal)	C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo	2014	WB	Mouse		Complement System	Factor B	Antibody	Plasma	item_985
A600	CVF, Cobra Venom Factor	C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo	2014	Complement Depletion Assay	Mouse		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1192
A006	iC3b EIA	C4d deposits on the surface of RBCs in trauma patients and interferes with their function	2014	ELISA	Human	Trauma	Complement System	iC3b	ELISA	Serum	item_229
A213	C4 (C4d) Antibody (monoclonal)	C4d deposits on the surface of RBCs in trauma patients and interferes with their function	2014	FC	Human	Trauma	Complement System	C4d	Antibody	Red Blood Cells	item_751
8005	CICP EIA	Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy.	2014	ELISA	Human		Bone/Renal Health	CICP	ELISA	Fibroblasts	item_13
A006	iC3b EIA	Cerebrospinal fluid inflammatory markers in patients with Listeria monocytogenes meningitis	2014	ELISA	Human	Listeria meningitis	Complement System	iC3b	ELISA	CSF	item_232
A020	SC5b-9 Plus EIA	Cerebrospinal fluid inflammatory markers in patients with Listeria monocytogenes meningitis	2014	ELISA	Human	Listeria meningitis	Complement System	sC5b-9	ELISA	CSF	item_355
A021	C5a EIA	Cerebrospinal fluid inflammatory markers in patients with Listeria monocytogenes meningitis	2014	ELISA	Human	Listeria meningitis	Complement System	C5a	ELISA	CSF	item_422
A031	C3a Plus EIA	Cerebrospinal fluid inflammatory markers in patients with Listeria monocytogenes meningitis	2014	ELISA	Human	Listeria meningitis	Complement System	C3a	ELISA	CSF	item_531
A506	Factor B Depleted Sera	Characterization of BCAM0224, a multifunctional trimeric autotransporter from the human pathogen Burkholderia cenocepacia	2014	Serum Bactericidal Assay	Human	Burkholderia cenocepacia incubated	Complement System	Factor B	Depleted Sera	Serum	item_1150
A509	C1q Depleted Sera	Characterization of BCAM0224, a multifunctional trimeric autotransporter from the human pathogen Burkholderia cenocepacia	2014	Serum Bactericidal Assay	Human	Burkholderia cenocepacia incubated	Complement System	C1q	Depleted Sera	Serum	item_1171
A221	C7 Antibody (monoclonal)	Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release.	2014	Phagocytosis assay	Human		Complement System	C7	Antibody	Whole Blood	item_781
A020	SC5b-9 Plus EIA	Clinicopathological characteristics and outcomes of Chinese patients with scanty immune deposits lupus nephritis: a large cohort study from a single center	2014	ELISA	Human	Lupus Nephritis	Complement System	sC5b-9	ELISA	Plasma	item_350
A021	C5a EIA	Clinicopathological characteristics and outcomes of Chinese patients with scanty immune deposits lupus nephritis: a large cohort study from a single center	2014	ELISA	Human	Lupus Nephritis	Complement System	C5a	ELISA	Plasma	item_418
A027	Bb Plus Fragment EIA	Clinicopathological characteristics and outcomes of Chinese patients with scanty immune deposits lupus nephritis: a large cohort study from a single center	2014	ELISA	Human	Lupus Nephritis	Complement System	Bb	ELISA	Plasma	item_462
A031	C3a Plus EIA	Clinicopathological characteristics and outcomes of Chinese patients with scanty immune deposits lupus nephritis: a large cohort study from a single center	2014	ELISA	Human	Lupus Nephritis	Complement System	C3a	ELISA	Plasma	item_529
A111	Normal Human Serum Complement	Comparability of a three-dimensional structure in biopharmaceuticals using spectroscopic methods.	2014	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	WIL2-S cells	item_632
A020	SC5b-9 Plus EIA	Complement activation in patients with neuromyelitis optica	2014	ELISA	Human	Neuromyelitis optica	Complement System	sC5b-9	ELISA	Plasma	item_283
A031	C3a Plus EIA	Complement activation in patients with neuromyelitis optica	2014	ELISA	Human	Neuromyelitis optica	Complement System	C3a	ELISA	Plasma	item_484
A035	C4a Fragment EIA	Complement activation in patients with neuromyelitis optica	2014	ELISA	Human	Neuromyelitis optica	Complement System	C4a	ELISA	Plasma	item_579
A205	C3 (C3c) Antibody (monoclonal)	Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?	2014	FC	Cell Culture		Complement System	C3c	Antibody	HUVEC Cells	item_687
A020	SC5b-9 Plus EIA	Defining the complement biomarker profile of C3 glomerulopathy	2014	ELISA	Human	C3G	Complement System	sC5b-9	ELISA	Plasma	item_351
A021	C5a EIA	Defining the complement biomarker profile of C3 glomerulopathy	2014	ELISA	Human	C3G	Complement System	C5a	ELISA	Plasma	item_420
A027	Bb Plus Fragment EIA	Defining the complement biomarker profile of C3 glomerulopathy	2014	ELISA	Human	C3G	Complement System	Bb	ELISA	Plasma	item_463
A033	Ba Fragment EIA	Defining the complement biomarker profile of C3 glomerulopathy	2014	ELISA	Human	C3G	Complement System	Ba	ELISA	Plasma	item_573
60-2700	Rat Bioactive PTH ELISA	Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats	2014	ELISA	Rat		Bone/Renal Health	PTH	ELISA	Serum	item_135
8012	BAP EIA	Effects of high doses of cholecalciferol in normal subjects: a randomized double-blinded, placebo-controlled trial.	2014	ELISA	Human	Cholecalciferol	Bone/Renal Health	BAP	ELISA	Serum	item_59
A502	C6 Depleted Sera	Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection	2014	Cell Culture	Cell Culture		Complement System	C5	Depleted Sera	TIME-KSHV cells	item_1129
A506	Factor B Depleted Sera	Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection	2014	IF	Cell Culture		Complement System	Factor B	Depleted Sera	TIME-KSHV cells	item_1144
A508	C3 Depleted Sera	Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection	2014	IF	Cell Culture		Complement System	C3	Depleted Sera	TIME-KSHV cells	item_1152
A509	C1q Depleted Sera	Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection	2014	IF	Cell Culture		Complement System	C1q	Depleted Sera	TIME-KSHV cells	item_1157
21-6120	FGF-23 Ab (C-term 225-244)	FGF23 protein expression in coronary arteries is associated with impaired kidney function	2014	IHC	Human		Bone/Renal Health	FGF-23	Antibody	Artery Tissue	item_103
A006	iC3b EIA	Inhibition of C3 Convertase Activity by Hepatitis C Virus as an Additional Lesion in the Regulation of Complement Components	2014	ELISA	Human	HCV	Complement System	iC3b	ELISA	Serum	item_230
A401	C3 Protein	Inhibition of C3 Convertase Activity by Hepatitis C Virus as an Additional Lesion in the Regulation of Complement Components	2014	WB	Human		Complement System	C3	Protein	Serum	item_1064
60-2700	Rat Bioactive PTH ELISA	Intravenous phosphate loading increases fibroblast growth factor 23 in uremic rats	2014	ELISA	Rat		Bone/Renal Health	PTH	ELISA	Serum	item_134
A009	C4d Fragment EIA	Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum	2014	ELISA	Human	SPIO nanoworms	Complement System	C4d	ELISA	Serum	item_253
A020	SC5b-9 Plus EIA	Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum	2014	ELISA	Human	SPIO nanoworms	Complement System	sC5b-9	ELISA	Serum	item_352
A027	Bb Plus Fragment EIA	Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum	2014	ELISA	Human	SPIO nanoworms	Complement System	Bb	ELISA	Serum	item_464
A009	C4d Fragment EIA	Multifunctional silk-heparin biomaterials for vascular tissue engineering applications	2014	ELISA	Human		Complement System	C4d	ELISA	Plasma	item_252
A027	Bb Plus Fragment EIA	Multifunctional silk-heparin biomaterials for vascular tissue engineering applications	2014	ELISA	Human		Complement System	Bb	ELISA	Plasma	item_461
A600	CVF, Cobra Venom Factor	No expression of porcine endogenous retrovirus after pig to monkey xenotransplantation	2014	Complement Depletion Assay	Porcine		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1198
A250	C3d Antibody (monoclonal - neoantigen)	Polymorphism of the Complement Receptor 1 Gene Correlates With the Hematologic Response to Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria.	2014	FC	Human	PNH	Complement System	C3d	Antibody	Red Blood Cells	item_864
60-2500	Rat PTH ELISA	Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis	2014	ELISA	Rat		Bone/Renal Health	PTH	ELISA	Plasma	item_131
8019	Serum PYD EIA	Proteomic analysis of altered extracellular matrix turnover in bleomycin-induced pulmonary fibrosis.	2014	ELISA	Mouse		Bone/Renal Health	PYD	ELISA	Lung Tissue	item_79
8005	CICP EIA	Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421.	2014	ELISA	Human		Bone/Renal Health	CICP	ELISA	Serum	item_12
8012	BAP EIA	Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421.	2014	ELISA	Human		Bone/Renal Health	BAP	ELISA	Serum	item_57
8019	Serum PYD EIA	Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421.	2014	ELISA	Human		Bone/Renal Health	PYD	ELISA	Serum	item_73
A111	Normal Human Serum Complement	The Vi capsular polysaccharide enables Salmonella enterica serovar typhi to evade microbe-guided neutrophil chemotaxis.	2014	ELISA	Bacteria		Complement System	Normal Human Serum	Reagent	Salmonella enterica	item_619
8007	DPD EIA	The role of the renal ammonia transporter Rhcg in metabolic responses to dietary protein.	2014	ELISA	Mouse		Bone/Renal Health	DPD	ELISA	Urine	item_29
60-1305	Mouse Osteocalcin ELISA	The role of the renal ammonia transporter Rhcg in metabolic responses to dietary protein.	2014	ELISA	Mouse		Bone/Renal Health	Osteocalcin	ELISA	Plasma	item_111
60-6100	Human FGF-23 C-Term ELISA	The use of fibroblast growth factor 23 testing in patients with kidney disease.	2014	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_169
60-6600	Human FGF-23 (Intact) ELISA	The use of fibroblast growth factor 23 testing in patients with kidney disease.	2014	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_199
A020	SC5b-9 Plus EIA	Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial	2014	ELISA	Human		Complement System	sC5b-9	ELISA	Serum	item_349
60-2700	Rat Bioactive PTH ELISA	Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD	2014	ELISA	Rat		Bone/Renal Health	PTH	ELISA	Serum	item_136
60-6300	Mouse/Rat FGF-23 C-Term ELISA	Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD	2014	ELISA	Rat		Bone/Renal Health	FGF-23	ELISA	Serum	item_191
60-6100	Human FGF-23 C-Term ELISA	Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin	2014	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_171
A600	CVF, Cobra Venom Factor	Yersinia pseudotuberculosis uses Ail and YadA to circumvent neutrophils by directing Yop translocation during lung infection	2014	Complement Depletion Assay	Mouse		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1191
A247	Factor I Antibody (monoclonal) #1	Generation of Multiple Fluid-Phase C3b:Plasma Protein Complexes during Complement Activation: Possible Implications in C3 Glomerulopathies	2013	Complement Inhibition Assay	Human	C3G	Complement System	Factor I	Antibody	Serum	item_859
60-6100	Human FGF-23 C-Term ELISA	A low fractional excretion of Phosphate/Fgf23 ratio is associated with severe abdominal Aortic calcification in stage 3 and 4 kidney disease patients	2013	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Serum	item_167
8033	TRAP5b EIA	A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells.	2013	ELISA	Human		Bone/Renal Health	TRAP5b	ELISA	Monocytes	item_84
A018	CH50 Eq EIA	Amblyomma americanum tick saliva serine protease inhibitor 6 is a cross-class inhibitor of serine proteases and papain-like cysteine proteases that delays plasma clotting and inhibits platelet aggregation	2013	ELISA	Human	AamS6 tick protein incubated	Complement System	CH50	ELISA	Serum	item_276
60-6100	Human FGF-23 C-Term ELISA	Associations among total and food additive phosphorus intake and carotid intima-media thickness--a cross-sectional study in a middle-aged population in Southern Finland	2013	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_166
A018	CH50 Eq EIA	Bifunctional lipocalin ameliorates murine immune complex-induced acute lung injury	2013	ELISA	Human	OmCI tick protein incubated	Complement System	CH50	ELISA	Serum	item_277
A211	C4 (C4c) Antibody (monoclonal)	Binding of Complement Inhibitor C4b-binding Protein to a Highly Virulent Streptococcus Pyogenes M1 Strain Is Mediated by Protein H and Enhances Adhesion to and Invasion of Endothelial Cells.	2013	FC	Human	S. pyogenes incubated	Complement System	C4c	Antibody	Serum	item_739
A213	C4 (C4d) Antibody (monoclonal)	Binding of Complement Inhibitor C4b-binding Protein to a Highly Virulent Streptococcus Pyogenes M1 Strain Is Mediated by Protein H and Enhances Adhesion to and Invasion of Endothelial Cells.	2013	FC, WB	Human	S. pyogenes incubated	Complement System	C4d	Antibody	Serum	item_753
A035	C4a Fragment EIA	Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent	2013	ELISA	Human		Complement System	C4a	ELISA	Serum	item_593
A020	SC5b-9 Plus EIA	Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent.	2013	ELISA	Human		Complement System	sC5b-9	ELISA	Serum	item_347
A111	Normal Human Serum Complement	Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction	2013	Mass Spec	Human		Complement System	Normal Human Serum	Reagent	Red Blood Cells	item_650
A031	C3a Plus EIA	Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components	2013	ELISA	Human	Borrelia valaisiana incubated	Complement System	C3a	ELISA	Serum	item_523
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components	2013	IF	Bacteria		Complement System	sC5b-9	Antibody	Borrelia valaisiana	item_826
A300	C1-INH Antibody (polyclonal)	Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components	2013	WB	Bacteria		Complement System	C1-INH	Antibody	Borrelia valaisiana	item_889
A306	C5 Antibody (polyclonal)	Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components	2013	WB	Bacteria		Complement System	C5	Antibody	Borrelia valaisiana	item_936
A203	C1q Antibody (monoclonal)	Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.	2013	FC	Human	aHUS	Complement System	C1q	Antibody	HUVEC Cells	item_680
A205	C3 (C3c) Antibody (monoclonal)	Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.	2013	FC	Human	aHUS	Complement System	C3c	Antibody	HUVEC Cells	item_695
A209	iC3b Antibody (monoclonal - neoantigen)	Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.	2013	FC	Human	aHUS	Complement System	iC3b	Antibody	HUVEC Cells	item_716
A020	SC5b-9 Plus EIA	Complement activation in pediatric patients with recurrent acute otitis media	2013	ELISA	Human		Complement System	sC5b-9	ELISA	Ear Fluid (MEE)	item_344
A020	SC5b-9 Plus EIA	Complement activation in pediatric patients with recurrent acute otitis media	2013	ELISA	Human		Complement System	sC5b-9	ELISA	Serum	item_345
A021	C5a EIA	Complement activation in pediatric patients with recurrent acute otitis media	2013	ELISA	Human		Complement System	C5a	ELISA	Ear Fluid (MEE)	item_415
A021	C5a EIA	Complement activation in pediatric patients with recurrent acute otitis media	2013	ELISA	Human		Complement System	C5a	ELISA	Serum	item_416
A031	C3a Plus EIA	Complement activation in pediatric patients with recurrent acute otitis media	2013	ELISA	Human		Complement System	C3a	ELISA	Ear Fluid (MEE)	item_524
A031	C3a Plus EIA	Complement activation in pediatric patients with recurrent acute otitis media	2013	ELISA	Human		Complement System	C3a	ELISA	Serum	item_525
A035	C4a Fragment EIA	Complement activation in pediatric patients with recurrent acute otitis media	2013	ELISA	Human		Complement System	C4a	ELISA	Ear Fluid (MEE)	item_591
A035	C4a Fragment EIA	Complement activation in pediatric patients with recurrent acute otitis media	2013	ELISA	Human		Complement System	C4a	ELISA	Serum	item_592
A311	Factor B Antibody (polyclonal)	Complement activation in pediatric patients with recurrent acute otitis media	2013	IF, WB	Cell Culture		Complement System	Factor B	Antibody	HMEE Cells	item_972
A111	Normal Human Serum Complement	Complement c5a generation by staphylococcal biofilms	2013	FC	Human	Staphylococcus epidermidis incubated	Complement System	Normal Human Serum	Reagent	Serum	item_648
A506	Factor B Depleted Sera	Complement c5a generation by staphylococcal biofilms	2013	FC	Human	Staphylococcus epidermidis incubated	Complement System	Factor B	Depleted Sera	Serum	item_1149
A509	C1q Depleted Sera	Complement c5a generation by staphylococcal biofilms	2013	FC	Human	Staphylococcus epidermidis incubated	Complement System	C1q	Depleted Sera	Serum	item_1169
8019	Serum PYD EIA	Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.	2013	ELISA	Mouse		Bone/Renal Health	PYD	ELISA	Serum	item_77
A239	sC5b-9 Antibody (monoclonal - neoantigen)	CspA from Borrelia burgdorferi inhibits the terminal complement pathway.	2013	IF	Bacteria		Complement System	sC5b-9	Antibody	Borrelia burgdorferi	item_827
A307	C6 Antibody (polyclonal)	CspA from Borrelia burgdorferi inhibits the terminal complement pathway.	2013	IF	Bacteria		Complement System	C6	Antibody	Borrelia burgdorferi	item_949
A308	C7 Antibody (polyclonal)	CspA from Borrelia burgdorferi inhibits the terminal complement pathway.	2013	IF	Bacteria		Complement System	C7	Antibody	Borrelia burgdorferi	item_952
A309	C8 Antibody (polyclonal)	CspA from Borrelia burgdorferi inhibits the terminal complement pathway.	2013	IF	Bacteria		Complement System	C8	Antibody	Borrelia burgdorferi	item_957
A310	C9 Antibody (polyclonal)	CspA from Borrelia burgdorferi inhibits the terminal complement pathway.	2013	IF	Bacteria		Complement System	C9	Antibody	Borrelia burgdorferi	item_962
A600	CVF, Cobra Venom Factor	Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release	2013	Complement Depletion Assay	Mouse		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1190
A312	Factor H Antibody (polyclonal)	Cyclosporine induces endothelial cell release of complement-activating microparticles	2013	FC	Human	Microparticles incubation	Complement System	Factor H	Antibody	Endothelial Cells	item_1001
60-2305	Mouse PTH 1-84 ELISA	Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia	2013	ELISA	Mouse		Bone/Renal Health	PTH	ELISA	Serum	item_123
60-6300	Mouse/Rat FGF-23 C-Term ELISA	Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia	2013	ELISA	Mouse		Bone/Renal Health	FGF-23	ELISA	Serum	item_185
A006	iC3b EIA	Genetic variation and cerebrospinal fluid levels of mannose binding lectin in pneumococcal meningitis patients	2013	ELISA	Human		Complement System	iC3b	ELISA	CSF	item_228
A020	SC5b-9 Plus EIA	Genetic variation and cerebrospinal fluid levels of mannose binding lectin in pneumococcal meningitis patients.	2013	ELISA	Human		Complement System	sC5b-9	ELISA	CSF	item_346
A021	C5a EIA	Genetic variation and cerebrospinal fluid levels of mannose binding lectin in pneumococcal meningitis patients.	2013	ELISA	Human		Complement System	C5a	ELISA	CSF	item_417
A031	C3a Plus EIA	Genetic variation and cerebrospinal fluid levels of mannose binding lectin in pneumococcal meningitis patients.	2013	ELISA	Human		Complement System	C3a	ELISA	CSF	item_527
A111	Normal Human Serum Complement	Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles	2013	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	Huh7.5 Cells	item_627
A031	C3a Plus EIA	Human factor H-related protein 2 (CFHR2) regulates complement activation	2013	ELISA	Human		Complement System	C3a	ELISA	Serum	item_528
A033	Ba Fragment EIA	Human factor H-related protein 2 (CFHR2) regulates complement activation	2013	ELISA	Human		Complement System	Ba	ELISA	Serum	item_572
A020	SC5b-9 Plus EIA	In Vitro Hematological and In Vivo Vasoactivity Assessment of Dextran Functionalized Graphene	2013	ELISA	Human		Complement System	sC5b-9	ELISA	Plasma	item_348
A027	Bb Plus Fragment EIA	In Vitro Hematological and In Vivo Vasoactivity Assessment of Dextran Functionalized Graphene	2013	ELISA	Human		Complement System	Bb	ELISA	Plasma	item_460
8012	BAP EIA	Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional study.	2013	ELISA	Human	Women Using Hormonal Contraceptives	Bone/Renal Health	BAP	ELISA	Plasma	item_55
60-6100	Human FGF-23 C-Term ELISA	Intact fibroblast growth factor 23 and fragments in plasma from Gambian children	2013	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_163
A600	CVF, Cobra Venom Factor	Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis	2013	IF	Mouse		Complement System	Cobra Venom Factor	Reagent	Ear dermis Tissue	item_1196
A306	C5 Antibody (polyclonal)	Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency	2013	WB	Mouse		Complement System	C5	Antibody	Plasma	item_943
A111	Normal Human Serum Complement	Loss of very-long O-antigen chains optimizes capsule-mediated immune evasion by Salmonella enterica serovar Typhi.	2013	FC	Bacteria		Complement System	Normal Human Serum	Reagent	Salmonella enterica	item_621
A111	Normal Human Serum Complement	Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers.	2013	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	MDA-MB-231 Cells	item_629
60-6100	Human FGF-23 C-Term ELISA	Novel SLC34A3 mutation causing hereditary hypophosphataemic rickets with hypercalciuria in a Gambian family	2013	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_165
A111	Normal Human Serum Complement	Novel humanized anti-CD20 antibody BM-ca binds to a unique epitope and exerts stronger cellular activity than others	2013	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	RC-K8 cells	item_625
A111	Normal Human Serum Complement	Novel humanized anti-CD20 antibody BM-ca binds to a unique epitope and exerts stronger cellular activity than others	2013	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	SU-DHL-4 cells	item_626
A037	C1-lnhibitor Plus EIA	P-I snake venom metalloproteinase is able to activate the complement system by direct cleavage of central components of the cascade.	2013	ELISA	Human	Bothrops pirajai venom	Complement System	C1-INH	ELISA	Serum	item_599
A305	C4 Antibody (polyclonal)	P-I snake venom metalloproteinase is able to activate the complement system by direct cleavage of central components of the cascade.	2013	Silver Stain	Snake		Complement System	C4	Antibody	Bothrops pirajai venom	item_935
A401	C3 Protein	P-I snake venom metalloproteinase is able to activate the complement system by direct cleavage of central components of the cascade.	2013	Silver Stain	Snake		Complement System	C3	Protein	Bothrops pirajai venom	item_1071
A402	C4 Protein	P-I snake venom metalloproteinase is able to activate the complement system by direct cleavage of central components of the cascade.	2013	Silver Stain	Snake		Complement System	C4	Protein	Bothrops pirajai venom	item_1077
A403	C5 Protein	P-I snake venom metalloproteinase is able to activate the complement system by direct cleavage of central components of the cascade.	2013	Silver Stain	Snake		Complement System	C5	Protein	Bothrops pirajai venom	item_1086
A426	C1-INH Protein	P-I snake venom metalloproteinase is able to activate the complement system by direct cleavage of central components of the cascade.	2013	Silver Stain	Snake		Complement System	C1-INH	Protein	Bothrops pirajai venom	item_1122
60-6100	Human FGF-23 C-Term ELISA	Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children	2013	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_168
A111	Normal Human Serum Complement	Real time assays for quantifying cytotoxicity with single cell resolution.	2013	CDC Assay	Cell Culture	Lymphoma cells	Complement System	Normal Human Serum	Reagent	Jeko-1 Cells	item_630
A207	C3 (C3d) Antibody (monoclonal)	Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases.	2013	FC	Human	S. pneumoniae incubated	Complement System	C3d	Antibody	Serum	item_702
A312	Factor H Antibody (polyclonal)	Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity	2013	WB	Cell Culture		Complement System	Factor H	Antibody	CLL Cells	item_991
A410	Factor H Protein	Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity	2013	WB	Cell Culture		Complement System	Factor H	Protein	CLL Cells	item_1102
A400	C1q Protein	SIGN-R1, a C-type lectin, enhances apoptotic cell clearance through the complement deposition pathway by interacting with C1q in the spleen	2013	FC	Human		Complement System	C1q	Protein	Thymocyte Cells	item_1041
A600	CVF, Cobra Venom Factor	SIGN-R1, a C-type lectin, enhances apoptotic cell clearance through the complement deposition pathway by interacting with C1q in the spleen	2013	Complement Depletion Assay	Mouse		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1189
A312	Factor H Antibody (polyclonal)	The C-type lectin of the aggrecan G3 domain activates complement	2013	ELISA	Human		Complement System	Factor H	Antibody	Purified protein	item_998
A509	C1q Depleted Sera	The C-type lectin of the aggrecan G3 domain activates complement	2013	ELISA	Human	C1q Depleted	Complement System	C1q	Depleted Sera	Serum	item_1165
A201	C1q Antibody (monoclonal)	The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78	2013	FC	Cell Culture		Complement System	C1q	Antibody	OPM-2 cells	item_658
A400	C1q Protein	The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP79	2013	ELISA	N/A		Complement System	C1q	Protein	PAT-SM6 Antibody (coating)	item_1052
A111	Normal Human Serum Complement	The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP80	2013	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	OPM-2 cells	item_628
A233	Factor P Antibody (monoclonal) #1	The Role of Properdin in Zymosan- And Escherichia Coli-Induced Complement Activation.	2013	FC	Human		Complement System	Factor P	Antibody	Serum	item_808
A031	C3a Plus EIA	Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system	2013	ELISA	Human		Complement System	C3a	ELISA	Serum	item_526
A020	SC5b-9 Plus EIA	A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function	2012	ELISA	Human	GEnCs and HUVEC exposed	Complement System	sC5b-9	ELISA	Serum	item_342
A021	C5a EIA	A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function	2012	ELISA	Human	GEnCs and HUVEC exposed	Complement System	C5a	ELISA	Serum	item_414
A031	C3a Plus EIA	A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function	2012	ELISA	Human	GEnCs and HUVEC exposed	Complement System	C3a	ELISA	Serum	item_521
A205	C3 (C3c) Antibody (monoclonal)	A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function	2012	FC	Cell Culture		Complement System	C3c	Antibody	GEnCs cells	item_685
A205	C3 (C3c) Antibody (monoclonal)	A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function	2012	FC	Cell Culture		Complement System	C3c	Antibody	HUVEC Cells	item_686
A111	Normal Human Serum Complement	Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes	2012	VCA	Virus	Purified	Complement System	Normal Human Serum	Reagent	HIV	item_653
A009	C4d Fragment EIA	Assessment of endothelium and inflammatory response at the onset of reperfusion injury in hand surgery	2012	ELISA	Human		Complement System	C4d	ELISA	Plasma	item_251
A031	C3a Plus EIA	Assessment of endothelium and inflammatory response at the onset of reperfusion injury in hand surgery	2012	ELISA	Human		Complement System	C3a	ELISA	Plasma	item_522
A037	C1-lnhibitor Plus EIA	Assessment of endothelium and inflammatory response at the onset of reperfusion injury in hand surgery	2012	ELISA	Human		Complement System	C1-INH	ELISA	Serum	item_607
21-6110	FGF-23 Ab (C-term 186-206)	Biological variability of plasma intact and C-terminal FGF23 measurements	2012	IP, WB	Human		Bone/Renal Health	FGF-23	Antibody	Plasma	item_100
21-6120	FGF-23 Ab (C-term 225-244)	Biological variability of plasma intact and C-terminal FGF23 measurements	2012	IP, WB	Human		Bone/Renal Health	FGF-23	Antibody	Plasma	item_105
21-6120	FGF-23 Ab (C-term 225-244)	Biological variability of plasma intact and C-terminal FGF23 measurements	2012	WB	Human		Bone/Renal Health	FGF-23	Antibody	Plasma	item_107
60-6100	Human FGF-23 C-Term ELISA	Biological variability of plasma intact and C-terminal FGF23 measurements	2012	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_164
60-6600	Human FGF-23 (Intact) ELISA	Biological variability of plasma intact and C-terminal FGF23 measurements	2012	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_198
60-6100	Human FGF-23 C-Term ELISA	Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients	2012	ELISA	Human	Chronic Kidney Disease	Bone/Renal Health	FGF-23	ELISA	Serum	item_162
60-6600	Human FGF-23 (Intact) ELISA	Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients	2012	ELISA	Human	Chronic Kidney Disease	Bone/Renal Health	FGF-23	ELISA	Serum	item_197
8033	TRAP5b EIA	Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.	2012	ELISA	Human		Bone/Renal Health	TRAP5b	ELISA	Multiple Myeloma cells	item_83
A400	C1q Protein	C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies	2012	ELISA	Human	IgG-APS, IgG-MHS, IgM-APS, IgM-NHS	Complement System	C1q	Protein	IgG Antibody	item_1033
8007	DPD EIA	Changes in biomarkers of bone resorption over the first six months after pediatric hematopoietic cell transplantation.	2012	ELISA	Human	Hematopoietic cell transplantation	Bone/Renal Health	DPD	ELISA	Urine	item_25
8010	PYD EIA	Changes in biomarkers of bone resorption over the first six months after pediatric hematopoietic cell transplantation.	2012	ELISA	Human	Hematopoietic cell transplantation	Bone/Renal Health	PYD	ELISA	Urine	item_45
8005	CICP EIA	Changes in serum collagen markers, IGF-I, and knee joint laxity across the menstrual cycle.	2012	ELISA	Human		Bone/Renal Health	CICP	ELISA	Serum	item_10
A002	CIC-Raji Cell Replacement EIA	Circulating Immune Complex Levels are Associated with Disease Severity and Seasonality in Children with Malaria from Mali	2012	ELISA	Human		Complement System	C3d	ELISA	Serum	item_222
8005	CICP EIA	Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia.	2012	ELISA	Human		Bone/Renal Health	CICP	ELISA	Plasma	item_11
A227	Factor B (Bb) Antibody (monoclonal)	Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein	2012	FC	Human	Meningococcal infected	Complement System	Bb	Antibody	Serum	item_794
A233	Factor P Antibody (monoclonal) #1	Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein	2012	FC	Human	Meningococcal infected	Complement System	Factor P	Antibody	Serum	item_809
A209	iC3b Antibody (monoclonal - neoantigen)	Control of Entamoeba histolytica adherence involves metallosurface protease 1, an M8 family surface metalloprotease with homology to leishmanolysin.	2012	FC	Parasite		Complement System	iC3b	Antibody	Entamoeba histolytica	item_732
A504	C8 Depleted Sea	Control of Entamoeba histolytica adherence involves metallosurface protease 1, an M8 family surface metalloprotease with homology to leishmanolysin.	2012	FC	Parasite		Complement System	C8	Depleted Sera	Entamoeba histolytica	item_1139
A301	C1q Antibody (polyclonal)	DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells	2012	ELISA, IF, WB	Human		Complement System	C1q	Antibody	Dendritic Cell	item_900
60-3100	Human PTH ELISA	Early skeletal and biochemical alterations in pediatric chronic kidney disease	2012	ELISA	Human		Bone/Renal Health	PTH	ELISA	Plasma	item_144
60-6100	Human FGF-23 C-Term ELISA	Early skeletal and biochemical alterations in pediatric chronic kidney disease	2012	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_160
8012	BAP EIA	Effects of combined maternal administration with alpha-ketoglutarate (AKG) and β-hydroxy-β-methylbutyrate (HMB) on prenatal programming of skeletal properties in the offspring.	2012	ELISA	Porcine		Bone/Renal Health	BAP	ELISA	Serum	item_72
A020	SC5b-9 Plus EIA	Elevated Properdin and Enhanced Complement Activation in First-Degree Relatives of South Asian Subjects With Type 2 Diabetes	2012	ELISA	Human		Complement System	sC5b-9	ELISA	Plasma	item_343
A027	Bb Plus Fragment EIA	Elevated Properdin and Enhanced Complement Activation in First-Degree Relatives of South Asian Subjects With Type 2 Diabetes	2012	ELISA	Human		Complement System	Bb	ELISA	Plasma	item_458
A247	Factor I Antibody (monoclonal) #1	Functional Analyses of Complement Convertases Using C3 and C5-Depleted Sera	2012	Complement Inhibition Assay	Sheep		Complement System	Factor I	Antibody	Erythrocytes	item_861
A501	C5 Depleted Sera	Functional Analyses of Complement Convertases Using C3 and C5-Depleted Sera	2012	Complement Inhibition Assay	Sheep		Complement System	C5	Depleted Sera	Erythrocytes	item_1128
A508	C3 Depleted Sera	Functional Analyses of Complement Convertases Using C3 and C5-Depleted Sera	2012	Complement Inhibition Assay	Sheep		Complement System	C3	Depleted Sera	Erythrocytes	item_1155
A018	CH50 Eq EIA	Gene expression changes in human islets exposed to type 1 diabetic serum	2012	ELISA	Human	Islet Cells	Complement System	CH50	ELISA	Serum	item_275
A111	Normal Human Serum Complement	Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis.	2012	CDC Assay	Human		Complement System	Normal Human Serum	Reagent	Peripheral blood mononuclear cells	item_642
8001	Osteocalcin EIA	Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.	2012	ELISA	Human		Bone/Renal Health	Osteocalcin	ELISA	Serum	item_2
8033	TRAP5b EIA	Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.	2012	ELISA	Human		Bone/Renal Health	TRAP5b	ELISA	Serum	item_82
A400	C1q Protein	MBL interferes with endovascular trophoblast invasion in pre-eclampsia	2012	ELISA	Human		Complement System	C1q	Protein	Extravillous trophoblast cells	item_1032
A027	Bb Plus Fragment EIA	Mannose binding lectin is required for alphavirus-induced arthritis/myositis	2012	ELISA	Human		Complement System	Bb	ELISA	Synovial fluid	item_459
A111	Normal Human Serum Complement	Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement	2012	TER Measurements	Cell Culture		Complement System	Normal Human Serum	Reagent	RPE Cells	item_637
A405	C7 Protein	Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement	2012	TER Measurements	Cell Culture		Complement System	C7	Protein	RPE Cells	item_1088
A503	C7 Depleted Sera	Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement	2012	TER Measurements	Cell Culture		Complement System	C6	Depleted Sera	RPE Cells	item_1135
A400	C1q Protein	Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes	2012	Complement Activation Assay	Cell Culture	Bone marrow cells	Complement System	C1q	Protein	C57BL/6	item_1025
A405	C7 Protein	O-antigen-deficient Francisella tularensis Live Vaccine Strain mutants are ingested via an aberrant form of looping phagocytosis and show altered kinetics of intracellular trafficking in human macrophages	2012	Bacterial plating	Human	C7 Depleted	Complement System	C7	Protein	Serum	item_1089
A001	CIC-C1q EIA	Oral rosmarinic acid-enhanced Mentha spicata modulates synovial fluid biomarkers of inflammation in horses challenged with intra-articular LPS	2012	ELISA	Human		Complement System	C1q	ELISA	Synovial fluid	item_218
A111	Normal Human Serum Complement	Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities	2012	CDC Assay	Human	CD-20 AbX antibody	Complement System	Normal Human Serum	Reagent	WIL2-S cells	item_641
A400	C1q Protein	Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities	2012	ELISA	N/A		Complement System	C1q	Protein	CD-20 Antibody (AbX)	item_1050
A247	Factor I Antibody (monoclonal) #1	The Relative Roles of Factor H Binding Protein, Neisserial Surface Protein A, and Lipooligosaccharide Sialylation in Regulation of the Alternative Pathway of Complement on Meningococci	2012	Complement Inhibition Assay	Goat		Complement System	Factor I	Antibody	Serum	item_858
A400	C1q Protein	The salivary scavenger and agglutinin binds MBL and regulates the lectin pathway of complement in solution and on surfaces	2012	ELISA	N/A		Complement System	C1q	Protein	rSALSA	item_1051
A600	CVF, Cobra Venom Factor	Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons	2012	Complement Depletion Assay	Baboon		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1175
60-6100	Human FGF-23 C-Term ELISA	Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function	2012	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Serum	item_161
A031	C3a Plus EIA	Absence of Gal epitope prolongs survival of swine lungs in an ex vivo model of hyperacute rejection	2011	ELISA	Human		Complement System	C3a	ELISA	Plasma	item_518
A312	Factor H Antibody (polyclonal)	Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury	2011	WB	Mouse		Complement System	Factor H	Antibody	Serum	item_1015
A018	CH50 Eq EIA	Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease	2011	ELISA	Human		Complement System	CH50	ELISA	Serum	item_273
A020	SC5b-9 Plus EIA	Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease	2011	ELISA	Human		Complement System	sC5b-9	ELISA	Serum	item_340
A031	C3a Plus EIA	Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease	2011	ELISA	Human		Complement System	C3a	ELISA	Serum	item_519
A031	C3a Plus EIA	Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β	2011	ELISA	Human		Complement System	C3a	ELISA	Peripheral blood mononuclear cells	item_520
A401	C3 Protein	Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β	2011	ELISA	Human		Complement System	C3	Protein	Peripheral blood mononuclear cells	item_1060
A403	C5 Protein	Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β	2011	ELISA	Human		Complement System	C5	Protein	Peripheral blood mononuclear cells	item_1080
A209	iC3b Antibody (monoclonal - neoantigen)	Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases	2011	IHC	Human	Asthmatic Alzheimer's	Complement System	iC3b	Antibody	Lung Tissue	item_724
A209	iC3b Antibody (monoclonal - neoantigen)	Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases	2011	IHC	Human		Complement System	iC3b	Antibody	Lung Tissue	item_725
A217	C5 Antibody (monoclonal)	Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases	2011	ELISA	Human		Complement System	C5	Antibody	Serum	item_771
A410	Factor H Protein	Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases	2011	ELISA	Human		Complement System	Factor H	Protein	Serum	item_1105
A702	C3d Antibody (monoclonal) biotin	Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases	2011	FC	Human		Complement System	C3d	Antibody	Red Blood Cells	item_1208
A111	Normal Human Serum Complement	Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys	2011	CDC Assay	Human		Complement System	Normal Human Serum	Reagent	B-Cells	item_639
A001	CIC-C1q EIA	Do circulating antibodies against C1q reflect the activity of lupus nephritis?	2011	ELISA	Human		Complement System	C1q	ELISA	Serum	item_217
A311	Factor B Antibody (polyclonal)	Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice	2011	IF, WB	Mouse	Temporal Bone	Complement System	Factor B	Antibody	Bone Tissue	item_979
A311	Factor B Antibody (polyclonal)	Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice	2011	IF, WB	Mouse		Complement System	Factor B	Antibody	Middle Ear Fluid	item_980
A201	C1q Antibody (monoclonal)	Expression of complement components, receptors and regulators by human dendritic cells	2011	ELISA	Human		Complement System	C1q	Antibody	Dendritic Cell	item_661
A211	C4 (C4c) Antibody (monoclonal)	Expression of complement components, receptors and regulators by human dendritic cells	2011	ELISA	Human		Complement System	C4c	Antibody	Dendritic Cell	item_737
A303	C2 Antibody (Ig Fraction) (polyclonal)	Expression of complement components, receptors and regulators by human dendritic cells	2011	WB	Human		Complement System	C2	Antibody	Monocyte Derived Dendritic Cell	item_918
A311	Factor B Antibody (polyclonal)	Expression of complement components, receptors and regulators by human dendritic cells	2011	WB	Human		Complement System	Factor B	Antibody	Monocyte Derived Dendritic Cell	item_978
A312	Factor H Antibody (polyclonal)	Expression of complement components, receptors and regulators by human dendritic cells	2011	WB	Human		Complement System	Factor H	Antibody	Monocyte Derived Dendritic Cell	item_1009
A313	Factor I Antibody (polyclonal)	Expression of complement components, receptors and regulators by human dendritic cells	2011	WB	Human		Complement System	Factor I	Antibody	Monocyte Derived Dendritic Cell	item_1022
A400	C1q Protein	Expression of complement components, receptors and regulators by human dendritic cells	2011	ELISA	Human		Complement System	C1q	Protein	Dendritic Cell	item_1031
A401	C3 Protein	Expression of complement components, receptors and regulators by human dendritic cells	2011	ELISA	Human		Complement System	C3	Protein	Dendritic Cell	item_1059
A402	C4 Protein	Expression of complement components, receptors and regulators by human dendritic cells	2011	ELISA	Human		Complement System	C4	Protein	Dendritic Cell	item_1073
A215	C4BP Antibody (monoclonal)	Functional recruitment of human complement inhibitor C4B-binding protein to outer membrane protein Rck of Salmonella.	2011	FC	Bacteria		Complement System	C4BP	Antibody	Salmonella enterica	item_757
A001	CIC-C1q EIA	Heightened measures of immune complex and complement function and immune complex-mediated granulocyte activation in human lymphatic filariasis	2011	ELISA	Human	Lymphatic filariasis	Complement System	C1q	ELISA	Plasma	item_216
A018	CH50 Eq EIA	Heightened measures of immune complex and complement function and immune complex-mediated granulocyte activation in human lymphatic filariasis	2011	ELISA	Human	Lymphatic filariasis	Complement System	CH50	ELISA	Plasma	item_274
A020	SC5b-9 Plus EIA	Heightened measures of immune complex and complement function and immune complex-mediated granulocyte activation in human lymphatic filariasis	2011	ELISA	Human	Lymphatic filariasis	Complement System	sC5b-9	ELISA	Plasma	item_341
A027	Bb Plus Fragment EIA	Heightened measures of immune complex and complement function and immune complex-mediated granulocyte activation in human lymphatic filariasis	2011	ELISA	Human	Lymphatic filariasis	Complement System	Bb	ELISA	Plasma	item_457
A111	Normal Human Serum Complement	Human monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activity	2011	CDC Assay	Cell Culture	positive and negative cell lines	Complement System	Normal Human Serum	Reagent	sLea antigen	item_624
A021	C5a EIA	Human pentraxin 3 binds to the complement regulator c4b-binding protein	2011	ELISA	Human		Complement System	C5a	ELISA	Fibroblasts	item_413
A211	C4 (C4c) Antibody (monoclonal)	Human pentraxin 3 binds to the complement regulator c4b-binding protein	2011	FC	Cell Culture		Complement System	C4c	Antibody	Jurkat Cells	item_733
A111	Normal Human Serum Complement	Humanization and characterization of an anti-human TNF-α murine monoclonal antibody.	2011	CDC Assay	Human		Complement System	Normal Human Serum	Reagent	Peripheral blood mononuclear cells	item_640
60-3000	Human PTH ELISA 1 84 Bioactive	Impact of season and diet on vitamin D status of African American and Caucasian children	2011	ELISA	Human		Bone/Renal Health	PTH	ELISA	Serum	item_140
A021	C5a EIA	Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.	2011	ELISA	Human		Complement System	C5a	ELISA	Serum	item_412
A233	Factor P Antibody (monoclonal) #1	Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.	2011	WB	Human		Complement System	Factor P	Antibody	Serum	item_812
A235	Factor P Antibody (monoclonal) #2	Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.	2011	IF, FC	Human		Complement System	Factor P	Antibody	Serum	item_821
A512	Factor P Depleted Sera	Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.	2011	FC	Human		Complement System	Factor P	Depleted Sera	Serum	item_1174
A006	iC3b EIA	Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro	2011	ELISA	Human		Complement System	iC3b	ELISA	Plasma	item_227
A009	C4d Fragment EIA	Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro	2011	ELISA	Human		Complement System	C4d	ELISA	Plasma	item_250
A027	Bb Plus Fragment EIA	Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro	2011	ELISA	Human		Complement System	Bb	ELISA	Plasma	item_456
8005	CICP EIA	Migration Capacity and Viability of Human Primary Osteoblasts in Synthetic Three-dimensional Bone Scaffolds Made of Tricalciumphosphate.	2011	ELISA	Human		Bone/Renal Health	CICP	ELISA	Osteoblasts	item_18
8005	CICP EIA	Modulation of fibroblast inflammatory response by surface modification of a perfluorinated ionomer.	2011	ELISA	N/A		Bone/Renal Health	CICP	ELISA	Nafion	item_22
A706	C6 Antibody (monoclonal) biotin	Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood	2011	ELISA	Human		Complement System	C6	Antibody	Plasma	item_1214
A706	C6 Antibody (monoclonal) biotin	Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humans	2011	ELISA	Human		Complement System	C6	Antibody	Serum	item_1215
A706	C6 Antibody (monoclonal) biotin	Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humans	2011	ELISA	Porcine		Complement System	C6	Antibody	Serum	item_1220
8019	Serum PYD EIA	Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model.	2011	ELISA	Mouse		Bone/Renal Health	PYD	ELISA	Serum	item_76
8033	TRAP5b EIA	Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model.	2011	ELISA	Mouse		Bone/Renal Health	TRAP5b	ELISA	Serum	item_92
8010	PYD EIA	Role of collagen content and cross-linking in large pulmonary arterial stiffening after chronic hypoxia.	2011	ELISA	Mouse		Bone/Renal Health	PYD	ELISA	Artery Tissue	item_49
A211	C4 (C4c) Antibody (monoclonal)	SLE serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production	2011	FC	Human	Systemic Lupus Erythematosus	Complement System	C4c	Antibody	Serum	item_745
8007	DPD EIA	Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function	2011	ELISA	Mouse		Bone/Renal Health	DPD	ELISA	Urine	item_28
A400	C1q Protein	Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection	2011	FC	Human		Complement System	C1q	Protein	Peripheral blood mononuclear cells	item_1040
60-6100	Human FGF-23 C-Term ELISA	Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature	2011	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Serum	item_159
8001	Osteocalcin EIA	Use of small interfering ribonucleic acids to inhibit the adipogenic effect of alcohol on human bone marrow-derived mesenchymal cells.	2011	ELISA	Human				ELISA	Mesenchymal Cells	item_1
A309	C8 Antibody (polyclonal)	Abundant lipid and protein components of drusen.	2010	IF	Human	Drusen	Complement System	C8	Antibody	Eye Tissue	item_959
A312	Factor H Antibody (polyclonal)	Attenuation of renal ischemia and reperfusion injury by human adrenomedullin and its binding protein	2010	WB	Human		Complement System	Factor H	Antibody	Plasma	item_1007
A201	C1q Antibody (monoclonal)	C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production	2010	FC	Human	Apoptosis	Complement System	C1q	Antibody	Neuron Cells	item_667
A201	C1q Antibody (monoclonal)	C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production	2010	FC	Human		Complement System	C1q	Antibody	Neuron Cells	item_668
8012	BAP EIA	Calcium requirements and metabolism in Chinese-American boys and girls.	2010	ELISA	Human		Bone/Renal Health	BAP	ELISA	Serum	item_54
A300	C1-INH Antibody (polyclonal)	Changes in the levels of some acute-phase proteins in human immunodeficiency virus-1 infected patients, following interleukin-2 treatment	2010	Radial immunodiffusion	Human	HIV	Complement System	C1-INH	Antibody	Serum	item_893
A310	C9 Antibody (polyclonal)	Changes in the levels of some acute-phase proteins in human immunodeficiency virus-1 infected patients, following interleukin-2 treatment	2010	Radial immunodiffusion	Human	HIV	Complement System	C9	Antibody	Serum	item_966
21-6120	FGF-23 Ab (C-term 225-244)	Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active	2010	WB	Human		Bone/Renal Health	FGF-23	Antibody	Plasma	item_106
60-6100	Human FGF-23 C-Term ELISA	Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active	2010	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_157
A201	C1q Antibody (monoclonal)	Complement C1q enhances homing-related responses of hematopoietic stem/progenitor cells	2010	FC, WB	Human		Complement System	C1q	Antibody	Hematopoietic stem/progenitor cells	item_672
A400	C1q Protein	Complement C1q enhances homing-related responses of hematopoietic stem/progenitor cells	2010	Chemotaxis Assay	Human		Complement System	C1q	Protein	Hematopoietic stem/progenitor cells	item_1029
A301	C1q Antibody (polyclonal)	Early Involvement of Immune/Inflammatory Response Genes in Retinal Degeneration in DBA/2J Mice	2010	IF	Mouse		Complement System	C1q	Antibody	Microglial Cells	item_904
A700	C1q Antibody (monoclonal) biotin	Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury	2010	ELISA	Mouse		Complement System	C1q	Antibody	Intestinal Lysate	item_1205
A712	Factor B (Bb) Antibody (monoclonal) biotin	Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury	2010	ELISA	Mouse		Complement System	Bb	Antibody	Intestinal Lysate	item_1222
60-6100	Human FGF-23 C-Term ELISA	Evaluation of a Method for Fibroblast Growth factor-23: A Novel Biomarker of Adverse Outcomes in Patients With Renal Disease.	2010	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_147
60-6100	Human FGF-23 C-Term ELISA	Evaluation of a Method for Fibroblast Growth factor-23: A Novel Biomarker of Adverse Outcomes in Patients With Renal Disease.	2010	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Serum	item_148
60-6600	Human FGF-23 (Intact) ELISA	Evaluation of a Method for Fibroblast Growth factor-23: A Novel Biomarker of Adverse Outcomes in Patients With Renal Disease.	2010	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_192
60-6600	Human FGF-23 (Intact) ELISA	Evaluation of a Method for Fibroblast Growth factor-23: A Novel Biomarker of Adverse Outcomes in Patients With Renal Disease.	2010	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Serum	item_193
A215	C4BP Antibody (monoclonal)	Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis.	2010	WB	Borrelia recurrentis		Complement System	C4BP	Antibody	Cell Lysate	item_758
A410	Factor H Protein	Interaction of pneumococcal histidine triad proteins with human complement	2010	ELISA, FC	Bacteria		Complement System	Factor H	Protein	Streptococcus pneumoniae	item_1101
8012	BAP EIA	Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women.	2010	ELISA	Human		Bone/Renal Health	BAP	ELISA	Serum	item_53
A009	C4d Fragment EIA	Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.	2010	ELISA	Human	Breast Cancer	Complement System	C4d	ELISA	Plasma	item_249
A301	C1q Antibody (polyclonal)	Mutations within a human IgG2 antibody form distinct and homogeneous disulfide isomers but do not affect Fc gamma receptor or C1q binding	2010	ELISA	N/A		Complement System	C1q	Antibody	CD44 (coating)	item_907
A400	C1q Protein	Mutations within a human IgG2 antibody form distinct and homogeneous disulfide isomers but do not affect Fc gamma receptor or C1q binding	2010	ELISA	N/A		Complement System	C1q	Protein	CD44 (coating)	item_1049
A018	CH50 Eq EIA	Novel adenovirus vectors 'capsid-displaying' a human complement inhibitor	2010	ELISA	Human, Primate		Complement System	CH50	ELISA	Serum	item_282
A031	C3a Plus EIA	Novel adenovirus vectors 'capsid-displaying' a human complement inhibitor	2010	ELISA	Human, Primate		Complement System	C3a	ELISA	Serum	item_545
A215	C4BP Antibody (monoclonal)	Polyamines can increase resistance of Neisseria gonorrhoeae to mediators of the innate human host defense.	2010	WB	Human	Neisseria gonorrhoeae	Complement System	C4BP	Antibody	Serum	item_763
A249	C8 Antibody (monoclonal)	Polyamines can increase resistance of Neisseria gonorrhoeae to mediators of the innate human host defense.	2010	WB	Human	Neisseria gonorrhoeae	Complement System	C8	Antibody	Serum	item_862
A312	Factor H Antibody (polyclonal)	Resuscitation of uncontrolled traumatic hemorrhage induced by severe liver injury: the use of human adrenomedullin and adrenomedullin binding protein-1	2010	WB	Human		Complement System	Factor H	Antibody	Plasma	item_1008
60-6100	Human FGF-23 C-Term ELISA	The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease	2010	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_158
60-6600	Human FGF-23 (Intact) ELISA	The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease	2010	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_196
8005	CICP EIA	Use of small interfering ribonucleic acids to inhibit the adipogenic effect of alcohol on human bone marrow-derived mesenchymal cells.	2010	ELISA	Human		Bone/Renal Health	CICP	ELISA	Mesenchymal Cells	item_9
A600	CVF, Cobra Venom Factor	Zwitterionic chitosan derivatives for pH-sensitive stealth coating	2010	Complement Activation Assay	Human		Complement System	Cobra Venom Factor	Reagent	Plasma	item_1179
A001	CIC-C1q EIA	Alternative complement pathway deregulation is correlated with dengue severity	2009	ELISA	Human	Dengue	Complement System	C1q	ELISA	Plasma	item_215
A400	C1q Protein	Alternative complement pathway deregulation is correlated with dengue severity	2009	ELISA	Human	Dengue	Complement System	C1q	Protein	Plasma	item_1030
A401	C3 Protein	Alternative complement pathway deregulation is correlated with dengue severity	2009	ELISA	Human	Dengue	Complement System	C3	Protein	Plasma	item_1058
A201	C1q Antibody (monoclonal)	C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells	2009	FC	Human		Complement System	C1q	Antibody	Jurkat Cells	item_666
A241	Clusterin Antibody (monoclonal)	C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function	2009	ELISA	Cell Culture		Complement System	Clusterin	Antibody	HUVECs	item_853
A201	C1q Antibody (monoclonal)	Complement Activation on Platelets Correlates with a Decrease in Circulating Immature Platelets in Patients with Immune Thrombocytopenic Purpura	2009	ELISA	Human		Complement System	C1q	Antibody	Plasma	item_660
A209	iC3b Antibody (monoclonal - neoantigen)	Complement Activation on Platelets Correlates with a Decrease in Circulating Immature Platelets in Patients with Immune Thrombocytopenic Purpura	2009	ELISA	Human		Complement System	iC3b	Antibody	Plasma	item_710
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Complement Activation on Platelets Correlates with a Decrease in Circulating Immature Platelets in Patients with Immune Thrombocytopenic Purpura	2009	ELISA	Human		Complement System	sC5b-9	Antibody	Plasma	item_837
A400	C1q Protein	Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells	2009	IF	Human		Complement System	C1q	Protein	Prostate Tissue	item_1042
A502	C6 Depleted Sera	Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells	2009	WB	Cell Culture		Complement System	C6	Depleted Sera	DU-145 Cells	item_1131
A503	C7 Depleted Sera	Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells	2009	WB	Cell Culture		Complement System	C7	Depleted Sera	DU-145 Cells	item_1136
A504	C8 Depleted Sera	Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells	2009	WB	Cell Culture		Complement System	C7	Depleted Sera	DU-145 Cells	item_1138
A505	C9 Depleted Sera	Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells	2009	WB	Cell Culture		Complement System	C8	Depleted Sera	DU-145 Cells	item_1141
A509	C1q Depleted Sera	Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells	2009	WB	Cell Culture		Complement System	C1q	Depleted Sera	DU-145 Cells	item_1159
A006	iC3b EIA	Complement activation by bisretinoid constituents of RPE lipofuscin.	2009	ELISA	Human		Complement System	iC3b	ELISA	Serum	item_226
A506	Factor B Depleted Sera	Complement activation by bisretinoid constituents of RPE lipofuscin.	2009	ELISA	Human		Complement System	Factor B	Depleted Sera	Serum	item_1146
A509	C1q Depleted Sera	Complement activation by bisretinoid constituents of RPE lipofuscin.	2009	ELISA	Human		Complement System	C1q	Depleted Sera	Serum	item_1164
A309	C8 Antibody (polyclonal)	Complement membrane attack complex formation and infectivity of Trichinella spiralis and T. nativa in rats.	2009	IF, IHC	Mouse	Trichinella spiralis	Complement System	C8	Antibody	Muscle	item_961
A310	C9 Antibody (polyclonal)	Complement membrane attack complex formation and infectivity of Trichinella spiralis and T. nativa in rats.	2009	IF, IHC	Mouse	Trichinella spiralis	Complement System	C9	Antibody	Muscle	item_968
A600	CVF, Cobra Venom Factor	Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production	2009	Complement Depletion Assay	Mouse		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1188
60-6100	Human FGF-23 C-Term ELISA	Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis	2009	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	HEK293 cells	item_155
60-6100	Human FGF-23 C-Term ELISA	Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis	2009	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_156
60-6600	Human FGF-23 (Intact) ELISA	Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis	2009	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_195
60-6100	Human FGF-23 C-Term ELISA	Determination of fibroblast growth factor 23	2009	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Plasma	item_154
A312	Factor H Antibody (polyclonal)	Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase.	2009	WB	Mouse		Complement System	Factor H	Antibody	Serum	item_1014
A600	CVF, Cobra Venom Factor	Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles	2009	Complement Activation Assay	Human	Gold Nanoparticles incubated	Complement System	Cobra Venom Factor	Reagent	Plasma	item_1178
A400	C1q Protein	Local inflammation induces complement crosstalk which amplifies the antimicrobial response	2009	ELISA	N/A		Complement System	C1q	Protein	C1q Protein	item_1048
A600	CVF, Cobra Venom Factor	Natural antibody to conserved targets of Haemophilus influenzae limits colonization of the murine nasopharynx	2009	Complement Depletion Assay	Mouse		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1187
A020	SC5b-9 Plus EIA	Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury	2009	ELISA	Human		Complement System	sC5b-9	ELISA	ARPE-19 Cells	item_339
A111	Normal Human Serum Complement	Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury	2009	TER Measurements	Human		Complement System	Normal Human Serum	Reagent	ARPE-19 Cells	item_651
A405	C7 Protein	Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury	2009	TER Measurements	Human		Complement System	C7	Protein	ARPE-19 Cells	item_1090
A503	C7 Depleted Sera	Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury	2009	TER Measurements	Human		Complement System	C7	Depleted Sera	ARPE-19 Cells	item_1137
8010	PYD EIA	Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatment.	2009	ELISA	Mouse		Bone/Renal Health	PYD	ELISA	Urine	item_48
A312	Factor H Antibody (polyclonal)	Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation	2009	ELISA	N/A	SLRP	Complement System	Factor H	Antibody	Purified protein	item_1017
A509	C1q Depleted Sera	Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation	2009	ELISA	N/A	SLRP	Complement System	C1q	Depleted Sera	Purified protein	item_1172
A308	C7 Antibody (polyclonal)	Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS	2009	Radial immunodiffusion	Human		Complement System	C7	Antibody	Plasma	item_954
A308	C7 Antibody (polyclonal)	Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS	2009	Radial immunodiffusion	Human		Complement System	C7	Antibody	Serum	item_955
A501	C5 Depleted Sera	Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement	2009	Complement Activation Assay	Cell Culture		Complement System	C5	Depleted Sera	Vero E6 cells	item_1126
A508	C3 Depleted Sera	Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement	2009	Complement Activation Assay	Cell Culture		Complement System	C3	Depleted Sera	Vero E6 cells	item_1151
A509	C1q Depleted Sera	Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement	2009	Complement Activation Assay	Cell Culture		Complement System	C1q	Depleted Sera	Vero E6 cells	item_1156
A237	Vitronectin Antibody (monoclonal)	A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity.	2008	ELISA	N/A		Complement System	Vitronectin	Antibody	Recombinant protein	item_825
A111	Normal Human Serum Complement	Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action	2008	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	Daudi Cells	item_622
A111	Normal Human Serum Complement	Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action	2008	CDC Assay	Cell Culture		Complement System	Normal Human Serum	Reagent	Ramos Cells	item_623
A221	C7 Antibody (monoclonal)	Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury.	2008	FC, IF	Rat		Complement System	C7	Antibody	Spinal Cord Tissue	item_783
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury.	2008	FC, IF	Rat		Complement System	sC5b-9	Antibody	Spinal Cord Tissue	item_851
A201	C1q Antibody (monoclonal)	Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium	2008	ELISA, FC	Human	DEC, UtMEC, ADMEC, HUVEC	Complement System	C1q	Antibody	Endothelial Cells	item_665
A211	C4 (C4c) Antibody (monoclonal)	Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium	2008	IHC	Human		Complement System	C4c	Antibody	Endothelium Tissue	item_746
A304	C3 Antibody (polyclonal)	Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium	2008	IHC	Human		Complement System	C3	Antibody	Decidual Endothelial Cells	item_928
A400	C1q Protein	Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium	2008	WB	Human		Complement System	C1q	Protein	Purified protein	item_1044
A037	C1-lnhibitor Plus EIA	Depressed activation of the lectin pathway of complement in hereditary angioedema	2008	ELISA	Human	Hereditary Angioedema	Complement System	C1-INH	ELISA	Serum	item_606
A241	Clusterin Antibody (monoclonal)	Expression of a Mutant Form of the Ferritin Light Chain Gene Induces Neurodegeneration and Iron Overload in Transgenic Mice	2008	IHC	Mouse	Neurodegeneration	Complement System	Clusterin	Antibody	Brain Tissue	item_857
A313	Factor I Antibody (polyclonal)	Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice	2008	WB	Mouse		Complement System	Factor I	Antibody	Serum	item_1023
A009	C4d Fragment EIA	Floridoside Extracted From the Red Alga Mastocarpus Stellatus Is a Potent Activator of the Classical Complement Pathway.	2008	ELISA	Human	Floridoside incubated	Complement System	C4d	ELISA	Serum	item_236
A121	Guinea Pig Serum Complement	Floridoside Extracted From the Red Alga Mastocarpus Stellatus Is a Potent Activator of the Classical Complement Pathway.	2008	Complement Activation Assay	Human	Floridoside incubated	Complement System	Guinea Pig Serum	Reagent	Serum	item_654
A400	C1q Protein	Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment	2008	ELISA	Hamster	pEE-QuVHVL Transfected	Complement System	C1q	Protein	CHO Cells	item_1027
A312	Factor H Antibody (polyclonal)	Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein	2008	FC, IF	Human	Aspergillus incubated	Complement System	Factor H	Antibody	Plasma	item_1002
A600	CVF, Cobra Venom Factor	Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV	2008	Complement Depletion Assay	Mouse		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1186
A211	C4 (C4c) Antibody (monoclonal)	Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome	2008	FC	Hamster	MCP Transfected	Complement System	C4c	Antibody	CHO Cells	item_736
A209	iC3b Antibody (monoclonal - neoantigen)	Plaque complement activation and cognitive loss in Alzheimer’s disease.	2008	ICC, IHC	Human		Complement System	iC3b	Antibody	Brain Tissue	item_721
A310	C9 Antibody (polyclonal)	Plaque complement activation and cognitive loss in Alzheimer’s disease.	2008	ICC, IHC	Human		Complement System	C9	Antibody	Brain Tissue	item_965
A400	C1q Protein	Structural characterization of a human Fc fragment engineered for lack of effector functions	2008	ELISA	N/A		Complement System	C1q	Protein	C1q Protein	item_1047
A239	sC5b-9 Antibody (monoclonal - neoantigen)	The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro	2008	IF	Human		Complement System	sC5b-9	Antibody	Placenta Tissue	item_841
A304	C3 Antibody (polyclonal)	Variability and action mechanism of a family of anticomplement proteins in Ixodes ricinus	2008	ELISA	Human	Ixodes ricinus incubated	Complement System	C3	Antibody	Serum	item_922
A311	Factor B Antibody (polyclonal)	Variability and action mechanism of a family of anticomplement proteins in Ixodes ricinus	2008	ELISA, WB	Human	Ixodes ricinus incubated	Complement System	Factor B	Antibody	Red Blood Cells	item_975
60-2500	Rat PTH ELISA	Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells	2007	ELISA	Rat		Bone/Renal Health	PTH	ELISA	Serum	item_130
A211	C4 (C4c) Antibody (monoclonal)	Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistance	2007	FC	Human	Neisseria gonorrhoeae	Complement System	C4c	Antibody	Serum	item_744
A227	Factor B (Bb) Antibody (monoclonal)	Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistance	2007	ELISA	Human	Neisseria gonorrhoeae	Complement System	Bb	Antibody	Serum	item_792
A209	iC3b Antibody (monoclonal - neoantigen)	Pneumolysin, PspA, and PspC Contribute to Pneumococcal Evasion of Early Innate Immune Responses During Bacteremia in Mice.	2007	WB	Bacteria		Complement System	iC3b	Antibody	Pneumococci	item_707
A312	Factor H Antibody (polyclonal)	Pro-inflammatory cytokines from Kupffer cells downregulate hepatocyte expression of adrenomedullin binding protein-1	2007	WB	Rat		Complement System	Factor H	Antibody	Hepatocytes	item_1018
A312	Factor H Antibody (polyclonal)	Pro-inflammatory cytokines from Kupffer cells downregulate hepatocyte expression of adrenomedullin binding protein-1	2007	WB	Rat		Complement System	Factor H	Antibody	Kupffer cells	item_1019
A211	C4 (C4c) Antibody (monoclonal)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	FC	Human	Moraxella catarrhalis	Complement System	C4c	Antibody	Serum	item_742
A211	C4 (C4c) Antibody (monoclonal)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	FC	Human	Neisseria gonorrhoeae	Complement System	C4c	Antibody	Serum	item_743
A213	C4 (C4d) Antibody (monoclonal)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	FC	Human	Moraxella catarrhalis	Complement System	C4d	Antibody	Serum	item_749
A213	C4 (C4d) Antibody (monoclonal)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	FC	Human	Neisseria gonorrhoeae	Complement System	C4d	Antibody	Serum	item_750
A215	C4BP Antibody (monoclonal)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	FC	Human	Moraxella catarrhalis	Complement System	C4BP	Antibody	Serum	item_760
A215	C4BP Antibody (monoclonal)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	FC	Human	Neisseria gonorrhoeae	Complement System	C4BP	Antibody	Serum	item_761
A237	Vitronectin Antibody (monoclonal)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	WB	Human	Moraxella catarrhalis	Complement System	Vitronectin	Antibody	Serum	item_824
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	WB	Human	Moraxella catarrhalis	Complement System	sC5b-9	Antibody	Serum	item_849
A301	C1q Antibody (polyclonal)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	WB	Human	Moraxella catarrhalis	Complement System	C1q	Antibody	Serum	item_903
A304	C3 Antibody (polyclonal)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	FC, WB	Human	Moraxella catarrhalis	Complement System	C3	Antibody	Serum	item_923
A305	C4 Antibody (polyclonal)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	WB	Human	Moraxella catarrhalis	Complement System	C4	Antibody	Serum	item_933
A308	C7 Antibody (polyclonal)	Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade	2006	WB	Human	Moraxella catarrhalis	Complement System	C7	Antibody	Serum	item_956
A209	iC3b Antibody (monoclonal - neoantigen)	Complement activation in the Parkinson’s disease substantia nigra: an immunocytochemical study.	2006	ICC, IHC	Human		Complement System	iC3b	Antibody	Brain Tissue	item_720
A310	C9 Antibody (polyclonal)	Complement activation in the Parkinson’s disease substantia nigra: an immunocytochemical study.	2006	ICC, IHC	Human		Complement System	C9	Antibody	Brain Tissue	item_964
A303	C2 Antibody (Ig Fraction) (polyclonal)	Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions	2006	WB	Human		Complement System	C2	Antibody	Serum	item_917
A111	Normal Human Serum Complement	Engineered antibody Fc variants with enhanced effector function	2006	CDC Assay	Human	Rituximab	Complement System	Normal Human Serum	Reagent	WIL2-S cells	item_638
A229	Factor H Antibody (monoclonal)	LfhA, a novel factor H-binding protein of Leptospira interrogans	2006	IF, WB	Bacteria		Complement System	Factor H	Antibody	Leptospira interrogans	item_797
A305	C4 Antibody (polyclonal)	Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation	2006	WB	Human	Escherichia coli incubated	Complement System	C4	Antibody	Serum	item_934
A237	Vitronectin Antibody (monoclonal)	Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC)	2006	ELISA	Human	Systemic Lupus Erythematosus	Complement System	Vitronectin	Antibody	Serum	item_823
A241	Clusterin Antibody (monoclonal)	Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC)	2006	ELISA	Human	Systemic Lupus Erythematosus	Complement System	Clusterin	Antibody	Serum	item_855
A400	C1q Protein	Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC)	2006	ELISA	N/A	Standard curve generation	Complement System	C1q	Protein	Purified protein	item_1046
A401	C3 Protein	Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC)	2006	ELISA	N/A	Standard curve generation	Complement System	C3	Protein	Purified protein	item_1067
A402	C4 Protein	Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC)	2006	ELISA	N/A	Standard curve generation	Complement System	C4	Protein	Purified protein	item_1075
A410	Factor H Protein	Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family	2006	ELISA	Human		Complement System	Factor H	Protein	Plasma	item_1104
A411	Factor I Protein	Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family	2006	ELISA	Human		Complement System	Factor I	Protein	Plasma	item_1112
A203	C1q Antibody (monoclonal)	Structural transitions of complement component C3 and its activation products	2006	Electron Microscopy	Human		Complement System	C1q	Antibody	Purified protein	item_679
8005	CICP EIA	The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein.	2006	ELISA	Human		Bone/Renal Health	CICP	ELISA	Osteoblasts	item_8
A201	C1q Antibody (monoclonal)	Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain.	2005	IHC	Rhesus Monkey		Complement System	C1q	Antibody	Brain Tissue	item_677
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain.	2005	IHC	Rhesus Monkey		Complement System	sC5b-9	Antibody	Brain Tissue	item_852
A250	C3d Antibody (monoclonal - neoantigen)	Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain.	2005	IHC	Rhesus Monkey		Complement System	C3d	Antibody	Brain Tissue	item_867
A251	C4d Antibody (monoclonal - neoantigen)	Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain.	2005	IHC	Rhesus Monkey		Complement System	C4d	Antibody	Brain Tissue	item_870
A306	C5 Antibody (polyclonal)	Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain.	2005	IHC	Rhesus Monkey		Complement System	C5	Antibody	Brain Tissue	item_948
A310	C9 Antibody (polyclonal)	Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain.	2005	IHC	Rhesus Monkey		Complement System	C9	Antibody	Brain Tissue	item_969
60-3100	Human PTH ELISA	Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease	2005	ELISA	Human		Bone/Renal Health	PTH	ELISA	Serum	item_143
60-6100	Human FGF-23 C-Term ELISA	Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease	2005	ELISA	Human		Bone/Renal Health	FGF-23	ELISA	Serum	item_153
A215	C4BP Antibody (monoclonal)	Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding	2005	WB	Human	Haemophilus ducreyi incubated	Complement System	C4BP	Antibody	Serum	item_764
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding	2005	Radiation Immunoassay	Human	Haemophilus ducreyi incubated	Complement System	sC5b-9	Antibody	Serum	item_848
A600	CVF, Cobra Venom Factor	The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces	2005	Complement Depletion Assay	Mouse		Complement System	Cobra Venom Factor	Reagent	Protein Injection	item_1185
A300	C1-INH Antibody (polyclonal)	Human oligodendroglial cells express low levels of C1 inhibitor and membrane cofactor protein mRNAs	2004	IF	Human		Complement System	C1-INH	Antibody	Astrocyte cells	item_890
A300	C1-INH Antibody (polyclonal)	Human oligodendroglial cells express low levels of C1 inhibitor and membrane cofactor protein mRNAs	2004	IF	Human		Complement System	C1-INH	Antibody	Microglial Cells	item_891
A300	C1-INH Antibody (polyclonal)	Human oligodendroglial cells express low levels of C1 inhibitor and membrane cofactor protein mRNAs	2004	IF	Human		Complement System	C1-INH	Antibody	Oligodendrocyte cells	item_892
60-2500	Rat PTH ELISA	Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl	2004	ELISA	Cell Culture		Bone/Renal Health	PTH	ELISA	HEK 293 4.0-7 cells	item_129
A207	C3 (C3d) Antibody (monoclonal)	Evasion of Phagocytosis through Cooperation between Two Ligand-binding Regions in Streptococcus pyogenes M Protein.	2003	FC	Human	S. pyrogenes incubated	Complement System	C3d	Antibody	Serum	item_701
A211	C4 (C4c) Antibody (monoclonal)	Evasion of Phagocytosis through Cooperation between Two Ligand-binding Regions in Streptococcus pyogenes M Protein.	2003	FC	Human	S. pyrogenes incubated	Complement System	C4c	Antibody	Serum	item_741
A213	C4 (C4d) Antibody (monoclonal)	Evasion of Phagocytosis through Cooperation between Two Ligand-binding Regions in Streptococcus pyogenes M Protein.	2003	FC	Human	S. pyrogenes incubated	Complement System	C4d	Antibody	Serum	item_748
A241	Clusterin Antibody (monoclonal)	Transcript profiling of human platelets using microarray and serial analysis of gene expression	2003	WB	Human		Complement System	Clusterin	Antibody	Platelets	item_856
A027	Bb Plus Fragment EIA	Complement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligodeoxynucleotide	2002	ELISA	Rhesus Monkey		Complement System	Bb	ELISA	Serum	item_481
A031	C3a Plus EIA	Complement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligodeoxynucleotide	2002	ELISA	Rhesus Monkey		Complement System	C3a	ELISA	Serum	item_547
A035	C4a Fragment EIA	Complement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligodeoxynucleotide	2002	ELISA	Rhesus Monkey		Complement System	C4a	ELISA	Serum	item_597
A209	iC3b Antibody (monoclonal - neoantigen)	Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7.	2002	Confocal Microscopy	Cell Culture		Complement System	iC3b	Antibody	Jurkat Cells	item_708
A205	C3 (C3c) Antibody (monoclonal)	Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells	2002	FC	Hamster	MCP Transfected	Complement System	C3c	Antibody	CHO Cells	item_692
A211	C4 (C4c) Antibody (monoclonal)	Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells	2002	FC	Hamster	MCP Transfected	Complement System	C4c	Antibody	CHO Cells	item_735
A217	C5 Antibody (monoclonal)	Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells	2002	FC	Hamster	MCP Transfected	Complement System	C5	Antibody	CHO Cells	item_766
A211	C4 (C4c) Antibody (monoclonal)	Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae	2001	FC	Human	Neisseria gonorrhoeae	Complement System	C4c	Antibody	Serum	item_740
A215	C4BP Antibody (monoclonal)	Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae	2001	FC	Human	Neisseria gonorrhoeae	Complement System	C4BP	Antibody	Serum	item_759
A223	C9 Antibody (monoclonal)	Deficiency of Complement Defense Protein CD59 May Contribute to Neurodegeneration in Alzheimer's Disease	2000	ELISA	Human	Alzheimer's	Complement System	C9	Antibody	Brain Tissue	item_786
A027	Bb Plus Fragment EIA	Evidence for activation of the alternative complement pathway in patients with juvenile rheumatoid arthritis	2000	ELISA	Human	Rheumatoid Arthritis	Complement System	Bb	ELISA	Plasma	item_454
A209	iC3b Antibody (monoclonal - neoantigen)	Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.	2000	IHC	Human	Fetal	Complement System	iC3b	Antibody	Brain Tissue	item_723
A223	C9 Antibody (monoclonal)	Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion	1999	IHC	Human	Otitis Media with Effusion	Complement System	C9	Antibody	Middle Ear Mucosa Tissue	item_785
A310	C9 Antibody (polyclonal)	Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion	1999	IHC	Human	Otitis Media with Effusion	Complement System	C9	Antibody	Middle Ear Mucosa Tissue	item_967
A203	C1q Antibody (monoclonal)	Neutrophils from Patients with Advanced Human Immunodeficiency Virus Infection Have Impaired Complement Receptor Function and Preserved FcÎ³ Receptor Function	1999	ELISA	Purified Protein	HIV	Complement System	C1q	Antibody	Purified Protein	item_681
A306	C5 Antibody (polyclonal)	Neutrophils from Patients with Advanced Human Immunodeficiency Virus Infection Have Impaired Complement Receptor Function and Preserved FcÎ³ Receptor Function	1999	ELISA	Purified Protein	HIV	Complement System	C5	Antibody	Purified Protein	item_947
A252	Bb Antibody (monoclonal - neoantigen)	A Novel Sialic Acid Binding Site on Factor H Mediates Serum Resistance of Sialylated Neisseria gonorrhoeae	1998	ELISA	Human		Complement System	Bb	Antibody	Serum	item_872
A252	Bb Antibody (monoclonal - neoantigen)	A conserved element in the serine protease domain of complement factor B.	1998	ELISA, WB	Cell Culture		Complement System	Bb	Antibody	COS-7 Cells	item_871
A209	iC3b Antibody (monoclonal - neoantigen)	Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide.	1998	ELISA	Human		Complement System	iC3b	Antibody	Amyloid-βeta peptides & NHS	item_715
A239	sC5b-9 Antibody (monoclonal - neoantigen)	Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide.	1998	ELISA	Human		Complement System	sC5b-9	Antibody	Amyloid-βeta peptides & NHS	item_839
A203	C1q Antibody (monoclonal)	Involvement of C3a and C5a in Interleukin-8 Secretion by Human Polymorphonuclear Cells in Response to Capsular Material of Cryptococcus neoformans.	1998	Complement Activation Assay	Human	Cryptococcus neoformans	Complement System	C1q	Antibody	Polymorphonuclear Cells	item_678
A306	C5 Antibody (polyclonal)	Involvement of C3a and C5a in Interleukin-8 Secretion by Human Polymorphonuclear Cells in Response to Capsular Material of Cryptococcus neoformans.	1998	Complement Activation Assay	Human	Cryptococcus neoformans	Complement System	C5	Antibody	Polymorphonuclear Cells	item_937
A027	Bb Plus Fragment EIA	Effects of Synthetic Oligonucleotides on human complement and coagulation	1997	ELISA	Human		Complement System	Bb	ELISA	Plasma	item_478
A009	C4d Fragment EIA	Sensitivity and Specificity of plasma and urine complement split products as indicators of lupus disease activity	1996	ELISA	Human	Systemic Lupus Erythematosus	Complement System	C4d	ELISA	Plasma	item_264
A020	SC5b-9 Plus EIA	Sensitivity and Specificity of plasma and urine complement split products as indicators of lupus disease activity	1996	ELISA	Human	Systemic Lupus Erythematosus	Complement System	sC5b-9	ELISA	Plasma	item_371
A027	Bb Plus Fragment EIA	Sensitivity and Specificity of plasma and urine complement split products as indicators of lupus disease activity	1996	ELISA	Human	Systemic Lupus Erythematosus	Complement System	Bb	ELISA	Plasma	item_477
A401	C3 Protein	Sensitivity and Specificity of plasma and urine complement split products as indicators of lupus disease activity	1996	WB	N/A		Complement System	C3	Protein	C3 Protein	item_1069
A009	C4d Fragment EIA	Complement activation during painful crisis in sickle cell anemia	1995	ELISA	Human	Sickel Cell Anemia	Complement System	C4d	ELISA	Plasma	item_263
A027	Bb Plus Fragment EIA	Complement activation during painful crisis in sickle cell anemia	1995	ELISA	Human	Sickel Cell Anemia	Complement System	Bb	ELISA	Plasma	item_475
A031	C3a Plus EIA	Complement activation during painful crisis in sickle cell anemia	1995	ELISA	Human	Sickel Cell Anemia	Complement System	C3a	ELISA	Plasma	item_541
A027	Bb Plus Fragment EIA	Complement activation and immune complexes in children with polyarticular juvenile rhuematoid arthritis: a longitudinal study	1994	ELISA	Human	Rheumatoid Arthritis	Complement System	Bb	ELISA	Plasma	item_476
A027	Bb Plus Fragment EIA	Assessment of Disease activity and impending flare in patients with systemic lupus erythematosis	1992	ELISA	Human	Systemic Lupus Erythematosus	Complement System	Bb	ELISA	Plasma	item_455
A207	C3 (C3d) Antibody (monoclonal)	Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism	1992	FC	Cell Culture	MCP Transfected	Complement System	C3d	Antibody	NIH/3T3 Cells	item_698
A502	C6 Depleted Sera	Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism	1992	FC	Cell Culture	MCP Transfected	Complement System	C6	Depleted Sera	NIH/3T3 Cells	item_1130